import{_ as v}from"./TableOfContents.b53ff9d3.js";import{_ as j}from"./client-only.4d90d418.js";import k from"./Icon.8c43bd88.js";import{_ as f}from"./ContentImage.9264c351.js";import{_ as g}from"./CardInfo.6b0ba685.js";import{_ as b,o,c as u,b as t,w as s,a as e,d as a,h as i,f as x,g as w,i as p}from"./entry.8eaf72fd.js";import"./useUserPreferences.abd3a4f8.js";import"./config.e42eccbf.js";const q={},V={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},S={class:"e-article",lang:"et",style:{hyphens:"auto"}},A=e("h1",{class:"mb-0"},"Viirused",-1),I=e("h5",{class:"font-normal uppercase leading-tight"},"Viirused: teadusinfo",-1),M={id:"s1"},D=e("h2",{id:"s1t"},"1. Viirused versus bakterid",-1),C=e("p",{class:"font-bold"}," Bakterid ja viirused v√µivad p√µhjustada paljusid tuntud nakkushaigusi. Kuid millised on erinevused nende kahe nakkusetekitaja vahel? ",-1),O=e("p",null,[e("span",{class:"e-term font-Heading"},"Bakterid"),a(" on √ºliv√§ikesed mikroorganismid, mis koosnevad √ºhest rakust. Nad on v√§ga mitmekesised ja v√µivad olla erineva kuju ja struktuuriga.Bakterid v√µivad elada peaaegu igas m√µeldavas keskkonnas, sealhulgas inimkehas v√µi selle pinnal, kuid vaid k√§put√§is baktereid p√µhjustab inimestel infektsioone. Neid baktereid nimetatakse "),e("i",null,"patogeenseteks"),a(".")],-1),z=e("p",null,[e("span",{class:"e-term font-Heading"},"Viirused"),a(" on isegi v√§iksemad kui bakterid. Nagu bakterid, on nad v√§ga mitmekesised ning erineva kuju ja tunnustega. Viirused on parasiidid. See t√§hendab, et nad vajavad kasvamiseks elusaid rakke v√µi kudesid. Viirused v√µivad tungida keharakkudesse, kasutades rakkude komponente kasvamiseks ja paljunemiseks. M√µned viirused tapavad peremeesrakke oma eluts√ºkli osana. Erinevused viiruste ja bakterite vahel on n√§ha joonisel 1 ja tabelis 1.")],-1),F=e("b",null,"Joonis 1.",-1),N=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabel 1.</b> Erinevused bakterite ja viiruste vahel</caption><thead><tr><th></th><th>Bakterid</th><th>Viirused</th></tr></thead><tbody><tr><th class="align-baseline"> Elus v√µi eluta? </th><td><b>Elusorganism.</b><br> Bakterid on elusorganismid, mis koosnevad √ºhest rakust, mis suudab toota energiat, teha ise toitu, liikuda ja paljuneda (tavaliselt jagunemise teel). See v√µimaldab bakteritel elada paljudes kohtades ‚Äì pinnases, vees, taimedes ja inimkehas ‚Äì ning teenida mitmeid eesm√§rke. <br> Bakterite hulka kuuluvad nii parasiidid kui ka mitteparasiidid. </td><td><b>Elusa ja eluta looduse piirimail.</b><br>Viirused kasvavad ja paljunevad ainult peremeesrakkudes, mida nad nakatavad. V√§ljaspool neid elusrakke leiduvad viirused on uinuvad. Nende &quot;elu&quot; n√µuab seet√µttu elusraku biokeemilise tegevuse √ºlev√µtmist.<br>K√µik viirused on rakusisesed parasiidid. </td></tr><tr><th class="align-baseline">Rakulisus</th><td>Koosneb √ºhest rakust.</td><td>Ei koosne rakkudest.</td></tr><tr><th class="align-baseline">Paljunemine</th><td>Jaguneb kaheks</td><td>Tungib peremeesrakku ja v√µtab raku √ºle, p√µhjustades viiruse DNA/RNA koopiate tegemise. H√§vitab peremeesraku, vabastades uusi viirusi.</td></tr><tr><th class="align-baseline">Suurus</th><td>Bakterid on palju suuremad, nende suurus j√§√§b vahemikku 800 nm kuni 1000 nm. Baktereid saab n√§ha valgusmikroskoobi abil.</td><td>Viiruste suurus on vahemikus 20 nm kuni 400 nm. Viirused on n√§htavad ainult elektronmikroskoobi all.</td></tr><tr><th class="align-baseline">Kasu</th><td>Paljud bakterid on kasulikud. N: teatud bakterid on vajalikud soolestikus.</td><td>Viirused ei ole √ºldjuhul kasulikud, kuid leiavad rakendust geenitehnoloogias.</td></tr><tr><th class="align-baseline">Infektsioon</th><td>Bakteriaalne infektsioon piirdub tavaliselt m√µne kehaosaga, mida kirjeldatakse kui lokaliseeritud infektsiooni. Infektsioonid v√µivad olla p√µhjustatud bakteritest v√µi bakterite poolt toodetud toksiinidest (endotoksiinidest).</td><td>Viirusinfektsioon on s√ºsteemne. Viirused nakatavad peremeesrakku ja paljunevad seej√§rel tuhandetes, lahkudes peremeesrakust ja nakatades teisi keharakke.</td></tr><tr><th class="align-baseline">Haigus</th><td>Bakteriaalsete haiguste hulka kuuluvad kopsup√µletik, tuberkuloos, teetanus ja toidum√ºrgitus.</td><td>Viirusinfektsioonist p√µhjustatud s√ºsteemsete haiguste hulka kuuluvad gripp, leetrid, lastehalvatus, AIDS ja COVID-19.</td></tr><tr><th class="align-baseline">Ravi</th><td>Antibiootikumid, ennetavad vaktsiinid.</td><td>Vaktsiinid takistavad levikut ja viirusevastased ravimid aitavad paljunemist aeglustada, kuid ei suuda seda t√§ielikult peatada.</td></tr></tbody></table>',1),P=e("b",null,"Antibiootikumid",-1),$=e("b",null,"Viirusevastased ravimid",-1),B=e("b",null,"Immuuns√ºsteem",-1),T=i('<section class="e-card"><h4 class="mt-4">Viited</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/" target="_blank" rel="noopener noreferrer">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16" target="_blank" rel="noopener noreferrer">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="http://www.hcrowder.com/disease-reading.html" target="_blank" rel="noopener noreferrer"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>',1),E=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Miks antibiootikumid ei tapa viiruseid?</h2><p> Antibiootikumid ei saa tappa viirusi, kuna viirustel on teistsugune struktuur ja paljunemine kui bakteritel. Antibiootikumid avaldavad toimet bakterite (mitte viiruste) kasvumehhanismidele, et tappa v√µi p√§rssida konkreetseid baktereid. </p><p> Veelgi enam, antibiootikumide √ºlekasutamine v√µi eba√µige kasutamine on tekitanud √ºlemaailmse tervishoiuprobleemi, nn <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiootikumiresistentsuse</a>. Vaata tabelist 2, millistel juhtudel v√µivad antibiootikumid abiks olla ja millistel mitte (NB! otsuse antibiootikumi kasutamise kohta teeb igal juhul arst). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabel 2.</b> Vajadus antibiootikumide j√§rele √ºlemiste hingamisteede nakkushaiguste korral </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respi¬≠ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>anti¬≠biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Source: <a href="https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</a></p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),R={id:"s3"},H=e("h2",{id:"s3t"},"3. Kuidas vaktsiinid toimivad",-1),W=e("h3",null,"Organismi loomulik vastus",-1),K=e("p",null,[e("span",{class:"e-term font-Heading"},"Patogeen"),a(" on bakter, viirus, parasiit v√µi seen, mis v√µib p√µhjustada organismis haigusi. Iga patogeen koosneb mitmest osast, mis on tavaliselt konkreetsele patogeenile ainulaadsed. Patogeeni osa, mis p√µhjustab antikehade moodustumist, nimetatakse antigeeniks. Patogeeni antigeenile vastuseks toodetud antikehad on immuuns√ºsteemi oluline osa. Antikehi v√µib pidada seet√µtt keha kaitses√ºsteemi ‚Äús√µduriteks‚Äù. Iga meie immuuns√ºsteemi antikeha on ‚Äúkoolitatud‚Äù √§ra tundma √ºhte kindlat antigeeni. Meie kehas on tuhandeid erinevaid antikehi. Kui inimkeha puutub esimest korda kokku antigeeniga, kulub immuuns√ºsteemil aega, et reageerida ja toota antigeenile spetsiifilisi antikehi (Joonis 2). ")],-1),Y=e("p",null," Kui antigeenspetsiifilised antikehad on toodetud, t√∂√∂tavad nad koos √ºlej√§√§nud immuuns√ºsteemiga patogeeni h√§vitamiseks ja haiguse peatamiseks. √úhe patogeeni vastased antikehad ei kaitse √ºldiselt teise patogeeni eest, v√§lja arvatud juhul, kui kaks patogeeni on √ºksteisega v√§ga sarnased. Kui keha toodab antikehi oma esmase vastusena antigeenile, loob see ka antikehi tootvad m√§lurakud, mis j√§√§vad ellu ka p√§rast seda, kui antikehad patogeeni h√§vitavad. Kui keha puutub sama patogeeniga kokku rohkem kui √ºks kord, on antikeha vastus palju kiirem ja t√µhusam kui esimesel korral, kuna m√§lurakkude abil toodetakse kiiresti selle antigeeni vastaseid antikehi. See t√§hendab, et kui inimene puutub tulevikus kokku ohtliku patogeeniga, suudab tema immuuns√ºsteem koheselt reageerida, kaitstes teda haiguste eest. ",-1),U=e("b",null,"Joonis 2.",-1),J=e("h3",null,"Mil moel vaktsiinid toimivad?",-1),L=e("p",null," Vaktsiinid v√§hendavad haigestumisriski, aktiveerides keha loomulikud kaitsemehhanismid. ",-1),G=e("p",null," Vaktsiinid sisaldavad teatud antigeeni n√µrgestatud v√µi mitteaktiivseid osi, mis k√§ivitavad organismis immuunvastuse (Joonis 3). Uuemad vaktsiinid sisaldavad pigem antigeenide tootmise ‚Äújuhiseid‚Äù kui antigeeni ennast. Olenemata sellest, kas vaktsiin koosneb antigeenist endast v√µi juhistest, et organism hakkaks antigeeni (N: viiruse √ºhte valku) tootma, ei p√µhjusta see inimesel haigust, vaid paneb tema immuuns√ºsteemi sellele reageerima, nagu oleks see esmane reaktsioon tegelikule patogeenile. ",-1),Q=e("b",null,"Joonis 3.",-1),X=i('<p> Kui keha on juba viirusega kokku puutunud ja viirusele immuunvastuse andnud (tootes B- ja T-rakud), salvestab see B- ja T-rakud, nii et kui sama viirus v√µi bakter kunagi uuesti keha nakatab, asub immuuns√ºsteem kaitsele, et v√§ltida haigestumist patogeeniga. </p><h3> Vaktsineerimine ja sellega seotud v√§ljakutsed </h3><p> Meil ‚Äã‚Äãon olemas vaktsiinid enam kui 20 eluohtliku haiguse ennetamiseks, aidates igas vanuses inimestel elada kauem ja tervemalt. Vaktsineerimine hoiab praegu igal aastal √§ra 2‚Äì3 miljoni surmajuhtumi sellistesse haigustesse nagu difteeria, teetanus, l√§kak√∂ha, gripp ja leetrid. </p><p> Kuigi meil on vaktsiiinid paljude t√µsiste viirusnakkuste, nagu leetrid, mumps, A- ja B-hepatiit, vastu, suudavad m√µned viirused ‚Äì n√§iteks need, mis p√µhjustavad k√ºlmetushaigusi, muteeruda. Kui viirus muteerub, muutub see piisavalt nii, et immuuns√ºsteem ei pruugi seda enam √§ra tunda, st ta ei tea, kuidas seda tappa. Nii v√µib viirus nakatada organismi, kuna see ‚Äúhiilib‚Äù immuuns√ºsteemist k√µrvale. Seega on seda t√º√ºpi viiruste vastu vaktsineerimine keerulisem. </p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Z=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Vaktsiinide v√§ljat√∂√∂tamise protsess, vaktsiinide ohutus</h2><h3>V√§ljat√∂√∂tamine</h3><p> Vaktsiinide v√§ljat√∂√∂tamine algab tavaliselt uurimislaboris, mis v√µib asuda √ºlikoolis, meditsiinikeskuses v√µi v√§ikeses biotehnoloogiaettev√µttes. Vaktsiini v√§ljat√∂√∂tamise k√§igus t√∂√∂tavad teadlased v√§lja erinevaid vaktsiinikandidaate, et testida ja m√µ√µta nende m√µju (v√µi selle puudumist). T√∂√∂tavate ideede leidmiseks on sageli vaja aastaid uurimist√∂√∂d. </p><p> Vaktsiini v√§ljat√∂√∂tamise ajal v√µivad mitu erinevat teadlast v√µi uurimisr√ºhma t√∂√∂tada samade eesm√§rkide nimel. T√∂√∂ edenemist tutvustatakse erinevatel kohtumistel (N: konverentsidel) ja eelretsenseeritavate ajakirjade artiklites. Kui m√µni t√∂√∂ tundub paljut√µotav, v√µidakse kaasata ka farmaatsiateadlased, et laiendada uurimist√∂√∂d tootearenduse suunas. </p><h3>Testimine</h3><p> Kui leitakse paljut√µotav vaktsiinikandidaat, tuleb seda katsetada loomadel. Seda nimetatakse eelkliiniliseks faasiks. K√µigepealt kasutatakse v√§ikseid loomi, nagu hiired, rotid, k√º√ºlikud jne. Kui vaktsiinikandidaat avaldab m√µju v√§ikestele loomadele, tuleb seda tavaliselt t√µestada suuremate loomade, n√§iteks ahvide puhul. Kui vaktsiin k√§ivitab immuunvastuse, testitakse seda inimkatsetes kolmes etapis (WHO, 2021). </p><p> 1. etapis antakse vaktsiini v√§ikesele arvule vabatahtlikele, et hinnata selle ohutust, veenduda, et see tekitab immuunvastuse ja m√§√§rata √µige annus. √úldiselt testitakse selles etapis vaktsiine v√§ikeses noorte tervete t√§iskasvanud vabatahtlike r√ºhmas. </p><p> 2. etapis antakse vaktsiin juba mitmesajale vabatahtlikule, et hinnata t√§iendavalt selle ohutust ja v√µimet tekitada immuunvastust. Selles etapis osalejatel on samad omadused (nagu vanus, sugu), kui inimestel, kellele vaktsiin on m√µeldud. Selles faasis on tavaliselt mitu katset, et hinnata erinevaid vanuser√ºhmi (eakad, t√§iskasvanud, lapsed) ja vaktsiini erinevaid koostisi. Tavaliselt kaasatakse ka r√ºhm, kes ei saa vaktsiini, et teha kindlaks, kas muutused vaktsineeritute r√ºhmas on tingitud vaktsiinist v√µi on saadud juhuslikult. </p><p> 3. etapis manustatakse vaktsiini tuhandetele vabatahtlikele ja seda v√µrreldakse sarnase inimeste r√ºhmaga, kes ei saanud vaktsiini, kuid said v√µrdlustoote. Selle eesm√§rk on kindlaks teha, kas vaktsiin on t√µhus haiguse vastu, mille eest see on loodud kaitsma. Samuti on eesm√§rgiks uurida selle ohutust palju suuremas inimr√ºhmas. 3. etapi uuringud viiakse sageli l√§bi mitmes riigis, sh √ºhe riigi mitmes regioonis, et tagada vaktsiini t√µhusate tulemuste kehtivus erinevate populatsioonide peal. </p><p> 2. ja 3. etapi uuringute ajal on vabatahtlikud ja uuringut l√§bi viivad teadlased olukorras, kus nad ei tea, millised vabatahtlikud on saanud testitavat vaktsiini v√µi millised v√µrdluspreparaati. Seda nimetatakse pimekatseks ja see on vajalik, et tagada tulemuste objektiivsus, st et ei vabatahtlikud ega ka teadlased poleks m√µjutatud ootustest vaktsiini suhtes ei selle t√µhususe ega ohutuse m√µttes. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3> Autoriseerimine ja j√§lgimine </h3><p> Kui k√µigi nende kliiniliste uuringute tulemused on k√§tte saadud, on vaja teha rida edasisi samme. Euroopa Ravimiamet ja hiljem iga riigi vastav ametkond vaatavad uuringute andmed hoolikalt l√§bi ja otsustavad, kas anda vaktsiinile kasutusluba. K√µik katsed peavad olema korrektselt tehtud ja korralikult dokumenteeritud. Enne vaktsiini heakskiitmist peab olema t√µestatud, et vaktsiin on ohutu ja t√µhus paljudele inimestele. Vaktsiini ohutuse ja t√µhususe tase peab seejuures olema √§√§rmiselt k√µrge. </p><p> Vaktsiinide kasutamise ajal toimub nende t√§iendav ohutuse ja t√µhususe j√§lgimine. See v√µimaldab teadlastel j√§lgida vaktsiinide m√µju ja ohutust isegi siis, kui neid kasutatakse suurel hulgal inimestel ja pika aja jooksul. Neid andmeid kasutatakse vaktsiini kasutamise eeskirjade kohandamiseks. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),ee={id:"s5"},ae=i('<h2 id="s5t">5. Maskid viiruste ja bakterite vastu</h2><p> Maske kasutatakse tihti kaitseks viiruste ja bakterite eest. Need on muutunud eriti tavaliseks SARS-CoV-2 viiruse eest kaitsmisel. Erinevat t√º√ºpi maskide hulgas on <b>kirurgilised n√§omaskid</b> olnud COVID-19 pandeemia ajal k√µige sagedamini kasutatavateks n√§okateteks. Tavaliselt on need √ºhelt poolt sinist v√§rvi, mida tuleks hoida v√§liskihina (Joonis 4). Kirurgiliste maskide peamine eesm√§rk on kaitsta patsiente v√µimaliku kokkupuute eest kandja poolt v√§ljahingatavate bakterite ja viirustega. Maskid takistavad h√§sti koroonaviiruse levikut √µhu kaudu, kuid ei ole nii t√µhusad vahendid kandja enda kaitsmiseks viiruse eest. On leitud n√§iteks, et inimeste poolt hingamisel, r√§√§kimisel ja aevastamisel tekitatud vedelikuosakeste l√§bim√µ√µt algab 1.6 mikromeetrist ja v√µib ulatuda kuni paarisaja mikromeetrini </p><p> Et filtreerida sissehingatavat √µhku paremini, tuleks kasutada <b>FFP2 v√µi FFP3 maski</b> (mida sageli nimetatakse ka <b>respiraatoriteks</b>). Sertifitseeritud numeratsioon (FFP1, FPP2, FFP3 (vastavalt standardile EN 149-2001)), n√§itab nende filtreerimise t√µhusust. FFP2 ja FPP3 filtreerimise t√µhusus √µhus lendlevate (kaasa arvatud viirust sisaldavate) osakeste suhtes on vastavalt 92% ja 98%. M√µlemal maskil on ka k√ºllaltki v√§ike leke k√ºlgedelt: vastavalt &lt;8% ja &lt;2%. FFP2 v√§liskihil kasutatakse sageli spetsiaalset pol√ºmeeri. Kui t√∂√∂keskkonnas (n√§iteks tolmu kaitseks) kasutatavate respiraatorite puhul on lubatud ventiil (mis teeb v√§ljahingamise lihtsamaks), siis SARS-CoV-2 puhul tuleks kasutada ainult klapita respiraatoreid, et filtreerida ka v√§ljahingatava √µhku. </p><p> COVID-19 pandeemiaga v√µeti kasutusele uut t√º√ºpi n√§omaskid: <b>filtreeriv mask</b>. Seda t√º√ºpi mask on valmistatud mitmekihilisest kangast (√ºks neist peab olema nanokiudfilter, mis tagab bakterite ja kahjuliku peentolmu filtreerimisv√µime v√§hemalt 90%). See mask √ºhendab endas suure filtreerimisv√µime ja korduvkasutatavuse, kuna seda saab masinas pesta 60 kraadi juures. </p>',4),te={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},se=i('<p class="italic">Joonis 4. Erinevad maskit√º√ºbid</p><p><b>Maskide t√µhusust testitakse</b> pidevalt spetsiaalsetes laborites ehk nn. ekspositsioonikambrites. Nendes uuringutes t√§idab osakeste generaator kambri sama suurte aerosooliosakestega, mille abil viirus tavaliselt levib. J√§rgnvalt m√µ√µdetakse osakeste kontsentratsiooni maski taga ja v√µrreldakse kontsentratsiooniga v√§ljaspool seda ehk siis ekspositsioonikambris √ºldiselt. </p><p> Maskikandmise t√µhusust t√µendavad k√µige veenvamalt epidemioloogilised andmed, mis on v√µetud n√∂ p√§ris elust. Lyu ja Wehby (2020) poolt l√§biviidud uurimus n√§itas, et koroonasse nakatumise kasv aeglustus kohe, kui 15 USA osariigis ning Columbia ringkonnas kehtestatid maskikandmise kohustus. √úhes uurimuses (Leffler jt. 2020) vaadeldi koroonaga seotud surmajuhtumite statistikat kokku 198 riigis. Selle tulemusena leiti, et nendes riikides, kus oli kas sotsiaalseks normiks kanda maski v√µi kus ametlikult n√µuti pandeemia ajal maski kandmist, oli ka surmajuhtumite m√§√§r tunduvalt v√§iksem muudest riikidest. </p><p> Mitmed Facebooki jm sotsiaalmeedia kasutajad on jaganud eksitavaid postitusi n√§omaski pikaajalise kasutamise kohta, mis nende v√§itel p√µhjustab kehas hapnikuvaegust ‚Äì h√ºpoksiat. Samas n√§itavad teadusartiklid ja ekspertide anal√º√ºsid, et selliseid s√ºmptomeid ei esine enamikul inimestel, v√§lja arvatud juhul, kui kasutajal on eelnevalt olnud hingamisteede haigusi, nagu astma v√µi krooniline obstruktiivne kopsuhaigus. Riide ja kirurgiliste maskide puhul on h√ºpoksia ja h√ºperkapnia (liigse s√ºsinikdioksiidi sisaldus vereringes) oht veelgi ebat√µen√§olisem, kuna need ei liibu n√§o √ºmber. Siiski hoiatatakse, et n√§omaski ei tohi kasutada alla kahe aastaste v√µi hingamisraskustega laste puhul ning trenni tehes. </p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="" target="_blank">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19 </a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),ie=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"√ïpilastele edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),re=e("hr",{class:"mt-10 mb-40"},null,-1),ne={id:"s6"},oe=i('<h2 id="s6t">6. Viirused ja k√§te h√ºgieen</h2><h3>K√§te desinfitseerimisvahend v√µi seep?</h3><p> Meie k√§ed v√µivad olla nakkuste edasikandumisel kriitiliseks teguriks. P√µhjalikult k√§tele kandes ja <a href="https://www.cdc.gov/handwashing/when-how-handwashing.html" target="_blank" rel="noopener noreferrer">v√§hemalt 20 sekundit k√º√ºrides</a>, peatavad nii alkoholip√µhised k√§tepuhastusvahendid kui ka seep koroona t√º√ºpi viiruse leviku. Nii seep kui alkohol l√µhuvad viiruse membraani. Seep v√§hendab ka patogeenide kleepumist naha k√ºlge, v√µimaldades patogeenid sealt veega maha pesta. See mitte ainult ei neutraliseeri viirust, vaid ka v√µimaldab selle k√§telt eemaldamist. √úldiselt on hea k√§teh√ºgieen lihtne ennetusmeede, mida enamik saab v√§ikese vaevaga teha. Paljud uuringud on n√§idanud k√§teh√ºgieeni t√µhusust nakkuslike patogeenide, sealhulgas koroonaviiruste nagu SARS-CoV-2, edasikandumise √§rahoidmisel. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Koroonaviiruse n√µrgendamine seebiga</h3><p>Koronaviirused on saanud oma nime viirust √ºmbritseva &quot;krooni&quot; j√§rgi, mille moodustavad selle membraanile kinnitunud valgu piigid, mis vastutavad peremeesorganismi nakatamise eest. Membraan on viiruse &quot;kest&quot; ja viiruse n√µrk koht.</p><p>Seebimolekulidel on h√ºdrofiilne (vett armastav) &quot;pea&quot; ja h√ºdrofoobne (vett t√µrjuv) &quot;saba&quot;. ‚ÄúPea‚Äù aitab seebil veega seguneda, samas kui ‚Äúsaba‚Äù v√µib interakteeruda (seguneda) h√ºdrofoobsete molekulidega, n√§iteks lipiididega (rasvadega).</p><p>Meie √µnneks koosneb koroonaviiruse membraan enamasti lipiididest. Neid hoiavad koos molekulidevahelised n√µrgad keemilised vastasm√µjud. Seebimolekulide h√ºdrofoobsed (vett vihkavad) &quot;sabad&quot; v√µivad katkestada lipiidimolekulide vastasm√µju koroonaviiruse membraanis (vt Joonis 5).</p><p>Seega h√§irib ‚Äúsaba‚Äù membraani lipiidimolekulide vahelist n√µrka vastasm√µju, rebides need lahti. Kui viirus l√µhutakse enne, kui see on peremeesrakku turvaliselt varjunud, ei saa see enam oma nakatavat t√∂√∂d teha ‚Äì nagu masin, mille osad on v√§lja kukkunud. Seej√§rel √ºmbritsevad seebimolekulid viiruse osi nii, et k√µik sabad on suunatud sissepoole. Sellist kobarat nimetatakse mitselliks (vt Joonis 6). Seebiosakeste v√§ljapoole suunatud h√ºdrofiilsed pead v√µimaldavad mitselli veega k√§telt maha pesta. Ainult veest seega ei piisa.</p>',9),le={class:"grid gap-2 md:grid-cols-2 e-card"},ce=e("b",null,"Joonis 5.",-1),de=e("b",null,"Joonis 6.",-1),me=i('<p>Antud teave kehtib ka teiste √ºmbrisega viiruste kohta (gripp, B- ja C-hepatiit ning Ebola), kuna nende √ºmbrised koosnevad samuti fosfolipiididest.</p><section class="e-card"><h4 class="mt-0">Allikas</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>K√§te desinfitseerimisvahendi valimine</h3><p>Kui pole k√§ep√§rast seepi, soovitab Maailma Tervishoiu Organisatsioon (WHO) alkoholip√µhiseid k√§tepuhastusvahendeid.</p><p><b>Arvatakse, et alkoholip√µhised k√§tepuhastusvahendid takistavad mikroobide, sh bakterite ja m√µnede viiruste, valkude normaalset funktsioneerimist. Suure alkoholisisaldusega k√§tepuhastusvahendid v√µivad samuti lammutada koroonaviirust √ºmbritsevat lipiidkesta.</b> Et k√§tepuhastusvahendid oleksid t√µhusad, peavad need sisaldama v√§hemalt 60 protsenti alkoholi. Desinfitseerimisvahendis olevad lisandid v√µivad takistada alkoholi liiga kiiret aurustumist, v√µimaldades sellel kauem viirust leotada.</p><p>Siiski on alkoholip√µhiste k√§tepuhastusvahendite kasutamisega seotud ka teatud riskid. Lastel on suurenenud alkoholim√ºrgituse oht ja k√§tepuhastusvahendite sagedane kasutamine v√µib p√µhjustada antimikroobse resistentsuse. On olemas alternatiivsed alkoholivabad k√§tepuhastusvahendid, kus k√µige sagedamini kasutatakse bensalkooniumi. Hiljutised uuringud on n√§idanud, et alkoholivaba k√§tepuhastusvahend toimib sama h√§sti ega p√µhjusta alkoholiga k√§tepuhastusvahendi kasutamisel tuttavat &quot;p√µletustunnet&quot;.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ue=e("hr",{class:"mt-20 mb-40"},null,-1),he={id:"s7"},pe=i('<h2 id="s7t">7. Vaktsiinidega seotud m√º√ºdid</h2><h3 id="myth-1"><span class="text-rose-400">M√º√ºt nr 1:</span> Vaktsiinid p√µhjustavad autismi</h3><p>Laialt levinud hirm, et vaktsiinid suurendavad lastel autismiriski, sai alguse Briti kirurgi Andrew Wakefieldi 1997. aastal avaldatud uuringust. Artikkel avaldati mainekas meditsiiniajakirjas The Lancet, mis viitas sellele, et leetrite, mumpsi ja punetiste (MMR) vaktsiin v√µib olla p√µhjustanud Briti lastel autismi.</p><p>Sellest ajast alates on artikkel t√§ielikult √ºmber l√ºkatud t√µsiste protseduuriliste vigade, valimi ebapiisavuse (uuriti vaid 12 last), rahaliste huvide konflikti ja eetikareeglite rikkumiste t√µttu. Andrew Wakefield kaotas oma arstilitsentsi ja artikkel v√µeti The Lancetist tagasi.</p><p>√úkski hilisematest uuringutest ei ole n√§idanud seost vaktsiinide manustamise ja autismi v√§ljakujunemise vahel. Praeguseks on mitmed autismi ja vaktsineerimise vaheliste v√µimalike seoste uuringud v√§lja selgitanud, et autismi s√ºmptomid esinevad lastel juba enne MMR-vaktsiini saamist. Veelgi uuemad uuringud annavad t√µendeid selle kohta, et autism areneb v√§lja emakas, palju enne lapse s√ºndi v√µi vaktsineerimist.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ve=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Here‚Äôs What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety",target:"_blank",rel:"noopener noreferrer"},"Coronavirus disease (COVID-19): Vaccines safety")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ke=i('<h3 id="myth-2"><span class="text-rose-400">M√º√ºt nr 2:</span> Imikute immuuns√ºsteem ei talu korraga mitut vaktsiini</h3><p>P√µhjus, miks lastele antakse vaktsiine noores eas, on see, et neil on k√µrgeim risk haigestuda v√µi surra, kui nad haigestuvad nendesse haigustesse. Kuigi vasts√ºndinud on immuunsed m√µne haiguse (nt tuuler√µuged) suhtes, kuna neil on emalt saadud antikehad, kestab see immuunsus vaid paar kuud. Pealegi ei saa enamik imikuid oma emadelt difteeria, l√§kak√∂ha, lastehalvatuse, teetanuse, B-hepatiidi ega Hib-i vastu kaitsvaid antikehi.</p><p>Et v√§hendada lapsele arstivisiidil tehtavate s√ºstide arvu, pakutakse m√µnda vaktsiini kombineeritud vaktsiinina (√ºheks s√ºstiks on kombineeritud kaks v√µi enam erinevat vaktsiini). Kombineeritud vaktsiinid on n√§iteks difteeria-teetanuse-l√§kak√∂ha ja leetrite-mumpsi-punetiste vaktsiinid.</p><p>Teadusuuringute tulemused n√§itavad, et mitme vaktsiini samaaegne saamine ei p√µhjusta terviseprobleeme. Imikute immuuns√ºsteem on tugevam, kui v√µiks arvata. Veres leiduvate antikehade arvu p√µhjal oleks beebil teoreetiliselt v√µime reageerida palju suuremale arvule vaktsiinidele (j√§√§b ainult k√ºsimus, kas see on korraga 1000, 10 000 v√µi 100 000). Isegi kui k√µik ~10 (olenevalt riiklikust vaktsineerimiskavast) plaanitud vaktsiini manustatakse korraga, kasutaks see vaid murdosa beebi immuunv√µimest. Tegelikkuses puutuvad imikud iga p√§ev kokku lugematute bakterite ja viirustega ning immuniseerimine on sellega v√µrreldes t√ºhine. Samuti ei ole uuringud n√§idanud, et kokkupuude mitme vaktsiiniga esimese 23 elukuu jooksul oleks seotud suurenenud riskiga nakatuda muudesse infektsioonidesse, mis ei ole vaktsiinide sihtm√§rgiks.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3 id="myth-3"><span class="text-rose-400">M√º√ºt nr 3:</span> Loomulikul teel omandatud immuunsus on parem kui vaktsiiniga omandatud immuunsus</h3><p>On t√µsi, et loomulik nakatumine annab peaaegu alati tugevama immuunsuse haiguse vastu kui vaktsineerimine. Selle l√§henemisviisi ohud kaaluvad siiski √ºles suhtelise kasu. Loodusliku nakatumise j√§rgse immuunsuse eest makstavaks hinnaks v√µib olla tuuler√µugete v√µi pneumokokkide p√µhjustatud kopsup√µletik, Haemophilus influenzae b (Hib) p√µhjustatud intellektuaalne puue, ema punetistest p√µhjustatud s√ºnnidefektid, B-hepatiidi viiruse tagaj√§rjel saadud maksav√§hk, surm leetrite t√µttu jne. N√§iteks leetritesse haigestudes on teil v√µimalus oma s√ºmptomite t√µttu surra 1:500. Seevastu inimeste arv, kellel on MMR-vaktsiini saanud raskeid allergilisi reaktsioone, on alla 1:1000000.</p><p>Sellegipoolest on v√§he vaktsiine, mis kutsuvad esile parema immuunvastuse kui loomulikud infektsioonid. N√§iteks sisaldab inimese papilloomiviiruse (HPV) vaktsiin k√µrge puhtusastmega spetsiifilist valku, mis annab parema immuunvastuse kui loomulik infektsioon. Teised sarnased n√§ited on teetanuse, Haemophilus influenzae t√º√ºp b (Hib) ja pneumokoki vaktsiinid.</p><p>Seoses COVID-19-ga on andmed selles suhtes ebaselged. On n√§idatud, et p√ºsiv kaitse p√§rast nakatumist on ebat√µen√§oline. Leiti, et koroonaviirusega patsientidel tekkis oluline ‚Äúimmuunm√§lu&quot; - immuuns√ºsteemi reaktsioon tellis k√µigis neljas olulises immuuns√ºsteemi osas: aktiveerides m√§lu B-rakud, antikehad, m√§lu CD4+ T-rakud ja m√§lu CD8+ T-rakud, kusjuures kaitse hakkas v√§henema poole aasta p√§rast. Samuti on teadlased n√§idanud immuunvastuse suurt erinevust inimeste vahel - antikehade tasemete erinevus v√µib populatsiooni l√µikes erineda 200 korda.</p><p>Teised uuringud n√§itasid aga, et Moderna vaktsiini (mRNA) saanud vabatahtlike veres oli rohkem antikehi, kui inimestel, kes olid p√µdenud COVID-19. Seda asjaolu v√µib aga muuta haiguse t√µsidus, kuna haiguse t√µsiduse ja kestva immuunvastuse vahel on seos ‚Äì enamikul as√ºmptomaatilistel patsientidel oli p√§rast 6-kuulist nakatumist v√§ga v√§he antikehi. Seega on SARS-CoV-2 infektsioonist tekkiv loomulik immuunsus sageli ettearvamatu. Veelgi enam, mRNA vaktsiini poolt esile kutsutud antikehad olid suunatud retseptori sidumisdomeeni (RBD) laiemale hulgale kohtadele kui need, mis tekkisid loomuliku infektsiooniga.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3 id="myth-4"><span class="text-rose-400">M√º√ºt nr 4:</span> Vaktsiinid sisaldavad eluohtlikke toksiine</h3><p>Inimesed tunnevad muret formaldeh√º√ºdi, elavh√µbeda v√µi alumiiniumi kasutamise p√§rast vaktsiinides. √úhest k√ºljest on t√µsi, et need kemikaalid on teatud tasemel inimkehale m√ºrgised. Teisest k√ºljest on vaktsiinides kasutatu kemikaalide v√§ga v√§ikesi koguseid ja need kogused on v√§iksemad kui toitumisest saadavad v√µi formaldeh√º√ºdi toodavad meie enda ainevahetuss√ºsteemid kiiremini.</p><p>P√µhjused, miks teatud elemendid, n√§iteks alumiiniumsoolad, lisatakse vaktsiinidele, on see, et need toimivad adjuvandina, mis t√§hendab, et selle olemasolu suurendab vaktsineerimisel immuunvastust. Samuti sisaldavad alumiiniumsoolasid ainult teatud vaktsiinid, uued COVID-19 vaktsiinid neid n√§iteks ei sisalda. V√§ike osa vaktsiinidest on sisaldanud s√§ilitusainena timerosaali, kuid √ºkski lastel kasutatavatest vaktsiinidest ei sisalda seda praegu. Thimerosal sisaldab et√º√ºlelavh√µbedat, mis eritub inimkehast kiiresti, v√µrreldes bioakumuleeruva met√º√ºlelavh√µbedaga ‚Äì seega on suur erinevus, mis kujul m√ºrgine metall esineb. Sellest hoolimata ei sisalda COVID-19 vaktsiinid toksiine.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),fe=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.publichealth.org/public-awareness/understanding-vaccines/goes-vaccine/",target:"_blank",rel:"noopener noreferrer"},"What Goes Into A Vaccine?")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"What‚Äôs in Vaccines?")])])],-1),ge=i('<h3 id="myth-5"><span class="text-rose-400">M√º√ºt nr 5:</span> Nakatumiste arvu v√§henemise p√µhjuseks maailmas on parem h√ºgieen ja kanalisatsioon, mitte vaktsiinid.</h3><p>See on osaliselt t√µsi, et vaktsiinid ei v√§√§ri kogu tunnustust nakkushaiguste esinemissageduse v√§hendamise v√µi k√µrvaldamise eest. On n√§idatud, et palju on aidanud ka parem kanalisatsioon, toitumine ja antibiootikumide v√§ljat√∂√∂tamine. Saastunud vee kaudu levivad sellised nakkused, nagu t√º√ºfus ja koolera, mis olid 20. sajandi alguses peamised haiguste ja surma p√µhjustajad. Paremate sanitaartingimuste t√µttu on nende esinemine kindlasti oluliselt v√§henenud. Hiljutine √ºlevaade j√µudis j√§reldusele, et k√§te pesemine aitab √§ra hoida nakkushaigusi. Veel √ºks hiljutine t√µend p√§rineb COVID-19 pandeemia ajast, mis n√§itas, et paranenud h√ºgieen koos muude ohutusn√µuetega, on j√§rsult v√§hendanud ka hooajalise gripi esinemissagedust.</p><p>Kui need tegurid aga uuringutes eraldada ja nakkushaiguste esinemissagedust anal√º√ºsida, ei saa vaktsiinide rolli eitada. √úks n√§ide on leetrid Ameerika √úhendriikides. Kui 1963. aastal v√µeti kasutusele esimene leetrite vaktsiin, p√ºsis nakatumise m√§√§r ligikaudu 400 000 juhtumi juures aastas. Kuigi h√ºgieenilised harjumused ja sanitaartingimused ei muutunud j√§rgmisel k√ºmnendil palju, langes leetritesse nakatumise m√§√§r p√§rast vaktsiini kasutuselev√µttu j√§rsult, 1970. aastaks oli ainult ligikaudu 25 000 juhtu. Teine n√§ide on Hib-t√µbi. Andmete kohaselt langes selle haiguse esinemissagedus p√§rast vaktsiini kasutuselev√µttu 20 000-lt 1990. aastal ligikaudu 1500-le 1993. aastal.</p><p>Veel √ºks t√µend p√§rineb viimastest aastak√ºmnetest. H√ºgieenis ei ole arenenud maailmas muudatusi toimunud, k√ºll aga on v√§henenud vaktsineerimise m√§√§r. N√º√ºd t√§heldatakse mitmetes riikides, nagu √úhendkuningriik, USA, Saksamaa, Hispaania jne, √ºha rohkem leetreid ja muid vaktsiiniv√§lditavaid haigusi.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3 id="myth-6"><span class="text-rose-400">M√º√ºt nr 6:</span> Vaktsiinid v√µivad nakatada inimesi haigusega, mida see p√º√ºab √§ra hoida</h3><p>M√µned vaktsiinid on elusvaktsiinid, mis sisaldavad elusaid, kuid n√µrgestatud mikroorganisme/viirusi, mis on endiselt v√µimelised peremeesorganismis paljunema. Mikroorganismid on n√µrgestatud, mis t√§hendab, et nad on kaotanud suurema osa oma haigust p√µhjustavatest v√µimetest, kuid neil on endiselt olemas immunogeensed omadused. Seega on see alati palju kergem variant kui siis, kui laps nakatub haigust p√µhjustavasse ‚Äúp√§ris‚Äù viirusesse. N√µrgestatud elusvaktsiinideks on leetrite, mumpsi ja punetiste kombineeritud vaktsiin ning rotaviiruse, r√µugete, tuuler√µugete ja kollapalaviku vaktsiinid. Enamikul juhtudel on elusvaktsiinidel oluliselt suurem immunogeensus kui inaktiveeritud vaktsiinidel, kuna loomulikku infektsiooni imiteeritakse peaaegu t√§iuslikult, kutsudes esile laiema immunoloogilise vastuse. Kuid n√µrgenenud immuuns√ºsteemiga lastele, n√§iteks v√§hiravi saavatele lastele, neid vaktsiine ei eelistata.</p><p>On t√µsi, et elusvaktsiinid v√µivad p√µhjustada kergeid s√ºmptomeid, mis sarnanevad selle haigusega, mille eest nad kaitsevad. Vaktsiini saajad kogevad aga organismi immuunvastust vaktsiinile, mitte haigust ennast. On registreeritud ainult √ºks juhtum, kus vaktsiin p√µhjustas haigust. See oli suukaudne poliom√ºeliidi vaktsiin (OPV), mida enam ei kasutata ja mis on praegu asendatud tapetud viiruse vormiga, mida tuntakse inaktiveeritud poliom√ºeliidi vaktsiinina (IPV).</p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3 id="myth-7"><span class="text-rose-400">M√º√ºt nr 7:</span> Me ei pea enam vaktsineerima, sest nakatumise m√§√§r mitmetesse nakkushaigustesse on paljudes riikides nniikuinii madal</h3><p>T√§nu karjaimmuunsusele ei n√§e paljud inimesed vaktsineerimise j√§rele enam vajadust. Karjaimmuunsus tekib siis, kui suur osa kogukonnast (‚Äúkari‚Äù) muutub haiguse suhtes immuunseks, mist√µttu on haiguse levik inimeselt inimesele ebat√µen√§oline. Niikaua kui suurem osa inimestest on immuniseeritud mis tahes populatsioonis, on kaitstud ka immuniseerimata v√§hemus. See on oluline, sest teatud osa elanikkonnast ‚Äì imikud, rasedad naised, eakad ja n√µrgenenud immuuns√ºsteemiga inimesed ‚Äì ei saa m√µnikord/m√µndasid vaktsiine. Kui aga paljud inimesed iseennast ega oma lapsi enam ei vaktsineeri, kaob karjaimmuunsus, mis annab v√µimaluse viirustele ja bakteritele end levitada. Sageli tuuakse m√µni haigus kaasa rahvusvahelistelt reisidelt. Vaktsineerimata inimesel on sel juhul palju suurem risk haigestuda v√µi reisimise ajal nakatuda. Seda illustreerib leetrite esinemissageduse t√µus USA-s viimastel aastatel. Kuni haigused eksisteerivad, on meil oht nakatuda.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',12),be=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function we(h,d){const l=v,c=j,r=k,n=f,m=g;return o(),u("div",V,[t(c,null,{default:s(()=>[t(l,{class:"w-full lg:max-w-xs print:hidden",key:"viruses-bg-et"})]),_:1}),e("section",S,[t(r,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),A,I,e("section",M,[D,C,O,z,t(n,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Source: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[F,a(" Viiruse ja bakteri struktuurierinevused ")]),_:1}),N,t(m,{class:"mb-8"},{default:s(()=>[P,a(" v√µivad aidata immuuns√ºsteemil h√§vitada bakteriaalset nakkust, kuid on kasutud viirusnakkuste vastu. "),$,a(" toimivad teisiti kui antibiootikumid ja on praegu t√µhusad vaid m√µne viirushaiguse, n√§iteks gripi, herpese, B- ja C-hepatiidi ning HIV-viiruse vastu. Viirusnakkusi v√µib olla palju raskem tappa kui bakteriaalseid nakkusi, kuna viirus siseneb organismi rakkudesse. "),B,a(" v√µib nakatunud rakud tappa enne, kui viirus on v√µimeline paljunema. Viiruse paljunedes aga rakk l√µhkeb, mis v√µimaldab viirusel levida teistesse keharakkudesse. ")]),_:1}),T]),E,e("section",R,[H,W,K,Y,t(n,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[U,a(" Iga uue antigeeni jaoks peab meie keha looma spetsiifilise antikeha ")]),_:1}),J,L,G,t(n,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Allikas: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Q,a(" Antikehade arendamine vaktsineerimise kaudu ")]),_:1}),X]),Z,e("section",ee,[ae,e("div",te,[t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Kirurgiline mask ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respiraator) ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3 mask (respiraator) klapiga ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filteeriv mask ")]),_:1})]),se,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ie]),_:1})]),re,e("section",ne,[oe,e("div",le,[t(n,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ce,a(" Seebi molekulid h√§vitamas viirust ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[de,a(" Seebi molekulidest ja viiruse osast koosnev mitsell ")]),_:1})]),me]),ue,e("section",he,[pe,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ve]),_:1}),ke,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[fe]),_:1}),ge,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Rohkem COVID-19 m√º√ºte ja sellega seotud teadusuuringuid leiate aadressilt: "),be]),_:1})])])])}const _e=b(q,[["render",we]]),ye={},je={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},xe={class:"e-article",lang:"el",style:{hyphens:"auto"}},qe=e("h1",{class:"mb-0"},"ŒôŒøŒØ",-1),Ve=e("h5",{class:"font-normal uppercase leading-tight"},"ŒïœÄŒπœÉœÑŒ∑ŒºŒøŒΩŒπŒ∫Œ≠œÇ œÄŒªŒ∑œÅŒøœÜŒøœÅŒØŒµœÇ",-1),Se={id:"s1"},Ae=e("h2",{id:"s1t"},"1. ŒôŒøŒØ Vs Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±",-1),Ie=e("p",null,[e("b",null,"Œ§Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± Œ∫Œ±Œπ ŒøŒπ ŒπŒøŒØ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÄœÅŒøŒ∫Œ±ŒªŒ≠œÉŒøœÖŒΩ œÄŒøŒªŒªŒ≠œÇ Œ∫ŒøŒπŒΩŒ≠œÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ. Œ†ŒøŒπŒµœÇ ŒµŒØŒΩŒ±Œπ œåŒºœâœÇ ŒøŒπ Œ¥ŒπŒ±œÜŒøœÅŒ≠œÇ ŒºŒµœÑŒ±Œæœç Œ±œÖœÑœéŒΩ œÑœâŒΩ Œ¥œçŒø ŒµŒπŒ¥œéŒΩ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫œéŒΩ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœéŒΩ;")],-1),Me=e("p",null,[a(" Œ§Œ± "),e("span",{class:"e-term font-Heading"},"Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±"),a(" ŒµŒØŒΩŒ±Œπ ŒºŒπŒ∫œÅŒøœÉŒ∫ŒøœÄŒπŒ∫ŒøŒØ ŒºŒπŒ∫œÅŒøŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøŒØ œÄŒøœÖ Œ±œÄŒøœÑŒµŒªŒøœçŒΩœÑŒ±Œπ Œ±œÄœå Œ≠ŒΩŒ± ŒºœåŒΩŒø Œ∫œçœÑœÑŒ±œÅŒø. Œ†Œ±œÅŒøœÖœÉŒπŒ¨Œ∂ŒøœÖŒΩ ŒºŒµŒ≥Œ¨ŒªŒ∑ œÄŒøŒπŒ∫ŒπŒªŒØŒ± Œ∫Œ±Œπ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± Œ≠œáŒøœÖŒΩ œÄŒøŒªŒªŒ¨ œÉœáŒÆŒºŒ±œÑŒ± Œ∫Œ±Œπ Œ¥ŒøŒºŒπŒ∫Œ¨ œáŒ±œÅŒ±Œ∫œÑŒ∑œÅŒπœÉœÑŒπŒ∫Œ¨. Œ§Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± Œ∂ŒÆœÉŒøœÖŒΩ œÉœáŒµŒ¥œåŒΩ œÉŒµ Œ∫Œ¨Œ∏Œµ œÄŒµœÅŒπŒ≤Œ¨ŒªŒªŒøŒΩ, œÉœÖŒºœÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ±ŒΩŒøŒºŒ≠ŒΩŒøœÖ œÑŒøœÖ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒøœÖ œÉœéŒºŒ±œÑŒøœÇ. ŒúœåŒΩŒø ŒªŒØŒ≥Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩ ŒªŒøŒπŒºœéŒæŒµŒπœÇ œÉœÑŒøŒΩ Œ¨ŒΩŒ∏œÅœâœÄŒø. ŒëœÖœÑŒ¨ œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± Œ±ŒΩŒ±œÜŒ≠œÅŒøŒΩœÑŒ±Œπ œâœÇ œÄŒ±Œ∏ŒøŒ≥œåŒΩŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. ")],-1),De=e("p",null,[a(" ŒüŒπ "),e("span",{class:"e-term font-Heading"},"ŒπŒøŒØ"),a(" ŒµŒØŒΩŒ±Œπ Œ≠ŒΩŒ±œÇ Œ¨ŒªŒªŒøœÇ œÑœçœÄŒøœÇ ŒºŒπŒ∫œÅŒøœÉŒ∫ŒøœÄŒπŒ∫œéŒΩ ŒºŒπŒ∫œÅŒøŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœéŒΩ, ŒºŒπŒ∫œÅœåœÑŒµœÅŒøœÇ Œ±Œ∫œåŒºŒ∑ Œ∫Œ±Œπ Œ±œÄœå œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. EŒØŒΩŒ±Œπ œÄŒøŒªœç Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫ŒøŒØ ŒºŒµœÑŒ±Œæœç œÑŒøœÖœÇ Œ∫Œ±Œπ Œ≠œáŒøœÖŒΩ œÄŒøŒπŒ∫ŒØŒªŒ± œÉœáŒÆŒºŒ±œÑŒ± Œ∫Œ±Œπ œáŒ±œÅŒ±Œ∫œÑŒ∑œÅŒπœÉœÑŒπŒ∫Œ¨ œåœÄœâœÇ œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. ŒüŒπ ŒπŒøŒØ ŒµŒØŒΩŒ±Œπ œÄŒ±œÅŒ±œÉŒπœÑŒπŒ∫ŒøŒØ, œÄœÅŒ¨Œ≥ŒºŒ± œÄŒøœÖ œÉŒ∑ŒºŒ±ŒØŒΩŒµŒπ œåœÑŒπ œáœÅŒµŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ Œ∂œâŒΩœÑŒ±ŒΩŒ¨ Œ∫œçœÑœÑŒ±œÅŒ± ŒÆ ŒπœÉœÑŒøœçœÇ Œ≥ŒπŒ± ŒΩŒ± ŒºœÄŒøœÅŒ≠œÉŒøœÖŒΩ ŒΩŒ± Œ±ŒΩŒ±œÄœÑœÖœáŒ∏ŒøœçŒΩ. ŒüŒπ ŒπŒøŒØ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒµŒπœÉŒ≤Œ¨ŒªŒøœÖŒΩ œÉœÑŒ± Œ∫œçœÑœÑŒ±œÅŒ± œÑŒøœÖ œÉœéŒºŒ±œÑœåœÇ ŒºŒ±œÇ, œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπœéŒΩœÑŒ±œÇ œÑŒ± œÉœÖœÉœÑŒ±œÑŒπŒ∫Œ¨ œÑœâŒΩ Œ∫œÖœÑœÑŒ¨œÅœâŒΩ Œ≥ŒπŒ± ŒΩŒ± Œ±ŒΩŒ±œÄœÑœÖœáŒ∏ŒøœçŒΩ Œ∫Œ±Œπ ŒΩŒ± œÄŒøŒªŒªŒ±œÄŒªŒ±œÉŒπŒ±œÉœÑŒøœçŒΩ. ŒúŒµœÅŒπŒ∫ŒøŒØ ŒπŒøŒØ œÉŒ∫ŒøœÑœéŒΩŒøœÖŒΩ Œ±Œ∫œåŒºŒ∑ Œ∫Œ±Œπ œÑŒ± Œ∫œçœÑœÑŒ±œÅŒ±-ŒæŒµŒΩŒπœÉœÑŒ≠œÇ œâœÇ ŒºŒ≠œÅŒøœÇ œÑŒøœÖ Œ∫œçŒ∫ŒªŒøœÖ Œ∂œâŒÆœÇ œÑŒøœÖœÇ. ŒüŒπ Œ¥ŒπŒ±œÜŒøœÅŒ≠œÇ ŒºŒµœÑŒ±Œæœç ŒπœéŒΩ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ œÜŒ±ŒØŒΩŒøŒΩœÑŒ±Œπ œÉœÑŒø œÉœáŒÆŒºŒ± 1 Œ∫Œ±Œπ ŒºœÄŒøœÅŒµŒØœÑŒµ ŒΩŒ± œÑŒ± ŒµŒΩœÑŒøœÄŒØœÉŒµœÑŒµ Œ∫Œ±Œπ œÉœÑŒøŒΩ œÄŒØŒΩŒ±Œ∫Œ± 1. ")],-1),Ce=e("b",null,"Œ£œáŒÆŒºŒ± 1.",-1),Oe=i('<table class="mt-20"><caption class="text-left pb-4"><b>Œ†ŒØŒΩŒ±Œ∫Œ±œÇ 1.</b> ŒîŒπŒ±œÜŒøœÅŒ≠œÇ ŒπœéŒΩ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ</caption><thead><tr><th></th><th>ŒíŒ±Œ∫œÑŒÆœÅŒπŒ±</th><th>ŒôŒøŒØ</th></tr></thead><tbody><tr><th class="align-baseline"> ŒñœâŒΩœÑŒ±ŒΩœåœÇ / ŒúŒ∑ Œ∂œâŒΩœÑŒ±ŒΩœåœÇ </th><td><b>ŒñœâŒΩœÑŒ±ŒΩœåœÇ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœåœÇ.</b><br>Œ§Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒµŒØŒΩŒ±Œπ Œ∂œâŒΩœÑŒ±ŒΩŒøŒØ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøŒØ ŒºŒµ Œ≠ŒΩŒ± ŒºœåŒΩŒø Œ∫œçœÑœÑŒ±œÅŒø œÄŒøœÖ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÄŒ±œÅŒ¨Œ≥ŒøœÖŒΩ ŒµŒΩŒ≠œÅŒ≥ŒµŒπŒ±, ŒΩŒ± œÜœÑŒπŒ¨œáŒΩŒøœÖŒΩ œÑŒ∑ Œ¥ŒπŒ∫ŒÆ œÑŒøœÖœÇ œÑœÅŒøœÜŒÆ, ŒΩŒ± Œ∫ŒπŒΩŒøœçŒΩœÑŒ±Œπ Œ∫Œ±Œπ ŒΩŒ± Œ±ŒΩŒ±œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒ±Œπ (œÉœÖŒΩŒÆŒ∏œâœÇ ŒºŒµ Œ¥œÖŒ±Œ¥ŒπŒ∫ŒÆ œÉœáŒ¨œÉŒ∑). ŒëœÖœÑœå ŒµœÄŒπœÑœÅŒ≠œÄŒµŒπ œÉœÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒΩŒ± Œ∂ŒøœÖŒΩ œÉŒµ œÄŒøŒªŒªŒ¨ ŒºŒ≠œÅŒ∑ -œáœéŒºŒ±, ŒΩŒµœÅœå, œÜœÖœÑŒ¨ Œ∫Œ±Œπ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒø œÉœéŒºŒ±- Œ∫Œ±Œπ ŒΩŒ± ŒµŒæœÖœÄŒ∑œÅŒµœÑŒøœçŒΩ œÄŒøŒªŒªŒøœçœÇ œÉŒ∫ŒøœÄŒøœçœÇ. Œ£œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒøŒΩœÑŒ±Œπ œÑœåœÉŒø œÄŒ±œÅŒ¨œÉŒπœÑŒ± œåœÉŒø Œ∫Œ±Œπ ŒºŒ∑ œÄŒ±œÅŒ¨œÉŒπœÑŒ±. </td><td><b>ŒúŒ∑ Œ∂œâŒΩœÑŒ±ŒΩœåœÇ.</b><br>ŒüŒπ ŒπŒøŒØ Œ±ŒΩŒ±œÄœÑœçœÉœÉŒøŒΩœÑŒ±Œπ Œ∫Œ±Œπ Œ±ŒΩŒ±œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒ±Œπ ŒºœåŒΩŒø ŒºŒ≠œÉŒ± œÉœÑŒ± Œ∫œçœÑœÑŒ±œÅŒ± ŒæŒµŒΩŒπœÉœÑŒ≠œÇ œÄŒøœÖ ŒºŒøŒªœçŒΩŒøœÖŒΩ. ŒåœÑŒ±ŒΩ Œ≤œÅŒØœÉŒ∫ŒøŒΩœÑŒ±Œπ Œ≠Œæœâ Œ±œÄœå Œ±œÖœÑŒ¨ œÑŒ± Œ∂œâŒΩœÑŒ±ŒΩŒ¨ Œ∫œçœÑœÑŒ±œÅŒ±, ŒøŒπ ŒπŒøŒØ ŒµŒØŒΩŒ±Œπ Œ±Œ¥œÅŒ±ŒΩŒµŒØœÇ. Œó ¬´Œ∂œâŒÆ¬ª œÑŒøœÖœÇ, ŒµœÄŒøŒºŒ≠ŒΩœâœÇ, Œ±œÄŒ±ŒπœÑŒµŒØ œÑŒ∑ŒΩ ŒµŒ∫ŒºŒµœÑŒ¨ŒªŒªŒµœÖœÉŒ∑ œÑœâŒΩ Œ≤ŒπŒøœáŒ∑ŒºŒπŒ∫œéŒΩ Œ¥œÅŒ±œÉœÑŒ∑œÅŒπŒøœÑŒÆœÑœâŒΩ ŒµŒΩœåœÇ Œ∂œâŒΩœÑŒ±ŒΩŒøœç Œ∫œÖœÑœÑŒ¨œÅŒøœÖ.<br>ŒåŒªŒøŒπ ŒøŒπ ŒπŒøŒØ ŒµŒØŒΩŒ±Œπ ŒµŒΩŒ¥ŒøŒ∫œÖœÑœÑŒ±œÅŒπŒ∫Œ¨ œÄŒ±œÅŒ¨œÉŒπœÑŒ±. </td></tr><tr><th class="align-baseline">ŒëœÅŒπŒ∏ŒºœåœÇ Œ∫œÖœÑœÑŒ¨œÅœâŒΩ</th><td>ŒúŒøŒΩŒøŒ∫œçœÑœÑŒ±œÅŒø, Œ≠ŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒø</td><td>ŒßœâœÅŒØœÇ Œ∫œçœÑœÑŒ±œÅŒ±, œåœáŒπ Œ∂œâŒΩœÑŒ±ŒΩŒ¨</td></tr><tr><th class="align-baseline">ŒëŒΩŒ±œÄŒ±œÅŒ±Œ≥œâŒ≥ŒÆ</th><td>ŒîŒπŒ±ŒØœÅŒµœÉŒ∑ œÉœÑŒ± 2</td><td>ŒïŒπœÉŒ≤Œ¨ŒªŒªŒµŒπ Œ∫Œ±Œπ Œ∫Œ±œÑŒ±ŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ Œ≠ŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒø ŒæŒµŒΩŒπœÉœÑŒÆ, Œ±ŒΩŒ±Œ≥Œ∫Œ¨Œ∂ŒøŒΩœÑŒ¨œÇ œÑŒø ŒΩŒ± Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒÆœÉŒµŒπ Œ±ŒΩœÑŒØŒ≥œÅŒ±œÜŒ± œÑŒøœÖ œÖŒπŒπŒ∫Œøœç DNA/RNA. ŒöŒ±œÑŒ±œÉœÑœÅŒ≠œÜŒµŒπ œÑŒø Œ∫œçœÑœÑŒ±œÅŒø ŒæŒµŒΩŒπœÉœÑŒÆ Œ±œÄŒµŒªŒµœÖŒ∏ŒµœÅœéŒΩŒøŒΩœÑŒ±œÇ ŒΩŒ≠ŒøœÖœÇ ŒπŒøœçœÇ</td></tr><tr><th class="align-baseline">ŒúŒ≠Œ≥ŒµŒ∏ŒøœÇ</th><td>Œ§Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒµŒØŒΩŒ±Œπ œÄŒøŒªœç ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒ± Œ∫Œ±Œπ Œ∫œÖŒºŒ±ŒØŒΩŒøŒΩœÑŒ±Œπ Œ±œÄœå 800 nm Œ≠œâœÇ 1000 nm. Œ§Œ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒµŒΩœÑŒøœÄŒπœÉœÑŒøœçŒΩ ŒºŒµ œÑŒø œÜœâœÇ ŒµŒΩœåœÇ ŒºŒπŒ∫œÅŒøœÉŒ∫ŒøœÄŒØŒøœÖ.</td><td> Œ§Œø ŒºŒ≠Œ≥ŒµŒ∏ŒøœÇ œÑœâŒΩ ŒπœéŒΩ ŒµŒØŒΩŒ±Œπ Œ±œÄœå 20 nm Œ≠œâœÇ 400 nm. ŒüŒπ ŒπŒøŒØ ŒµŒØŒΩŒ±Œπ ŒøœÅŒ±œÑŒøŒØ ŒºœåŒΩŒø ŒºŒµ Œ∑ŒªŒµŒ∫œÑœÅŒøŒΩŒπŒ∫Œ¨ ŒºŒπŒ∫œÅŒøœÉŒ∫œåœÄŒπŒ±.</td></tr><tr><th class="align-baseline">Œ†ŒªŒµŒøŒΩŒ≠Œ∫œÑŒ∑ŒºŒ±</th><td>ŒüœÅŒπœÉŒºŒ≠ŒΩŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒµŒØŒΩŒ±Œπ œâœÜŒ≠ŒªŒπŒºŒ± (œÄ.œá. ŒøœÅŒπœÉŒºŒ≠ŒΩŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒµŒØŒΩŒ±Œπ œáœÅŒÆœÉŒπŒºŒ± œÉœÑŒø Œ≠ŒΩœÑŒµœÅŒø).</td><td>ŒüŒπ ŒπŒøŒØ Œ¥ŒµŒΩ ŒµŒØŒΩŒ±Œπ œâœÜŒ≠ŒªŒπŒºŒøŒπ. ŒüŒπ ŒπŒøŒØ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± ŒµŒØŒΩŒ±Œπ œáœÅŒÆœÉŒπŒºŒøŒπ œÉœÑŒ∑ Œ≥ŒµŒΩŒµœÑŒπŒ∫ŒÆ ŒºŒ∑œáŒ±ŒΩŒπŒ∫ŒÆ.</td></tr><tr><th class="align-baseline">ŒõŒøŒØŒºœâŒæŒ∑</th><td>Œó Œ≤Œ±Œ∫œÑŒ∑œÅŒπŒ±Œ∫ŒÆ ŒªŒøŒØŒºœâŒæŒ∑ œÄŒµœÅŒπŒøœÅŒØŒ∂ŒµœÑŒ±Œπ œÉœÖŒΩŒÆŒ∏œâœÇ œÉŒµ Œ≠ŒΩŒ± ŒºŒ≠œÅŒøœÇ œÑŒøœÖ œÉœéŒºŒ±œÑŒøœÇ, Œ∫Œ±Œπ œÄŒµœÅŒπŒ≥œÅŒ¨œÜŒµœÑŒ±Œπ œâœÇ œÑŒøœÄŒπŒ∫ŒÆ ŒºœåŒªœÖŒΩœÉŒ∑. ŒüŒπ ŒªŒøŒπŒºœéŒæŒµŒπœÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÄœÅŒøŒ∫ŒªŒ∑Œ∏ŒøœçŒΩ Œ±œÄœå Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒÆ Œ±œÄœå œÑŒøŒæŒØŒΩŒµœÇ (ŒµŒΩŒ¥ŒøœÑŒøŒæŒØŒΩŒµœÇ) œÄŒøœÖ œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒ±Œπ.</td><td>ŒúŒπŒ± ŒπŒøŒ≥ŒµŒΩŒÆœÇ ŒªŒøŒØŒºœâŒæŒ∑ ŒµŒØŒΩŒ±Œπ œÉœÖœÉœÑŒ∑ŒºŒπŒ∫ŒÆ. ŒüŒπ ŒπŒøŒØ ŒºŒøŒªœçŒΩŒøœÖŒΩ Œ≠ŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒø ŒæŒµŒΩŒπœÉœÑŒÆ Œ∫Œ±Œπ œÄŒøŒªŒªŒ±œÄŒªŒ±œÉŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ Œ∫Œ±œÑŒ¨ œáŒπŒªŒπŒ¨Œ¥ŒµœÇ, Œ±œÜŒÆŒΩŒøŒΩœÑŒ±œÇ œÑŒø Œ∫œçœÑœÑŒ±œÅŒø ŒæŒµŒΩŒπœÉœÑŒÆ Œ∫Œ±Œπ ŒºŒøŒªœçŒΩŒøŒΩœÑŒ±œÇ Œ¨ŒªŒªŒ± Œ∫œçœÑœÑŒ±œÅŒ± œÑŒøœÖ œÉœéŒºŒ±œÑŒøœÇ.</td></tr><tr><th class="align-baseline">ŒëœÉŒ∏Œ≠ŒΩŒµŒπŒ±</th><td>ŒüŒπ Œ≤Œ±Œ∫œÑŒ∑œÅŒπŒ±Œ∫Œ≠œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒΩ œÄŒΩŒµœÖŒºŒøŒΩŒØŒ±, œÜœÖŒºŒ±œÑŒØœâœÉŒ∑, œÑŒ≠œÑŒ±ŒΩŒø Œ∫Œ±Œπ œÑœÅŒøœÜŒπŒ∫ŒÆ Œ¥Œ∑ŒªŒ∑œÑŒ∑œÅŒØŒ±œÉŒ∑.</td><td>ŒüŒπ œÉœÖœÉœÑŒ∑ŒºŒ±œÑŒπŒ∫Œ≠œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩœÑŒ±Œπ Œ±œÄœå ŒπŒøŒ≥ŒµŒΩŒÆ ŒªŒøŒØŒºœâŒæŒ∑ œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒΩ œÑŒ∑ Œ≥œÅŒØœÄŒ∑, œÑŒ∑ŒΩ ŒπŒªŒ±œÅŒ¨, œÑŒ∑ŒΩ œÄŒøŒªŒπŒøŒºœÖŒµŒªŒØœÑŒπŒ¥Œ±, œÑŒø AIDS Œ∫Œ±Œπ œÑŒø COVID-19.</td></tr><tr><th class="align-baseline">ŒòŒµœÅŒ±œÄŒµŒØŒ±</th><td>Œ§Œ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ∫Œ±Œπ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄœÅŒøŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒΩ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±.</td><td>Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± ŒµŒºœÄŒøŒ¥ŒØŒ∂ŒøœÖŒΩ œÑŒ∑ŒΩ ŒµŒæŒ¨œÄŒªœâœÉŒ∑ Œ∫Œ±Œπ œÑŒ± Œ±ŒΩœÑŒπŒπŒπŒ∫Œ¨ œÜŒ¨œÅŒºŒ±Œ∫Œ± Œ≤ŒøŒ∑Œ∏ŒøœçŒΩ œÉœÑŒ∑ŒΩ ŒµœÄŒπŒ≤œÅŒ¨Œ¥œÖŒΩœÉŒ∑ œÑŒ∑œÇ Œ±ŒΩŒ±œÄŒ±œÅŒ±Œ≥œâŒ≥ŒÆœÇ, Œ±ŒªŒªŒ¨ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÑŒ∑ŒΩ œÉœÑŒ±ŒºŒ±œÑŒÆœÉŒøœÖŒΩ ŒµŒΩœÑŒµŒªœéœÇ.</td></tr></tbody></table>',1),ze=e("b",null,"Œ£Œ∑ŒºŒµŒØœâœÉŒ∑! Œ§Œ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨",-1),Fe=e("b",null,"Œ±ŒΩœÑŒπŒπŒπŒ∫Œ¨ œÜŒ¨œÅŒºŒ±Œ∫Œ±",-1),Ne=e("b",null,"Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ±",-1),Pe=i('<section class="e-card"><h4 class="mt-4">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/" rel="noreferrer noopener" target="_blank">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16" rel="noreferrer noopener" target="_blank">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="http://www.hcrowder.com/disease-reading.html" rel="noreferrer noopener" target="_blank">http://www.hcrowder.com/disease-reading.html</a></li></ul></section>',1),$e=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. ŒìŒπŒ±œÑŒØ œÑŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ¥ŒµŒΩ œÉŒ∫ŒøœÑœéŒΩŒøœÖŒΩ œÑŒøœÖœÇ ŒπŒøœçœÇ;</h2><p> Œ§Œ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÉŒ∫ŒøœÑœéœÉŒøœÖŒΩ œÑŒøœÖœÇ ŒπŒøœçœÇ ŒµœÄŒµŒπŒ¥ŒÆ ŒøŒπ ŒπŒøŒØ Œ≠œáŒøœÖŒΩ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ≠œÇ Œ¥ŒøŒºŒÆ Œ∫Œ±Œπ œÄŒøŒªŒªŒ±œÄŒªŒ±œÉŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ Œ±œÄœå œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. Œ§Œ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ œÉœÑŒøœáŒµœçŒøœÖŒΩ œÑŒøŒΩ ŒºŒ∑œáŒ±ŒΩŒπœÉŒºœå Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑œÇ œÑœâŒΩ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ (œåœáŒπ œÑœâŒΩ ŒπœéŒΩ) Œ≥ŒπŒ± ŒΩŒ± œÉŒ∫ŒøœÑœéœÉŒøœÖŒΩ ŒÆ ŒΩŒ± Œ∫Œ±œÑŒ±œÉœÑŒµŒØŒªŒøœÖŒΩ œÑŒ± œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, Œ∑ œÖœÄŒµœÅŒ≤ŒøŒªŒπŒ∫ŒÆ œáœÅŒÆœÉŒ∑ Œ∫Œ±Œπ Œ∑ Œ±Œ∫Œ±œÑŒ¨ŒªŒªŒ∑ŒªŒ∑ œÉœÖŒΩœÑŒ±Œ≥ŒøŒ≥œÅŒ¨œÜŒ∑œÉŒ∑ Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫œéŒΩ œÄŒ±Œ≥Œ∫ŒøœÉŒºŒØœâœÇ ŒøŒ¥Œ∑Œ≥ŒøœçŒΩ œÉœÑŒø œÄŒ±Œ≥Œ∫œåœÉŒºŒπŒø œÖŒ≥ŒµŒπŒøŒΩŒøŒºŒπŒ∫œå Œ∂ŒÆœÑŒ∑ŒºŒ± œÑŒ∑œÇ Œ±ŒΩŒ∏ŒµŒ∫œÑŒπŒ∫œåœÑŒ∑œÑŒ±œÇ œÉœÑŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨. ŒîŒµŒØœÑŒµ œÉœÑŒøŒΩ Œ†ŒØŒΩŒ±Œ∫Œ± 2 œÉŒµ œÄŒøŒπŒµœÇ œÉœÖŒΩŒ∏ŒÆŒ∫ŒµœÇ œÑŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± ŒµŒØŒΩŒ±Œπ œáœÅŒÆœÉŒπŒºŒ± (Œ£Œ∑ŒºŒµŒØœâœÉŒ∑! Œó Œ±œÄœåœÜŒ±œÉŒ∑ Œ≥ŒπŒ± œÑŒ∑ œáœÅŒÆœÉŒ∑ œÑŒøœÖœÇ Œ∏Œ± ŒªŒ∑œÜŒ∏ŒµŒØ Œ±œÄœå œÑŒøŒΩ Œ≥ŒπŒ±œÑœÅœå œÉŒ±œÇ). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Œ†ŒØŒΩŒ±Œ∫Œ±œÇ 2.</b> ŒëŒΩŒ¨Œ≥Œ∫Œ∑ Œ≥ŒπŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ±œÄœå Œ∫ŒøŒπŒΩŒ≠œÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ œÑŒøœÖ Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒπŒ∫Œøœç </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Œ£œÖŒΩŒÆŒ∏ŒµŒπœÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ œÑŒøœÖ Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒπŒ∫Œøœç</th><th colspan="3" class="border p-1">Œ£œÖŒΩŒÆŒ∏Œ∑œÇ ŒëŒπœÑŒØŒ±</th><th rowspan="2" class="border p-1">ŒßœÅŒµŒπŒ¨Œ∂ŒµœÑŒ±Œπ ŒëŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫œå;</th></tr><tr><th class="border p-1">ŒôœåœÇ</th><th class="border p-1">ŒôœåœÇ ŒÆ ŒíŒ±Œ∫œÑŒÆœÅŒπŒø</th><th class="border p-1">ŒíŒ±Œ∫œÑŒÆœÅŒπŒø</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">ŒöŒøŒπŒΩœå Œ∫œÅœÖŒøŒªœåŒ≥Œ∑ŒºŒ± / Œ∫Œ±œÑŒ±œÅœÅŒøŒÆ</td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ŒåœáŒπ</td></tr><tr><td class="border p-1">Œ†ŒøŒΩœåŒªŒ±ŒπŒºŒøœÇ</td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ŒåœáŒπ</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ŒåœáŒπ</td></tr><tr><td class="border p-1">ŒìœÅŒØœÄŒ∑</td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ŒåœáŒπ</td></tr><tr><td class="border p-1">ŒíœÅŒøŒ≥œáŒØœÑŒπŒ¥Œ± / Œ∫œÅœçœâŒºŒ± œÉœÑŒø œÉœÑŒÆŒ∏ŒøœÇ<br><span class="text-sm italic">(œÉŒµ Œ∫Œ±œÑŒ¨ œÑŒ± Œ¨ŒªŒªŒ± œÖŒ≥ŒπŒÆ œÄŒ±ŒπŒ¥ŒπŒ¨ Œ∫Œ±Œπ ŒµŒΩŒÆŒªŒπŒ∫ŒµœÇ)</span> *</td><td class="border p-1"></td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1">*ŒåœáŒπ</td></tr><tr><td class="border p-1">ŒõŒøŒØŒºœâŒæŒ∑ ŒºŒ≠œÉŒøœÖ Œ±œÖœÑŒπŒøœç</td><td class="border p-1"></td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">ŒõŒøŒØŒºœâŒæŒ∑ Œ∫œåŒªœÄŒøœÖ</td><td class="border p-1"></td><td class="border p-1">‚àö</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Œ£œÑœÅŒµœÄœÑœåŒ∫ŒøŒ∫Œ∫ŒøœÇ</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">‚àö</td><td class="border p-1">ŒùŒ±Œπ</td></tr><tr><td class="border p-1">ŒöŒøŒ∫Œ∫œçœÑŒ∑œÇ</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">‚àö</td><td class="border p-1">ŒùŒ±Œπ</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* ŒúŒµŒªŒ≠œÑŒµœÇ Œ¥ŒµŒØœáŒΩŒøœÖŒΩ œåœÑŒπ œÉŒµ œÖŒ≥ŒπŒÆ œÄŒ±ŒπŒ¥ŒπŒ¨ Œ∫Œ±Œπ ŒµŒΩŒÆŒªŒπŒ∫ŒµœÇ, œÑŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ≥ŒπŒ± œÑŒ∑ Œ≤œÅŒøŒ≥œáŒØœÑŒπŒ¥Œ± Œ¥ŒµŒΩ Œ∏Œ± Œ≤ŒøŒ∑Œ∏ŒÆœÉŒøœÖŒΩ œÑŒøœÖœÇ Œ±œÉŒ∏ŒµŒΩŒµŒØœÇ ŒΩŒ± Œ±ŒπœÉŒ∏Œ±ŒΩŒ∏ŒøœçŒΩ Œ∫Œ±ŒªœçœÑŒµœÅŒ±.</p><p class="text-xs text-slate-400">Œ†Œ∑Œ≥ŒÆ: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noreferrer noopener">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noreferrer noopener">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Be={id:"s3"},Te=e("h2",{id:"s3t"},"3. Œ†œéœÇ ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒøœçŒΩ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±",-1),Ee=e("h3",null," Œó œÜœÖœÉŒπŒ∫ŒÆ Œ±ŒΩœÑŒØŒ¥œÅŒ±œÉŒ∑ œÑŒøœÖ œÉœéŒºŒ±œÑŒøœÇ ",-1),Re=e("p",null,[a(" ŒàŒΩŒ± "),e("span",{class:"e-term font-Heading"},"œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø"),a(" ŒºœÄŒøœÅŒµŒØ ŒΩŒ± ŒµŒØŒΩŒ±Œπ Œ≤Œ±Œ∫œÑŒÆœÅŒπŒø, ŒπœåœÇ, œÄŒ±œÅŒ¨œÉŒπœÑŒø ŒÆ ŒºœçŒ∫Œ∑œÑŒ±œÇ Œ∫Œ±Œπ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÄœÅŒøŒ∫Œ±ŒªŒ≠œÉŒµŒπ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± œÉœÑŒø œÉœéŒºŒ±. ŒöŒ¨Œ∏Œµ œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø Œ±œÄŒøœÑŒµŒªŒµŒØœÑŒ±Œπ Œ±œÄœå œÄŒøŒªŒªŒ¨ ŒºŒπŒ∫œÅœåœÑŒµœÅŒ± œÑŒºŒÆŒºŒ±œÑŒ±, œÉœÖŒΩŒÆŒ∏œâœÇ ŒºŒøŒΩŒ±Œ¥ŒπŒ∫Œ¨ Œ≥ŒπŒ± œÑŒø œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø Œ∫Œ±Œπ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ. Œ§Œø œÑŒºŒÆŒºŒ± ŒµŒΩœåœÇ œÄŒ±Œ∏ŒøŒ≥œåŒΩŒøœÖ œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ œÑŒø œÉœáŒ∑ŒºŒ±œÑŒπœÉŒºœå Œ±ŒΩœÑŒπœÉœâŒºŒ¨œÑœâŒΩ ŒøŒΩŒøŒºŒ¨Œ∂ŒµœÑŒ±Œπ Œ±ŒΩœÑŒπŒ≥œåŒΩŒø. Œ§Œ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÄŒøœÖ œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒ±Œπ œâœÇ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ œÉœÑŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø œÑŒøœÖ œÄŒ±Œ∏ŒøŒ≥œåŒΩŒøœÖ ŒµŒØŒΩŒ±Œπ Œ±œÄŒ±œÅŒ±ŒØœÑŒ∑œÑŒ± Œ≥ŒπŒ± œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ±. ŒúœÄŒøœÅŒµŒØœÑŒµ ŒΩŒ± Œ∏ŒµœâœÅŒÆœÉŒµœÑŒµ œÑŒ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œâœÇ œÑŒøœÖœÇ œÉœÑœÅŒ±œÑŒπœéœÑŒµœÇ œÉœÑŒø Œ±ŒºœÖŒΩœÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± œÑŒøœÖ œÉœéŒºŒ±œÑœåœÇ œÉŒ±œÇ. ŒàœáŒøœÖŒºŒµ œáŒπŒªŒπŒ¨Œ¥ŒµœÇ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÉœÑŒø œÉœéŒºŒ± ŒºŒ±œÇ Œ∫Œ±Œπ œÑŒø Œ∫Œ±Œ∏Œ≠ŒΩŒ± ŒµŒØŒΩŒ±Œπ ŒµŒ∫œÄŒ±ŒπŒ¥ŒµœÖŒºŒ≠ŒΩŒø ŒΩŒ± Œ±ŒΩŒ±Œ≥ŒΩœâœÅŒØŒ∂ŒµŒπ Œ≠ŒΩŒ± œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø. ŒåœÑŒ±ŒΩ œÑŒø Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒø œÉœéŒºŒ± ŒµŒ∫œÑŒØŒ∏ŒµœÑŒ±Œπ œÉŒµ Œ≠ŒΩŒ± Œ±ŒΩœÑŒπŒ≥œåŒΩŒø Œ≥ŒπŒ± œÄœÅœéœÑŒ∑ œÜŒøœÅŒ¨, œáœÅŒµŒπŒ¨Œ∂ŒµœÑŒ±Œπ œáœÅœåŒΩŒøœÇ Œ≥ŒπŒ± ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± Œ∫Œ±Œπ ŒΩŒ± œÄŒ±œÅŒ¨Œ≥ŒµŒπ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± ŒµŒπŒ¥ŒπŒ∫Œ¨ Œ≥ŒπŒ± Œ±œÖœÑœå œÑŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø (Œ£œáŒÆŒºŒ± 2). ")],-1),He=e("p",null," Œ§Œ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÉŒµ Œ≠ŒΩŒ± œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø Œ≥ŒµŒΩŒπŒ∫Œ¨ Œ¥ŒµŒΩ œÄœÅŒøœÉœÑŒ±œÑŒµœçŒøœÖŒΩ Œ±œÄœå Œ≠ŒΩŒ± Œ¨ŒªŒªŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø, ŒµŒ∫œÑœåœÇ ŒµŒ¨ŒΩ Œ¥œçŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒ± ŒµŒØŒΩŒ±Œπ œÄŒøŒªœç œÄŒ±œÅœåŒºŒøŒπŒ± ŒºŒµœÑŒ±Œæœç œÑŒøœÖœÇ. ŒúœåŒªŒπœÇ œÄŒ±œÅŒ±œáŒ∏ŒøœçŒΩ œÑŒ± ŒµŒπŒ¥ŒπŒ∫Œ¨ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± Œ≥ŒπŒ± Œ∫Œ¨œÄŒøŒπŒø œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø œÉœÖŒΩŒµœÅŒ≥Œ¨Œ∂ŒøŒΩœÑŒ±Œπ ŒºŒµ œÑŒø œÖœÄœåŒªŒøŒπœÄŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± Œ≥ŒπŒ± ŒΩŒ± Œ∫Œ±œÑŒ±œÉœÑœÅŒ≠œàŒøœÖŒΩ œÑŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø Œ∫Œ±Œπ ŒΩŒ± œÉœÑŒ±ŒºŒ±œÑŒÆœÉŒøœÖŒΩ œÑŒ∑ ŒΩœåœÉŒø. ŒöŒ±Œ∏œéœÇ œÑŒø œÉœéŒºŒ± œÉœÑŒ∑ŒΩ Œ±œÅœáŒπŒ∫ŒÆ œÑŒøœÖ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ œÄŒ±œÅŒ¨Œ≥ŒµŒπ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÉŒµ Œ≠ŒΩŒ± Œ±ŒΩœÑŒπŒ≥œåŒΩŒø, Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒµŒØ ŒµœÄŒØœÉŒ∑œÇ Œ∫œçœÑœÑŒ±œÅŒ± ŒºŒΩŒÆŒºŒ∑œÇ œÑŒ± ŒøœÄŒøŒØŒ± œÄŒ±œÅŒ±ŒºŒ≠ŒΩŒøœÖŒΩ Œ∂œâŒΩœÑŒ±ŒΩŒ¨ Œ±Œ∫œåŒºŒ∑ Œ∫Œ±Œπ œåœÑŒ±ŒΩ œÑŒ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± ŒΩŒπŒ∫ŒÆœÉŒøœÖŒΩ œÑŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø Œ∫Œ±Œπ œÑŒ± ŒøœÄŒøŒØŒ± ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÄŒ±œÅŒ¨ŒæŒøœÖŒΩ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÑŒ∑ŒΩ ŒµœÄœåŒºŒµŒΩŒ∑ œÜŒøœÅŒ¨ œÄŒøœÖ Œ∏Œ± œÑŒ± œáœÅŒµŒπŒ±œÉœÑŒµŒØ Œø ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœåœÇ. ŒëœÇ œÖœÄŒøŒ∏Œ≠œÉŒøœÖŒºŒµ œåœÑŒπ œÑŒø œÉœéŒºŒ± ŒµŒ∫œÑŒØŒ∏ŒµœÑŒ±Œπ œÉœÑŒø ŒØŒ¥ŒπŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø œÄŒ¨ŒΩœâ Œ±œÄœå ŒºŒØŒ± œÜŒøœÅŒ¨, œÉŒµ Œ±œÖœÑŒÆ œÑŒ∑ŒΩ œÄŒµœÅŒØœÄœÑœâœÉŒ∑ Œ∑ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ Œ±ŒΩœÑŒπœÉœâŒºŒ¨œÑœâŒΩ ŒµŒØŒΩŒ±Œπ œÄŒøŒªœç œÄŒπŒø Œ≥œÅŒÆŒ≥ŒøœÅŒ∑ Œ∫Œ±Œπ œÄŒπŒø Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫ŒÆ Œ±œÄœå œÑŒ∑ŒΩ œÄœÅœéœÑŒ∑ œÜŒøœÅŒ¨ ŒµœÄŒµŒπŒ¥ŒÆ œÑŒ± Œ∫œçœÑœÑŒ±œÅŒ± ŒºŒΩŒÆŒºŒ∑œÇ ŒµŒØŒΩŒ±Œπ Œ≠œÑŒøŒπŒºŒ± ŒΩŒ± œÄŒ±œÅŒ¨ŒæŒøœÖŒΩ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± ŒµŒΩŒ±ŒΩœÑŒØŒøŒΩ Œ±œÖœÑŒøœç œÑŒøœÖ Œ±ŒΩœÑŒπŒ≥œåŒΩŒøœÖ. ŒëœÖœÑœå œÉŒ∑ŒºŒ±ŒØŒΩŒµŒπ œåœÑŒπ ŒµŒ¨ŒΩ œÑŒø Œ¨œÑŒøŒºŒø ŒµŒ∫œÑŒµŒ∏ŒµŒØ œÉŒµ Œ≠ŒΩŒ± ŒµœÄŒπŒ∫ŒØŒΩŒ¥œÖŒΩŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø œÉœÑŒø ŒºŒ≠ŒªŒªŒøŒΩ, œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÑŒøœÖ œÉœçœÉœÑŒ∑ŒºŒ± Œ∏Œ± ŒµŒØŒΩŒ±Œπ œÉŒµ Œ∏Œ≠œÉŒ∑ ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ Œ¨ŒºŒµœÉŒ±, œÄœÅŒøœÉœÑŒ±œÑŒµœçŒøŒΩœÑŒ±œÇ œÑŒø Œ±œÄœå œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±. ",-1),We=e("b",null,"Œ£œáŒÆŒºŒ± 2.",-1),Ke=e("h3",null,"Œ†œéœÇ Œ≤ŒøŒ∑Œ∏ŒøœçŒΩ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±;",-1),Ye=e("p",null," Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± ŒºŒµŒπœéŒΩŒøœÖŒΩ œÑŒøŒΩ Œ∫ŒØŒΩŒ¥œÖŒΩŒø ŒµŒºœÜŒ¨ŒΩŒπœÉŒ∑œÇ ŒºŒπŒ±œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±œÇ Œ∫Œ±Œ∏œéœÇ œÉœÖŒΩŒµœÅŒ≥Œ¨Œ∂ŒøŒΩœÑŒ±Œπ ŒºŒµ œÑŒπœÇ œÜœÖœÉŒπŒ∫Œ≠œÇ Œ¨ŒºœÖŒΩŒµœÇ œÑŒøœÖ œÉœéŒºŒ±œÑœåœÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ ŒøŒπŒ∫ŒøŒ¥œåŒºŒ∑œÉŒ∑ œÄœÅŒøœÉœÑŒ±œÉŒØŒ±œÇ. ŒåœÑŒ±ŒΩ Œ∫Œ¨ŒΩŒøœÖŒºŒµ Œ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒø, œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå ŒºŒ±œÇ œÉœçœÉœÑŒ∑ŒºŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒØŒΩŒµœÑŒ±Œπ Œ∫Œ±Œ∏œéœÇ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒ± ŒÆ Œ±ŒΩŒµŒΩŒµœÅŒ≥Œ¨ ŒºŒ≠œÅŒ∑ ŒµŒΩœåœÇ œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒøœÖ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœç (Œ±ŒΩœÑŒπŒ≥œåŒΩŒ±) œÄŒøœÖ œÄœÖœÅŒøŒ¥ŒøœÑŒøœçŒΩ ŒºŒπŒ± Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ ŒµŒΩœÑœåœÇ œÑŒøœÖ œÉœéŒºŒ±œÑŒøœÇ ŒºŒ±œÇ (Œ£œáŒÆŒºŒ± 3). Œ§Œ± œÄŒπŒø œÉœçŒ≥œáœÅŒøŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ± ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒøœçŒΩ ŒºŒµ Œ≤Œ¨œÉŒ∑ Œ∫Œ¨œÄŒøŒπŒ±œÇ ŒºŒøœÅœÜŒÆœÇ ¬´œÉœáŒµŒ¥ŒØŒøœÖ¬ª Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄŒ±œÅŒ±Œ≥œâŒ≥ŒÆ Œ±ŒΩœÑŒπŒ≥œåŒΩœâŒΩ Œ∫Œ±Œπ œåœáŒπ ŒºŒµ œÑŒø ŒØŒ¥ŒπŒø œÑŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø. ŒëŒΩŒµŒæŒ¨œÅœÑŒ∑œÑŒ± Œ±œÄœå œÑŒø Œ±ŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø Œ±œÄŒøœÑŒµŒªŒµŒØœÑŒ±Œπ Œ±œÄœå œÑŒø ŒØŒ¥ŒπŒø œÑŒø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø ŒÆ Œ±œÄœå œÑŒø ¬´œÉœáŒ≠Œ¥ŒπŒø¬ª Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄŒ±œÅŒ±Œ≥œâŒ≥ŒÆ œÑŒøœÖ Œ±ŒΩœÑŒπŒ≥œåŒΩŒøœÖ, Œ±œÖœÑŒÆ Œ∑ ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒ∑ ŒµŒ∫Œ¥ŒøœáŒÆ Œ¥ŒµŒΩ Œ∏Œ± œÄœÅŒøŒ∫Œ±ŒªŒ≠œÉŒµŒπ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± œÉœÑŒø Œ¨œÑŒøŒºŒø œÄŒøœÖ ŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø. ŒëŒΩœÑŒπŒ∏Œ≠œÑœâœÇ, Œ∏Œ± œâŒ∏ŒÆœÉŒµŒπ œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÑŒøœÖ œÉœçœÉœÑŒ∑ŒºŒ± ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ œÄŒµœÅŒØœÄŒøœÖ œåœÄœâœÇ Œ∏Œ± ŒµŒØœáŒµ Œ±ŒΩœÑŒπŒ¥œÅŒ¨œÉŒµŒπ œÉœÑŒ∑ŒΩ œÄœÅœéœÑŒ∑ œÑŒøœÖ ŒµœÄŒ±œÜŒÆ ŒºŒµ œÑŒø œÄœÅŒ±Œ≥ŒºŒ±œÑŒπŒ∫œå œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø. ",-1),Ue=e("b",null,"Œ£œáŒÆŒºŒ± 3.",-1),Je=i('<p> Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒøœçŒΩ ŒµŒ∫Œ∏Œ≠œÑŒøŒΩœÑŒ±œÇ œÑŒ± ŒªŒµœÖŒ∫Œ¨ Œ±ŒπŒºŒøœÉœÜŒ±ŒØœÅŒπŒ± œÑŒøœÖ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœç œÉœÑŒ∑ŒΩ ŒæŒ≠ŒΩŒ∑ œÄœÅœâœÑŒµŒêŒΩŒ∑ ŒµŒΩœåœÇ ŒπŒøœç. ŒúœåŒªŒπœÇ œÑŒø œÉœéŒºŒ± œÉŒ±œÇ Œ∫ŒªŒ∑Œ∏ŒµŒØ ŒΩŒ± Œ±ŒΩœÑŒπŒºŒµœÑœâœÄŒØœÉŒµŒπ Œ≠ŒΩŒ±ŒΩ Œπœå Œ∫Œ±Œπ œÄœÅŒ±Œ≥ŒºŒ±œÑŒøœÄŒøŒπŒÆœÉŒµŒπ ŒºŒπŒ± Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ œÉœÑŒøŒΩ Œπœå (Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥œéŒΩœÑŒ±œÇ Œí Œ∫Œ±Œπ Œ§ Œ∫œçœÑœÑŒ±œÅŒ±), ¬´Œ±œÄŒøŒ∏Œ∑Œ∫ŒµœçŒµŒπ¬ª œÑŒ± Œí Œ∫Œ±Œπ Œ§ Œ∫œçœÑœÑŒ±œÅŒ± Œ≠œÑœÉŒπ œéœÉœÑŒµ Œ±ŒΩ Œø ŒØŒ¥ŒπŒøœÇ ŒπœåœÇ ŒÆ Œ≤Œ±Œ∫œÑŒÆœÅŒπŒø ŒºŒøŒªœçŒΩŒµŒπ ŒæŒ±ŒΩŒ¨ œÑŒø œÉœéŒºŒ±, œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± ŒΩŒ± ŒºœÄŒøœÅŒµŒØ ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ ŒµŒºœÄŒøŒ¥ŒØŒ∂ŒøŒΩœÑŒ±œÇ œÑŒø œÄŒ±Œ∏ŒøŒ≥œåŒΩŒø œÄŒøœÖ œÉŒ±œÇ Œ∫Œ¨ŒΩŒµŒπ ŒΩŒ± Œ±ŒπœÉŒ∏Œ±ŒΩŒ∏ŒµŒØœÑŒµ Œ¨œÅœÅœâœÉœÑŒøŒπ. Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± ¬´œÉœÖœÉœÑŒÆŒΩŒøœÖŒΩ¬ª œÉœÑŒø œÉœéŒºŒ± œÑŒøŒΩ Œπœå Œ≠œÑœÉŒπ œéœÉœÑŒµ œÑŒø œÉœéŒºŒ± ŒΩŒ± ŒæŒµŒ∫ŒπŒΩŒÆœÉŒµŒπ ŒΩŒ± œÄŒ±œÅŒ¨Œ≥ŒµŒπ Œí Œ∫Œ±Œπ Œ§ Œ∫œçœÑœÑŒ±œÅŒ± œáœâœÅŒØœÇ ŒΩŒ± Œ≠œáŒµŒπ Œ±œÅœÅœâœÉœÑŒÆœÉŒµŒπ. </p><h3>ŒïŒºŒ≤ŒøŒªŒπŒ±œÉŒºœåœÇ Œ∫Œ±Œπ œÉœÖŒΩŒ±œÜŒµŒØœÇ œÄœÅŒøŒ∫ŒªŒÆœÉŒµŒπœÇ</h3><p> Œ§œéœÅŒ± Œ¥ŒπŒ±Œ∏Œ≠œÑŒøœÖŒºŒµ ŒµŒºŒ≤œåŒªŒπŒ± Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄœÅœåŒªŒ∑œàŒ∑ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅœâŒΩ Œ±œÄœå 20 Œ±œÄŒµŒπŒªŒ∑œÑŒπŒ∫œéŒΩ Œ≥ŒπŒ± œÑŒ∑ Œ∂œâŒÆ Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ, Œ≤ŒøŒ∑Œ∏œéŒΩœÑŒ±œÇ œÑŒøœÖœÇ Œ±ŒΩŒ∏œÅœéœÄŒøœÖœÇ œåŒªœâŒΩ œÑœâŒΩ Œ∑ŒªŒπŒ∫ŒπœéŒΩ ŒΩŒ± Œ∂ŒÆœÉŒøœÖŒΩ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒø Œ±ŒªŒªŒ¨ Œ∫Œ±Œπ œÄŒπŒø œÄŒøŒπŒøœÑŒπŒ∫Œ¨. Œü ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºœåœÇ œÉŒÆŒºŒµœÅŒ± Œ±œÄŒøœÑœÅŒ≠œÄŒµŒπ 2-3 ŒµŒ∫Œ±œÑŒøŒºŒºœçœÅŒπŒ± Œ∏Œ±ŒΩŒ¨œÑŒøœÖœÇ ŒµœÑŒ∑œÉŒØœâœÇ Œ±œÄœå Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œåœÄœâœÇ Œ∑ Œ¥ŒπœÜŒ∏ŒµœÅŒØœÑŒπŒ¥Œ±, Œø œÑŒ≠œÑŒ±ŒΩŒøœÇ, Œø Œ∫ŒøŒ∫Œ∫œçœÑŒ∑œÇ, Œ∑ Œ≥œÅŒØœÄŒ∑ Œ∫Œ±Œπ Œ∑ ŒπŒªŒ±œÅŒ¨. </p><p> ŒàœáŒøœÖŒºŒµ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœçœÇ ŒµŒΩŒ¨ŒΩœÑŒπŒ± œÉŒµ œÄŒøŒªŒªŒ≠œÇ œÉŒøŒ≤Œ±œÅŒ≠œÇ ŒπŒøŒ≥ŒµŒΩŒµŒØœÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ (œÄ.œá. ŒπŒªŒ±œÅŒ¨, œÄŒ±œÅœâœÑŒØœÑŒπŒ¥Œ±, Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ± Œë, Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ± Œí Œ∫Œ±Œπ ŒøœÅŒπœÉŒºŒ≠ŒΩŒøœÖœÇ ŒπŒøœçœÇ ‚Äì œåœÄœâœÇ Œ±œÖœÑŒøŒØ œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩ œÑŒø Œ∫ŒøŒπŒΩœå Œ∫œÅœÖŒøŒªœåŒ≥Œ∑ŒºŒ±). Œ©œÉœÑœåœÉŒø, œÑŒø œÄœÅœåŒ≤ŒªŒ∑ŒºŒ± œåœÑŒπ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒºŒµœÑŒ±ŒªŒªŒ±œáŒ∏ŒøœçŒΩ Œ±œÄœå œÑŒø Œ≠ŒΩŒ± Œ¨œÑŒøŒºŒø œÉœÑŒø Œ¨ŒªŒªŒø œÄŒ±œÅŒ±ŒºŒ≠ŒΩŒµŒπ. ŒåœÑŒ±ŒΩ Œø ŒπœåœÇ ŒºŒµœÑŒ±ŒªŒªŒ¨œÉœÉŒµœÑŒ±Œπ Œ±ŒªŒªŒ¨Œ∂ŒµŒπ Œ±œÅŒ∫ŒµœÑŒ¨, ŒºŒµ Œ±œÄŒøœÑŒ≠ŒªŒµœÉŒºŒ± œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± ŒΩŒ± ŒºŒ∑ŒΩ œÑŒøŒΩ Œ±ŒΩŒ±Œ≥ŒΩœâœÅŒØŒ∂ŒµŒπ œÄŒªŒ≠ŒøŒΩ. Œ§Œ± Œ∫œçœÑœÑŒ±œÅŒ± œÑŒøœÖ Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫Œøœç œÄŒøœÖ Œ±œÄŒøŒ∏Œ∑Œ∫ŒµœçŒøŒΩœÑŒ±Œπ Œ≥ŒπŒ± œÑŒ∑ Œ±ŒΩœÑŒπŒºŒµœÑœéœÄŒπœÉŒ∑ œÑŒøœÖ ŒπŒøœç Œ¥ŒµŒΩ œÑŒø Œ±ŒΩŒ±Œ≥ŒΩœâœÅŒØŒ∂ŒøœÖŒΩ œÄŒªŒ≠ŒøŒΩ œâœÇ œÑŒ∑ŒΩ ŒØŒ¥ŒπŒ± Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± Œ∫Œ±Œπ Œ¥ŒµŒΩ ŒæŒ≠œÅŒøœÖŒΩ œÄœéœÇ ŒΩŒ± œÑŒø œÉŒ∫ŒøœÑœéœÉŒøœÖŒΩ. ŒïœÜœåœÉŒøŒΩ Œø ŒπœåœÇ Œ¥ŒµŒΩ Œ≥ŒØŒΩŒµœÑŒ±Œπ Œ±ŒΩœÑŒπŒªŒ∑œÄœÑœåœÇ Œ±œÄœå œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ±, ŒºŒπŒ± ŒºœåŒªœÖŒΩœÉŒ∑ Œ±œÄœå œÑŒøŒΩ ŒØŒ¥ŒπŒø Œπœå ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÉœÖŒºŒ≤ŒµŒØ. Œü ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºœåœÇ Œ≥ŒπŒ± Œ±œÖœÑŒøœçœÇ œÑŒøœÖœÇ ŒπŒøœçœÇ ŒµŒØŒΩŒ±Œπ Œ¥œçœÉŒ∫ŒøŒªŒøœÇ ŒµœÄŒµŒπŒ¥ŒÆ Œ≠œáŒøœÖŒΩ ŒÆŒ¥Œ∑ Œ±ŒªŒªŒ¨ŒæŒµŒπ œÑŒ∑ ŒºŒøœÅœÜŒÆ œÑŒøœÖœÇ ŒºŒ≠œáœÅŒπ ŒΩŒ± Œ±ŒΩŒ±œÄœÑœÖœáŒ∏ŒøœçŒΩ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noreferrer noopener">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noreferrer noopener">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noreferrer noopener">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noreferrer noopener">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Le=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Œó Œ¥ŒπŒ±Œ¥ŒπŒ∫Œ±œÉŒØŒ± Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑œÇ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ, Œ±œÉœÜŒ¨ŒªŒµŒπŒ± ŒµŒºŒ≤ŒøŒªŒØœâŒΩ</h2><h3>ŒëŒΩŒ¨œÄœÑœÖŒæŒ∑</h3><p> Œó Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ ŒæŒµŒ∫ŒπŒΩŒ¨ œÉœÖŒΩŒÆŒ∏œâœÇ œÉŒµ Œ≠ŒΩŒ± ŒµœÅŒµœÖŒΩŒ∑œÑŒπŒ∫œå ŒµœÅŒ≥Œ±œÉœÑŒÆœÅŒπŒø Œ†Œ±ŒΩŒµœÄŒπœÉœÑŒ∑ŒºŒØŒøœÖ, ŒπŒ±œÑœÅŒπŒ∫Œøœç Œ∫Œ≠ŒΩœÑœÅŒøœÖ ŒÆ œÉŒµ ŒºŒπŒ± ŒºŒπŒ∫œÅŒÆ ŒµœÑŒ±ŒπœÅŒµŒØŒ± Œ≤ŒπŒøœÑŒµœáŒΩŒøŒªŒøŒ≥ŒØŒ±œÇ. ŒöŒ±œÑŒ¨ œÑŒ∑ŒΩ Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ, ŒøŒπ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ Œ±ŒΩŒ±œÄœÑœçœÉœÉŒøœÖŒΩ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ Œ±ŒΩœÑŒπŒ¥œÅŒ±œÉœÑŒÆœÅŒπŒ± Œ≥ŒπŒ± ŒΩŒ± Œ¥ŒøŒ∫ŒπŒºŒ¨œÉŒøœÖŒΩ Œ∫Œ±Œπ ŒΩŒ± ŒºŒµœÑœÅŒÆœÉŒøœÖŒΩ œÑŒ∑ŒΩ ŒµœÄŒØŒ¥œÅŒ±œÉŒÆ œÑŒøœÖœÇ (ŒÆ œÑŒ∑ŒΩ Œ≠ŒªŒªŒµŒπœàŒÆ œÑŒøœÖœÇ). Œ£œÖœáŒΩŒ¨ œáœÅŒµŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ œáœÅœåŒΩŒπŒ± Œ≠œÅŒµœÖŒΩŒ±œÇ Œ≥ŒπŒ± ŒΩŒ± Œ±ŒΩŒ±œÄœÑœÖœáŒ∏ŒøœçŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫Œ≠œÇ ŒπŒ¥Œ≠ŒµœÇ. </p><p> ŒîŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫ŒøŒØ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ ŒÆ ŒµœÅŒµœÖŒΩŒ∑œÑŒπŒ∫Œ≠œÇ ŒøŒºŒ¨Œ¥ŒµœÇ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÉœÖŒΩŒµœÅŒ≥Œ¨Œ∂ŒøŒΩœÑŒ±Œπ œÄŒ±œÅŒ¨ŒªŒªŒ∑ŒªŒ± Œ≥ŒπŒ± œÑŒ∑ŒΩ ŒµœÄŒØœÑŒµœÖŒæŒÆ Œ∫ŒøŒπŒΩœéŒΩ œÉœÑœåœáœâŒΩ Œ∫Œ±œÑŒ¨ œÑŒ∑ŒΩ Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑ ŒµŒΩœåœÇ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ. Œó œÄœÅœåŒøŒ¥ŒøœÇ œÑŒ∑œÇ ŒµœÅŒ≥Œ±œÉŒØŒ±œÇ œÄŒ±œÅŒøœÖœÉŒπŒ¨Œ∂ŒµœÑŒ±Œπ œÉŒµ Œ¥ŒπŒ¨œÜŒøœÅŒµœÇ œÉœÖŒΩŒ±ŒΩœÑŒÆœÉŒµŒπœÇ Œ∫Œ±Œπ Œ¥Œ∑ŒºŒøœÉŒπŒµœçŒµœÑŒ±Œπ œÉŒµ Œ±ŒæŒπœåŒªŒøŒ≥Œ± ŒµœÄŒπœÉœÑŒ∑ŒºŒøŒΩŒπŒ∫Œ¨ œÄŒµœÅŒπŒøŒ¥ŒπŒ∫Œ¨. ŒïŒ¨ŒΩ Œ∫Œ¨œÄŒøŒπŒ± ŒºŒµŒªŒ≠œÑŒ∑ œÜŒ±ŒØŒΩŒµœÑŒ±Œπ œÄŒøŒªŒªŒÆ œÖœÄŒøœÉœáœåŒºŒµŒΩŒ∑, ŒøŒπ œÜŒ±œÅŒºŒ±Œ∫ŒµœÖœÑŒπŒ∫ŒøŒØ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÄœÅŒøœÉŒµŒ≥Œ≥ŒØœÉŒøœÖŒΩ œåœÉŒøœÖœÇ ŒµœÅŒ≥Œ¨Œ∂ŒøŒΩœÑŒ±Œπ œÄŒ¨ŒΩœâ œÉŒµ Œ±œÖœÑŒÆ Œ≥ŒπŒ± ŒΩŒ± ŒµœÄŒµŒ∫œÑŒµŒØŒΩŒøœÖŒΩ œÑŒ∑ŒΩ Œ≠œÅŒµœÖŒΩŒ¨ œÑŒøœÖœÇ œÄœÅŒøœÇ œÑŒ∑ŒΩ Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑ œÄœÅŒøœäœåŒΩœÑœâŒΩ. </p><h3>ŒîŒøŒ∫ŒπŒºŒÆ</h3><p> ŒïŒ¨ŒΩ Œ≤œÅŒµŒ∏ŒµŒØ Œ≠ŒΩŒ± œÖœÄŒøœÉœáœåŒºŒµŒΩŒø ŒµŒºŒ≤œåŒªŒπŒø, œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± Œ¥ŒøŒ∫ŒπŒºŒ±œÉœÑŒµŒØ œÉŒµ Œ∂œéŒ±. ŒëœÖœÑœå Œ±œÄŒøœÑŒµŒªŒµŒØ œÑŒ∑ŒΩ œÄœÅŒø-Œ∫ŒªŒπŒΩŒπŒ∫ŒÆ œÜŒ¨œÉŒ∑ œÑŒ∑œÇ Œ≠œÅŒµœÖŒΩŒ±œÇ. Œ†œÅœéœÑŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒΩœÑŒ±Œπ ŒºŒπŒ∫œÅŒ¨ Œ∂œéŒ± œåœÄœâœÇ œÄŒøŒΩœÑŒØŒ∫ŒπŒ±, Œ±œÅŒøœÖœÅŒ±ŒØŒøŒπ, Œ∫ŒøœÖŒΩŒ≠ŒªŒπŒ± Œ∫Œ±Œπ Œ¨ŒªŒªŒ±. ŒïŒ¨ŒΩ œÑŒø œÖœÄŒøœàŒÆœÜŒπŒø ŒµŒºŒ≤œåŒªŒπŒø Œ≠œáŒµŒπ Œ±œÄŒøœÑŒ≠ŒªŒµœÉŒºŒ± œÉœÑŒ± ŒºŒπŒ∫œÅŒ¨ Œ∂œéŒ±, œÑœåœÑŒµ œÉœÖŒΩŒÆŒ∏œâœÇ œÄŒµœÅŒΩŒ¨ŒºŒµ Œ∫Œ±Œπ œÉŒµ Œ¥ŒøŒ∫ŒπŒºŒ≠œÇ œÉŒµ ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒ± Œ∂œéŒ±, œåœÄœâœÇ ŒøŒπ œÄŒØŒ∏Œ∑Œ∫ŒøŒπ. ŒïŒ¨ŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œÄœÖœÅŒøŒ¥ŒøœÑŒÆœÉŒµŒπ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ Œ∫Œ±Œπ œÉŒµ Œ±œÖœÑŒ¨, œÑœåœÑŒµ Œ¥ŒøŒ∫ŒπŒºŒ¨Œ∂ŒµœÑŒ±Œπ œÉŒµ Œ±ŒΩŒ∏œÅœéœÄŒøœÖœÇ œÉŒµ œÑœÅŒµŒπœÇ œÜŒ¨œÉŒµŒπœÇ Œ∫ŒªŒπŒΩŒπŒ∫œéŒΩ Œ¥ŒøŒ∫ŒπŒºœéŒΩ (WHO, 2021). </p><p> Œ£œÑŒ∑ Œ¶Œ¨œÉŒ∑ 1, œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œáŒøœÅŒ∑Œ≥ŒµŒØœÑŒ±Œπ œÉŒµ ŒºŒµœÅŒπŒ∫ŒøœçœÇ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ Œ≥ŒπŒ± ŒΩŒ± Œ±ŒæŒπŒøŒªŒøŒ≥ŒÆœÉŒøœÖŒΩ œÑŒ∑ŒΩ Œ±œÉœÜŒ¨ŒªŒµŒπŒ¨ œÑŒøœÖ, ŒΩŒ± ŒµœÄŒπŒ≤ŒµŒ≤Œ±ŒπœéœÉŒøœÖŒΩ œåœÑŒπ Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒµŒØ Œ±ŒΩŒøœÉŒøŒ±œÄœåŒ∫œÅŒπœÉŒ∑ Œ∫Œ±Œπ ŒΩŒ± Œ∫Œ±Œ∏ŒøœÅŒØœÉŒøœÖŒΩ œÑŒ∑ œÉœâœÉœÑŒÆ Œ¥ŒøœÉŒøŒªŒøŒ≥ŒØŒ±. ŒìŒµŒΩŒπŒ∫Œ¨, œÉŒµ Œ±œÖœÑŒÆ œÑŒ∑ œÜŒ¨œÉŒ∑, œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ¥ŒøŒ∫ŒπŒºŒ¨Œ∂ŒøŒΩœÑŒ±Œπ œÉŒµ ŒºŒπŒ± ŒºŒπŒ∫œÅŒÆ ŒøŒºŒ¨Œ¥Œ± ŒΩŒµŒ±œÅœéŒΩ, œÖŒ≥ŒπœéŒΩ ŒµŒΩŒ∑ŒªŒØŒ∫œâŒΩ ŒµŒ∏ŒµŒªŒøŒΩœÑœéŒΩ. </p><p> Œ£œÑŒ∑ œÜŒ¨œÉŒ∑ 2, œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œáŒøœÅŒ∑Œ≥ŒµŒØœÑŒ±Œπ œÉŒµ Œ±œÅŒ∫ŒµœÑŒ≠œÇ ŒµŒ∫Œ±œÑŒøŒΩœÑŒ¨Œ¥ŒµœÇ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ Œ≥ŒπŒ± ŒΩŒ± Œ±ŒæŒπŒøŒªŒøŒ≥Œ∑Œ∏ŒµŒØ œÄŒµœÅŒ±ŒπœÑŒ≠œÅœâ Œ∑ Œ±œÉœÜŒ¨ŒªŒµŒπŒ¨ œÑŒøœÖ Œ∫Œ±Œπ Œ∑ ŒπŒ∫Œ±ŒΩœåœÑŒ∑œÑŒ¨ œÑŒøœÖ ŒΩŒ± Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒÆœÉŒµŒπ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑. ŒüŒπ œÉœÖŒºŒºŒµœÑŒ≠œáŒøŒΩœÑŒµœÇ œÉŒµ Œ±œÖœÑŒÆ œÑŒ∑ œÜŒ¨œÉŒ∑ Œ≠œáŒøœÖŒΩ œÑŒ± ŒØŒ¥ŒπŒ± œáŒ±œÅŒ±Œ∫œÑŒ∑œÅŒπœÉœÑŒπŒ∫Œ¨ (œåœÄœâœÇ Œ∑ŒªŒπŒ∫ŒØŒ± Œ∫Œ±Œπ œÜœçŒªŒø) ŒºŒµ ŒµŒ∫ŒµŒØŒΩŒøœÖœÇ Œ≥ŒπŒ± œÑŒøœÖœÇ ŒøœÄŒøŒØŒøœÖœÇ œÄœÅŒøŒøœÅŒØŒ∂ŒµœÑŒ±Œπ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø. Œ•œÄŒ¨œÅœáŒøœÖŒΩ œÉœÖŒΩŒÆŒ∏œâœÇ œÄŒøŒªŒªŒ±œÄŒªŒ≠œÇ Œ¥ŒøŒ∫ŒπŒºŒ≠œÇ œÉŒµ Œ±œÖœÑŒÆ œÑŒ∑ œÜŒ¨œÉŒ∑ Œ≥ŒπŒ± œÑŒ∑ŒΩ Œ±ŒæŒπŒøŒªœåŒ≥Œ∑œÉŒ∑ Œ¥ŒπŒ±œÜœåœÅœâŒΩ Œ∑ŒªŒπŒ∫ŒπŒ±Œ∫œéŒΩ ŒøŒºŒ¨Œ¥œâŒΩ (œÄ.œá. Œ∑ŒªŒπŒ∫ŒπœâŒºŒ≠ŒΩŒøŒπ, ŒµŒΩŒÆŒªŒπŒ∫ŒµœÇ, œÄŒ±ŒπŒ¥ŒπŒ¨) Œ∫Œ±Œπ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ œÉŒ∫ŒµœÖŒ¨œÉŒºŒ±œÑŒ± ŒµŒºŒ≤ŒøŒªŒØœâŒΩ. ŒïœÄŒØœÉŒ∑œÇ, ŒºŒπŒ± ŒøŒºŒ¨Œ¥Œ± ŒµŒªŒ≠Œ≥œáŒøœÖ Œ¥ŒµŒΩ Œ∫Œ¨ŒΩŒµŒπ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œéœÉœÑŒµ ŒΩŒ± Œ¥ŒπŒ±œÜŒ±ŒΩŒµŒØ ŒµŒ¨ŒΩ ŒøŒπ Œ±ŒªŒªŒ±Œ≥Œ≠œÇ œÉœÑŒ∑ŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒ≠ŒΩŒ∑ ŒøŒºŒ¨Œ¥Œ± Œ±œÄŒøŒ¥ŒØŒ¥ŒøŒΩœÑŒ±Œπ œÉœÑŒø ŒµŒºŒ≤œåŒªŒπŒø ŒÆ Œ≠œáŒøœÖŒΩ œÉœÖŒºŒ≤ŒµŒØ œÑœÖœáŒ±ŒØŒ±. </p><p> Œ£œÑŒ∑ œÜŒ¨œÉŒ∑ 3 œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œáŒøœÅŒ∑Œ≥ŒµŒØœÑŒ±Œπ œÉŒµ œáŒπŒªŒπŒ¨Œ¥ŒµœÇ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ, ŒøŒπ ŒøœÄŒøŒØŒøŒπ ŒµŒªŒ≠Œ≥œáŒøŒΩœÑŒ±Œπ œÑŒ±œÖœÑœåœáœÅŒøŒΩŒ± ŒºŒµ ŒºŒπŒ± œÄŒ±œÅœåŒºŒøŒπŒ± ŒøŒºŒ¨Œ¥Œ± Œ±ŒΩŒ∏œÅœéœÄœâŒΩ œÄŒøœÖ Œ¥ŒµŒΩ Œ≠Œ∫Œ±ŒΩŒ±ŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø Œ±ŒªŒªŒ¨ Œ≠ŒªŒ±Œ≤Œ±ŒΩ Œ≠ŒΩŒ± œÉœÖŒ≥Œ∫œÅŒØœÉŒπŒºŒø œÄœÅŒøœäœåŒΩ. ŒëœÖœÑŒÆ Œ∑ œÜŒ¨œÉŒ∑ œÉœÑŒøœáŒµœçŒµŒπ ŒΩŒ± Œ∫Œ±Œ∏ŒøœÅŒØœÉŒµŒπ ŒµŒ¨ŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø ŒµŒØŒΩŒ±Œπ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œå Œ≠ŒΩŒ±ŒΩœÑŒπ œÑŒ∑œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±œÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ ŒøœÄŒøŒØŒ± Œ≠œáŒµŒπ œÉœáŒµŒ¥ŒπŒ±œÉœÑŒµŒØ ŒΩŒ± œÄœÅŒøœÉœÑŒ±œÑŒµœçŒµŒπ. ŒïœÄŒØœÉŒ∑œÇ, œÉœÑŒøœáŒµœçŒµŒπ ŒΩŒ± ŒºŒµŒªŒµœÑŒÆœÉŒµŒπ œÑŒ∑ŒΩ Œ±œÉœÜŒ¨ŒªŒµŒπŒ¨ œÑŒøœÖ œÉŒµ œÄŒøŒªœç ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒ∑ ŒøŒºŒ¨Œ¥Œ± Œ±ŒΩŒ∏œÅœéœÄœâŒΩ. ŒüŒπ Œ¥ŒøŒ∫ŒπŒºŒ≠œÇ œÑŒ∑œÇ œÜŒ¨œÉŒ∑œÇ 3 Œ¥ŒπŒµŒæŒ¨Œ≥ŒøŒΩœÑŒ±Œπ œÉœÖœáŒΩŒ¨ œÉŒµ œÄŒøŒªŒªŒ≠œÇ œáœéœÅŒµœÇ Œ∫Œ±Œπ œÄŒµœÅŒπŒøœáŒ≠œÇ ŒµŒΩœÑœåœÇ ŒºŒπŒ±œÇ œáœéœÅŒ±œÇ Œ≥ŒπŒ± ŒΩŒ± Œ¥ŒπŒ±œÉœÜŒ±ŒªŒπœÉœÑŒµŒØ œåœÑŒπ œÑŒ± ŒµœÖœÅŒÆŒºŒ±œÑŒ± œÑŒ∑œÇ Œ±œÄœåŒ¥ŒøœÉŒ∑œÇ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ œÄœÅŒøŒ∫œçœÄœÑŒøœÖŒΩ Œ±œÄœå œÄŒøŒªŒªŒøœçœÇ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫ŒøœçœÇ œÄŒªŒ∑Œ∏œÖœÉŒºŒøœçœÇ. </p><p> ŒöŒ±œÑŒ¨ œÑŒ∑ Œ¥ŒπŒ¨œÅŒ∫ŒµŒπŒ± œÑœâŒΩ Œ¥ŒøŒ∫ŒπŒºœéŒΩ œÑŒ∑œÇ œÜŒ¨œÉŒ∑œÇ 2 Œ∫Œ±Œπ 3, ŒøŒπ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ Œ∫Œ±Œπ ŒøŒπ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ œÄŒøœÖ Œ¥ŒπŒµŒæŒ¨Œ≥ŒøœÖŒΩ œÑŒ∑ ŒºŒµŒªŒ≠œÑŒ∑ Œ¥ŒµŒΩ Œ≥ŒΩœâœÅŒØŒ∂ŒøœÖŒΩ œÄŒøŒπŒøŒπ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ Œ≠œáŒøœÖŒΩ ŒªŒ¨Œ≤ŒµŒπ œÑŒø œÖœÄœå Œ¥ŒøŒ∫ŒπŒºŒÆ ŒµŒºŒ≤œåŒªŒπŒø ŒÆ œÑŒø œÉœÖŒ≥Œ∫œÅŒØœÉŒπŒºŒø œÄœÅŒøœäœåŒΩ. ŒëœÖœÑœå ŒøŒΩŒøŒºŒ¨Œ∂ŒµœÑŒ±Œπ ¬´œÑœÖœÜŒªœåœÑŒ∑œÑŒ±¬ª Œ∫Œ±Œπ ŒµŒØŒΩŒ±Œπ Œ±œÄŒ±œÅŒ±ŒØœÑŒ∑œÑŒø Œ≥ŒπŒ± ŒΩŒ± Œ¥ŒπŒ±œÉœÜŒ±ŒªŒπœÉœÑŒµŒØ œåœÑŒπ ŒøœçœÑŒµ ŒøŒπ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ ŒøœçœÑŒµ ŒøŒπ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ ŒµœÄŒ∑œÅŒµŒ¨Œ∂ŒøŒΩœÑŒ±Œπ œÉœÑŒ∑ŒΩ Œ±ŒæŒπŒøŒªœåŒ≥Œ∑œÉŒ∑ œÑŒ∑œÇ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ±œÇ ŒÆ œÑŒ∑œÇ Œ±œÉœÜŒ¨ŒªŒµŒπŒ±œÇ Œ≥ŒΩœâœÅŒØŒ∂ŒøŒΩœÑŒ±œÇ œÄŒøŒπŒøœÇ œÄŒÆœÅŒµ œÄŒøŒπŒø œÄœÅŒøœäœåŒΩ. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>ŒïŒæŒøœÖœÉŒπŒøŒ¥œåœÑŒ∑œÉŒ∑ Œ∫Œ±Œπ œÄŒ±œÅŒ±Œ∫ŒøŒªŒøœçŒ∏Œ∑œÉŒ∑</h3><p> ŒåœÑŒ±ŒΩ œÑŒ± Œ±œÄŒøœÑŒµŒªŒ≠œÉŒºŒ±œÑŒ± œåŒªœâŒΩ Œ±œÖœÑœéŒΩ œÑœâŒΩ Œ∫ŒªŒπŒΩŒπŒ∫œéŒΩ Œ¥ŒøŒ∫ŒπŒºœéŒΩ ŒµŒØŒΩŒ±Œπ Œ¥ŒπŒ±Œ∏Œ≠œÉŒπŒºŒ± Œ±Œ∫ŒøŒªŒøœÖŒ∏ŒµŒØ ŒºŒπŒ± œÉŒµŒπœÅŒ¨ Œ±œÄœå Œ¨ŒªŒªŒµœÇ ŒµŒΩŒ≠œÅŒ≥ŒµŒπŒµœÇ. ŒëŒæŒπœâŒºŒ±œÑŒøœçœáŒøŒπ œÑŒøœÖ ŒïœÖœÅœâœÄŒ±œäŒ∫Œøœç ŒüœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœç Œ¶Œ±œÅŒºŒ¨Œ∫œâŒΩ Œ∫Œ±Œπ Œ±œÅŒ≥œåœÑŒµœÅŒ± Œ∫Œ¨Œ∏Œµ œáœéœÅŒ±œÇ ŒæŒµœáœâœÅŒπœÉœÑŒ¨ ŒµŒæŒµœÑŒ¨Œ∂ŒøœÖŒΩ œÄœÅŒøœÉŒµŒ∫œÑŒπŒ∫Œ¨ œÑŒ± Œ¥ŒµŒ¥ŒøŒºŒ≠ŒΩŒ± œÑŒ∑œÇ ŒºŒµŒªŒ≠œÑŒ∑œÇ Œ∫Œ±Œπ Œ±œÄŒøœÜŒ±œÉŒØŒ∂ŒøœÖŒΩ ŒµŒ¨ŒΩ Œ∏Œ± ŒµŒ≥Œ∫œÅŒØŒΩŒøœÖŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø. ŒåŒªŒµœÇ ŒøŒπ Œ¥ŒøŒ∫ŒπŒºŒ≠œÇ œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± Œ≥ŒØŒΩŒøŒΩœÑŒ±Œπ œÉœâœÉœÑŒ¨ Œ∫Œ±Œπ ŒΩŒ± ŒµŒØŒΩŒ±Œπ Œ∫Œ±ŒªŒ¨ œÑŒµŒ∫ŒºŒ∑œÅŒπœâŒºŒ≠ŒΩŒµœÇ. ŒàŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒø œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± Œ±œÄŒøŒ¥ŒµŒπœáŒ∏ŒµŒØ Œ±œÉœÜŒ±ŒªŒ≠œÇ Œ∫Œ±Œπ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œå œÉŒµ Œ≠ŒΩŒ±ŒΩ ŒµœÖœÅœç œÄŒªŒ∑Œ∏œÖœÉŒºœå œÄœÅŒπŒΩ ŒµŒ≥Œ∫œÅŒπŒ∏ŒµŒØ. Œü œÄŒÆœáŒ∑œÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ Œ±œÉœÜŒ¨ŒªŒµŒπŒ± Œ∫Œ±Œπ œÑŒ∑ŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ ŒµŒØŒΩŒ±Œπ ŒµŒæŒ±ŒπœÅŒµœÑŒπŒ∫Œ¨ œÖœàŒ∑ŒªœåœÇ. ŒëœÖœÑœåœÇ œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ Œ±ŒæŒπŒøŒªŒøŒ≥ŒÆœÉŒµŒπœÇ œÑŒ∑œÇ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ±œÇ Œ∫Œ±Œπ œÑŒ∑œÇ Œ±œÉœÜŒ¨ŒªŒµŒπŒ±œÇ œÄœÅŒøŒ∫ŒµŒπŒºŒ≠ŒΩŒøœÖ ŒΩŒ± Œ¥ŒøŒ∏ŒµŒØ Œ≠Œ≥Œ∫œÅŒπœÉŒ∑ Œ±œÄœå Œ¥ŒπŒ¨œÜŒøœÅŒøœÖœÇ œÅœÖŒ∏ŒºŒπœÉœÑŒπŒ∫ŒøœçœÇ Œ∫Œ±Œπ œÄŒøŒªŒπœÑŒπŒ∫ŒøœçœÇ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœçœÇ Œ¥Œ∑ŒºœåœÉŒπŒ±œÇ œÖŒ≥ŒµŒØŒ±œÇ. </p><p> Œ†ŒµœÅŒ±ŒπœÑŒ≠œÅœâ œÄŒ±œÅŒ±Œ∫ŒøŒªŒøœçŒ∏Œ∑œÉŒ∑ œÑŒ∑œÇ Œ±œÉœÜŒ¨ŒªŒµŒπŒ±œÇ Œ∫Œ±Œπ œÑŒ∑œÇ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ±œÇ œÄœÅŒ±Œ≥ŒºŒ±œÑŒøœÄŒøŒπŒµŒØœÑŒ±Œπ Œ∫Œ±œÑŒ¨ œÑŒ∑ œáœÅŒÆœÉŒ∑ œÑœâŒΩ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ. ŒëœÖœÑœå Œ¥ŒØŒΩŒµŒπ œÑŒ∑ Œ¥œÖŒΩŒ±œÑœåœÑŒ∑œÑŒ± œÉœÑŒøœÖœÇ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ ŒΩŒ± œÄŒ±œÅŒ±Œ∫ŒøŒªŒøœÖŒ∏ŒøœçŒΩ œÑŒ∑ Œ¥œÅŒ¨œÉŒ∑ Œ∫Œ±Œπ œÑŒ∑ŒΩ Œ±œÉœÜŒ¨ŒªŒµŒπŒ± œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ, Œ±Œ∫œåŒºŒ∑ Œ∫Œ±Œπ œåœÑŒ±ŒΩ œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒµŒØœÑŒ±Œπ œÉŒµ œÄŒøŒªŒªŒøœçœÇ Œ±ŒΩŒ∏œÅœéœÄŒøœÖœÇ Œ≥ŒπŒ± ŒºŒµŒ≥Œ¨ŒªŒø œáœÅŒøŒΩŒπŒ∫œå Œ¥ŒπŒ¨œÉœÑŒ∑ŒºŒ±. ŒëœÖœÑŒ¨ œÑŒ± Œ¥ŒµŒ¥ŒøŒºŒ≠ŒΩŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒΩœÑŒ±Œπ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄœÅŒøœÉŒ±œÅŒºŒøŒ≥ŒÆ œÑœâŒΩ œÄŒøŒªŒπœÑŒπŒ∫œéŒΩ Œ≥ŒπŒ± œÑŒ∑ œáœÅŒÆœÉŒ∑ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noreferrer noopener">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Ge={id:"s5"},Qe=e("h2",{id:"s5t"},"5. ŒúŒ¨œÉŒ∫ŒµœÇ Œ∫Œ±œÑŒ¨ ŒπœéŒΩ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ",-1),Xe=e("p",null," ŒüŒπ ŒºŒ¨œÉŒ∫ŒµœÇ œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒΩœÑŒ±Œπ œÉœÖœáŒΩŒ¨ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± Œ±œÄœå ŒπŒøœçœÇ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ±. ŒïŒØœáŒ±ŒΩ Œ¥ŒπŒ±Œ¥ŒøŒ∏ŒµŒØ ŒµœÖœÅŒ≠œâœÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± Œ±œÄœå œÑŒøŒΩ Œπœå SARS-CoV-2. ŒúŒµœÑŒ±Œæœç œÑœâŒΩ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫œéŒΩ œÑœçœÄœâŒΩ ŒºŒ¨œÉŒ∫Œ±œÇ ŒøŒπ œáŒµŒπœÅŒøœÖœÅŒ≥ŒπŒ∫Œ≠œÇ ŒºŒ¨œÉŒ∫ŒµœÇ œÄœÅŒøœÉœéœÄŒøœÖ ŒÆœÑŒ±ŒΩ Œ±œÄœå œÑŒ± œÄŒπŒø œÉœÖœáŒΩŒ¨ œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒºŒµŒΩŒ± Œ∫Œ±ŒªœçŒºŒºŒ±œÑŒ± œÄœÅŒøœÉœéœÄŒøœÖ Œ∫Œ±œÑŒ¨ œÑŒ∑ŒΩ œÄŒ±ŒΩŒ¥Œ∑ŒºŒØŒ± œÑŒøœÖ COVID-19. Œ§œÖœÄŒπŒ∫Œ¨, Œ≠œáŒøœÖŒΩ ŒºœÄŒªŒµ œáœÅœéŒºŒ± œÉœÑŒ∑ ŒºŒØŒ± œÄŒªŒµœÖœÅŒ¨, Œ∑ ŒøœÄŒøŒØŒ± œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒµŒØœÑŒ±Œπ œâœÇ ŒµŒæœâœÑŒµœÅŒπŒ∫œå œÉœÑœÅœéŒºŒ± (ŒµŒπŒ∫œåŒΩŒ± 4). Œü Œ∫œçœÅŒπŒøœÇ œÉœÑœåœáŒøœÇ œÑŒ∑œÇ œáŒµŒπœÅŒøœÖœÅŒ≥ŒπŒ∫ŒÆœÇ ŒºŒ¨œÉŒ∫Œ±œÇ ŒµŒØŒΩŒ±Œπ Œ∑ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± œÑœâŒΩ Œ±œÉŒ∏ŒµŒΩœéŒΩ Œ±œÄœå œÑŒ∑ŒΩ œÄŒπŒ∏Œ±ŒΩŒÆ ŒµœÄŒ±œÜŒÆ ŒºŒµ Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± Œ∫Œ±Œπ ŒπŒøœçœÇ œÄŒøœÖ ŒµŒ∫œÄŒΩŒ≠ŒµŒπ Œ±œÖœÑœåœÇ œÄŒøœÖ œÜŒøœÅŒ¨ŒµŒπ œÑŒ∑ ŒºŒ¨œÉŒ∫Œ±. ŒàœÑœÉŒπ, Œ±œÄŒøœÑœÅŒ≠œÄŒøœÖŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫Œ¨ œÑŒ∑ŒΩ ŒµŒæŒ¨œÄŒªœâœÉŒ∑ œÑŒøœÖ Œ∫ŒøœÅŒøŒΩŒøœäŒøœç ŒºŒ≠œÉœâ œÑŒøœÖ Œ±Œ≠œÅŒ±, œåŒºœâœÇ ŒµŒØŒΩŒ±Œπ ŒªŒπŒ≥œåœÑŒµœÅŒø Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫Œ≠œÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± Œ±œÖœÑŒøœç œÄŒøœÖ œÜŒøœÅŒ¨ŒµŒπ œÑŒ∑ ŒºŒ¨œÉŒ∫Œ±. ",-1),Ze=e("p",null," ŒüŒπ ŒºŒ¨œÉŒ∫ŒµœÇ FFP2 ŒÆ FFP3 (œÄŒøœÖ œÉœÖœáŒΩŒ¨ ŒøŒΩŒøŒºŒ¨Œ∂ŒøŒΩœÑŒ±Œπ Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒÆœÅŒµœÇ) Œ∏Œ± œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒΩœÑŒ±Œπ Œ≥ŒπŒ± œÑŒø œÜŒπŒªœÑœÅŒ¨œÅŒπœÉŒºŒ± Œ∫Œ±Œπ œÑŒ∑ŒΩ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ ŒµŒπœÉœÄŒΩŒøŒÆ Œ±Œ≠œÅŒ±. Œ§Œø œÉœçœÉœÑŒ∑ŒºŒ± Œ±œÅŒØŒ∏ŒºŒ∑œÉŒ∑œÇ (FFP1, FPP2, FFP3) œÖœÄŒøŒ¥ŒµŒπŒ∫ŒΩœçŒµŒπ œÑŒ∑ŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ Œ±œÖœÑœéŒΩ œÑœâŒΩ œÉœÖœÉŒ∫ŒµœÖœéŒΩ (ŒºŒµ œÄŒπœÉœÑŒøœÄŒøŒØŒ∑œÉŒ∑ œåœÑŒπ œÄŒªŒ∑œÅŒøœçŒΩ œÑŒø œÄœÅœåœÑœÖœÄŒø EN 149-2001). ŒüŒπ ŒºŒ¨œÉŒ∫ŒµœÇ FFP2 Œ∫Œ±Œπ FPP3 Œ≠œáŒøœÖŒΩ Œ±œÄœåŒ¥ŒøœÉŒ∑ œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ Œ≥ŒπŒ± œÑŒ± Œ±ŒπœâœÅŒøœçŒºŒµŒΩŒ± œÉœâŒºŒ±œÑŒØŒ¥ŒπŒ± (œÉœÖŒºœÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ±ŒΩŒøŒºŒ≠ŒΩœâŒΩ ŒµŒ∫ŒµŒØŒΩœâŒΩ œÄŒøœÖ œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ œÑŒøŒΩ Œπœå) 92% Œ∫Œ±Œπ 98%, Œ±ŒΩœÑŒØœÉœÑŒøŒπœáŒ±. ŒöŒ±Œπ ŒøŒπ Œ¥œçŒø œÑœçœÄŒøŒπ ŒºŒ¨œÉŒ∫Œ±œÇ Œ≠œáŒøœÖŒΩ ŒµœÄŒØœÉŒ∑œÇ ŒºŒπŒ∫œÅŒÆ Œ¥ŒπŒ±œÅœÅŒøŒÆ œÄœÅŒøœÇ œÑŒ± ŒºŒ≠œÉŒ±: <8% Œ∫Œ±Œπ <2%, Œ±ŒΩœÑŒØœÉœÑŒøŒπœáŒ±. Œ£œÑŒ∑ ŒºŒ¨œÉŒ∫Œ± FFP2, œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒµŒØœÑŒ±Œπ œÉœÖœáŒΩŒ¨ ŒµŒπŒ¥ŒπŒ∫œå Œ∫Œ±ŒøœÖœÑœÉŒøœçŒ∫ œÉœÑŒø ŒµŒæœâœÑŒµœÅŒπŒ∫œå œÉœÑœÅœéŒºŒ± œÑŒøœÖ Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒÆœÅŒ±. ŒëŒΩ Œ∫Œ±Œπ œÉŒµ ŒµœÄŒ±Œ≥Œ≥ŒµŒªŒºŒ±œÑŒπŒ∫Œ¨ œÄŒµœÅŒπŒ≤Œ¨ŒªŒªŒøŒΩœÑŒ± Œ≠œáŒµŒπ ŒµœÄŒπœÑœÅŒ±œÄŒµŒØ ŒºŒπŒ± Œ≤Œ±ŒªŒ≤ŒØŒ¥Œ± (œÄŒøœÖ Œ¥ŒπŒµœÖŒ∫ŒøŒªœçŒΩŒµŒπ œÑŒ∑ŒΩ ŒµŒ∫œÄŒΩŒøŒÆ), œÉœÑŒ∑ŒΩ œÄŒµœÅŒØœÄœÑœâœÉŒ∑ œÑŒøœÖ SARS-CoV-2, Œ∏Œ± œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒøœçŒΩœÑŒ±Œπ ŒºœåŒΩŒø Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒÆœÅŒµœÇ œáœâœÅŒØœÇ Œ≤Œ±ŒªŒ≤ŒØŒ¥ŒµœÇ Œ≥ŒπŒ± ŒΩŒ± œÜŒπŒªœÑœÅŒ¨œÅŒøœÖŒΩ Œ∫Œ±Œπ œÑŒøŒΩ ŒµŒ∫œÄŒΩŒµœåŒºŒµŒΩŒø Œ±Œ≠œÅŒ±. ",-1),ea=e("p",null," ŒúŒµ œÑŒ∑ŒΩ œÄŒ±ŒΩŒ¥Œ∑ŒºŒØŒ± COVID-19, ŒµŒπœÉŒÆœáŒ∏Œ∑ ŒºŒπŒ± ŒΩŒ≠Œ± ŒºŒ¨œÉŒ∫Œ± œÄœÅŒøœÉœéœÄŒøœÖ: Œ∑ ŒºŒ¨œÉŒ∫Œ± œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ. ŒëœÖœÑœåœÇ Œø œÑœçœÄŒøœÇ ŒºŒ¨œÉŒ∫Œ±œÇ ŒµŒØŒΩŒ±Œπ Œ∫Œ±œÑŒ±œÉŒ∫ŒµœÖŒ±œÉŒºŒ≠ŒΩŒøœÇ Œ±œÄœå œÄŒøŒªœÖœÉœÑœÅœâŒºŒ±œÑŒπŒ∫œå œçœÜŒ±œÉŒºŒ± (œÑŒø Œ≠ŒΩŒ± œÉœÑœÅœéŒºŒ± œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± ŒµŒØŒΩŒ±Œπ œÜŒØŒªœÑœÅŒø ŒΩŒ±ŒΩŒøœäŒΩœéŒΩ œÄŒøœÖ ŒµŒ≥Œ≥œÖŒ¨œÑŒ±Œπ ŒπŒ∫Œ±ŒΩœåœÑŒ∑œÑŒ± œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ Œ≤Œ±Œ∫œÑŒ∑œÅŒπŒ±Œ∫ŒÆœÇ Œ∫Œ±Œπ ŒµœÄŒπŒ≤ŒªŒ±Œ≤ŒøœçœÇ ŒªŒµœÄœÑŒÆœÇ œÉŒ∫œåŒΩŒ∑œÇ œÑŒøœÖŒªŒ¨œáŒπœÉœÑŒøŒΩ 90%). ŒëœÖœÑŒÆ Œ∑ ŒºŒ¨œÉŒ∫Œ± œÉœÖŒΩŒ¥œÖŒ¨Œ∂ŒµŒπ œÖœàŒ∑ŒªŒÆ ŒπŒ∫Œ±ŒΩœåœÑŒ∑œÑŒ± œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ ŒºŒµ Œ¥œÖŒΩŒ±œÑœåœÑŒ∑œÑŒ± ŒµœÄŒ±ŒΩŒ±œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒØŒ∑œÉŒ∑œÇ Œ∫Œ±Œ∏œéœÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÄŒªœÖŒ∏ŒµŒØ œÉœÑŒø œÄŒªœÖŒΩœÑŒÆœÅŒπŒø œÉœÑŒøœÖœÇ 60 Œ≤Œ±Œ∏ŒºŒøœçœÇ. ",-1),aa={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},ta=i('<p class="mt-3 mb-8 text-sm text-center"><i><b>ŒïŒπŒ∫œåŒΩŒ± 1.</b> ŒîŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫ŒøŒØ œÑœçœÄŒøŒπ ŒºŒ¨œÉŒ∫Œ±œÇ</i></p><p> Œó Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÑœâŒΩ ŒºŒ±œÉŒ∫œéŒΩ Œ≠œáŒµŒπ Œ¥ŒøŒ∫ŒπŒºŒ±œÉœÑŒµŒØ œÉŒµ ŒµŒπŒ¥ŒπŒ∫Œ¨ ŒµœÅŒ≥Œ±œÉœÑŒÆœÅŒπŒ± (œÄ.œá. œÉŒµ Œ∏Œ¨ŒªŒ±ŒºŒø Œ≠Œ∫Œ∏ŒµœÉŒ∑œÇ). Œ£Œµ Œ±œÖœÑŒ≠œÇ œÑŒπœÇ ŒºŒµŒªŒ≠œÑŒµœÇ ŒºŒØŒ± Œ≥ŒµŒΩŒΩŒÆœÑœÅŒπŒ± œÉœâŒºŒ±œÑŒπŒ¥ŒØœâŒΩ Œ≠œáŒµŒπ ŒµœÄŒπŒºŒøŒªœÖŒΩŒ∏ŒµŒØ ŒºŒµ œÑŒøŒΩ Œπœå. Œ£œÑŒ∑ œÉœÖŒΩŒ≠œáŒµŒπŒ±, Œ±ŒΩŒµŒºŒπœÉœÑŒÆœÅŒµœÇ œÄŒØœÉœâ Œ±œÄœå œÑŒ∑ Œ≥ŒµŒΩŒΩŒÆœÑœÅŒπŒ± œÉœâŒºŒ±œÑŒπŒ¥ŒØœâŒΩ Œ≥ŒµŒºŒØŒ∂ŒøœÖŒΩ œÑŒøŒΩ Œ∏Œ¨ŒªŒ±ŒºŒø Œ≠Œ∫Œ∏ŒµœÉŒ∑œÇ ŒºŒµ ŒºŒπŒ∫œÅŒ¨ œÉœâŒºŒ±œÑŒØŒ¥ŒπŒ±, œÄŒ±œÅœåŒºŒøŒπŒ± ŒºŒµ œÑŒ± Œ±ŒµœÅŒøŒªœçŒºŒ±œÑŒ± œÄŒøœÖ œÄœÅŒøŒ∫œçœÄœÑŒøœÖŒΩ Œ±œÄœå œÑŒ∑ŒΩ Œ±ŒΩŒ±œÄŒΩŒøŒÆ œÜŒøœÅŒ≠œâŒΩ œÑŒøœÖ ŒπŒøœç. ŒöŒ±œÑœåœÄŒπŒΩ ŒºŒµœÑœÅŒπŒ≠œÑŒ±Œπ Œ∑ œÉœÖŒ≥Œ∫Œ≠ŒΩœÑœÅœâœÉŒ∑ œÉœâŒºŒ±œÑŒπŒ¥ŒØœâŒΩ œÄŒ¨ŒΩœâ œÉœÑŒπœÇ ŒºŒ¨œÉŒ∫ŒµœÇ Œ∫Œ±Œπ œÉœÖŒ≥Œ∫œÅŒØŒΩŒµœÑŒ±Œπ ŒºŒµ œÑŒ∑ œÉœÖŒ≥Œ∫Œ≠ŒΩœÑœÅœâœÉŒ∑ œÉœÑŒ∑ Œ≥ŒµŒΩŒπŒ∫ŒÆ Œ±œÑŒºœåœÉœÜŒ±ŒπœÅŒ± œÑŒøœÖ Œ∏Œ±ŒªŒ¨ŒºŒøœÖ Œ≠Œ∫Œ∏ŒµœÉŒ∑œÇ. </p><p> Œ©œÉœÑœåœÉŒø, œÑŒ± ŒπœÉœáœÖœÅœåœÑŒµœÅŒ± œÉœÑŒøŒπœáŒµŒØŒ± Œ≥ŒπŒ± œÑŒ∑ŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÑŒ∑œÇ ŒºŒ¨œÉŒ∫Œ±œÇ Œ≤Œ±œÉŒØŒ∂ŒøŒΩœÑŒ±Œπ œÉŒµ ŒµœÄŒπŒ¥Œ∑ŒºŒπŒøŒªŒøŒ≥ŒπŒ∫Œ¨ Œ¥ŒµŒ¥ŒøŒºŒ≠ŒΩŒ± Œ±œÄœå œÄœÅŒ±Œ≥ŒºŒ±œÑŒπŒ∫Œ≠œÇ Œ∫Œ±œÑŒ±œÉœÑŒ¨œÉŒµŒπœÇ. ŒìŒπŒ± œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ±, Œø Œ∑ŒºŒµœÅŒÆœÉŒπŒøœÇ œÅœÖŒ∏ŒºœåœÇ Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑œÇ œÑŒøœÖ COVID-19 ŒµœÄŒπŒ≤œÅŒ±Œ¥œçŒΩŒ∏Œ∑Œ∫Œµ ŒºŒµœÑŒ¨ Œ±œÄœå œÑŒ∑ œáœÅŒÆœÉŒ∑ œÑŒ∑œÇ ŒºŒ¨œÉŒ∫Œ±œÇ œÉŒµ 15 œÄŒøŒªŒπœÑŒµŒØŒµœÇ Œ∫Œ±Œπ œÑŒ∑ŒΩ Œ†ŒµœÅŒπœÜŒ≠œÅŒµŒπŒ± œÑŒ∑œÇ ŒöŒøŒªŒøœçŒºœÄŒπŒ± œÉœÑŒπœÇ ŒóŒ†Œë. ŒúŒπŒ± Œ¨ŒªŒªŒ∑ ŒºŒµŒªŒ≠œÑŒ∑ ŒµŒæŒ≠œÑŒ±œÉŒµ œÑŒøœÖœÇ Œ∏Œ±ŒΩŒ¨œÑŒøœÖœÇ Œ±œÄœå Œ∫ŒøœÅŒøŒΩŒøœäœå œÉŒµ 198 œáœéœÅŒµœÇ Œ∫Œ±Œπ Œ¥ŒπŒ±œÄŒØœÉœÑœâœÉŒµ œåœÑŒπ ŒµŒ∫ŒµŒØŒΩŒøŒπ ŒºŒµ œÄŒøŒªŒπœÑŒπœÉœÑŒπŒ∫ŒøœçœÇ Œ∫Œ±ŒΩœåŒΩŒµœÇ ŒÆ Œ∫œÖŒ≤ŒµœÅŒΩŒ∑œÑŒπŒ∫Œ≠œÇ œÄŒøŒªŒπœÑŒπŒ∫Œ≠œÇ œÄŒøœÖ ŒµœÖŒΩŒøŒøœçœÉŒ±ŒΩ œÑŒ∑ œáœÅŒÆœÉŒ∑ ŒºŒ¨œÉŒ∫Œ±œÇ ŒµŒØœáŒ±ŒΩ œáŒ±ŒºŒ∑ŒªœåœÑŒµœÅŒ± œÄŒøœÉŒøœÉœÑŒ¨ Œ∏Œ±ŒΩŒ¨œÑœâŒΩ. </p><p> Œ†ŒøŒªŒªŒøŒØ œáœÅŒÆœÉœÑŒµœÇ œÑŒøœÖ Facebook Œ∫Œ±Œπ œÑœâŒΩ ŒºŒ≠œÉœâŒΩ Œ∫ŒøŒπŒΩœâŒΩŒπŒ∫ŒÆœÇ Œ¥ŒπŒ∫œÑœçœâœÉŒ∑œÇ Œ≠œáŒøœÖŒΩ Œ∫ŒøŒπŒΩŒøœÄŒøŒπŒÆœÉŒµŒπ œÄŒ±œÅŒ±œÄŒªŒ±ŒΩŒ∑œÑŒπŒ∫Œ≠œÇ Œ±ŒΩŒ±œÅœÑŒÆœÉŒµŒπœÇ œÉœáŒµœÑŒπŒ∫Œ¨ ŒºŒµ œÑŒø œåœÑŒπ Œ∑ œÄŒ±œÅŒ±œÑŒµœÑŒ±ŒºŒ≠ŒΩŒ∑ œáœÅŒÆœÉŒ∑ ŒºŒ¨œÉŒ∫Œ±œÇ œÄœÅŒøœÉœéœÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ Œ±ŒΩŒµœÄŒ¨œÅŒ∫ŒµŒπŒ± ŒøŒæœÖŒ≥œåŒΩŒøœÖ œÉœÑŒø œÉœéŒºŒ± - œÖœÄŒøŒæŒØŒ±. Œ©œÉœÑœåœÉŒø, ŒµœÅŒµœÖŒΩŒ∑œÑŒπŒ∫Œ¨ Œ¨œÅŒ∏œÅŒ± Œ∫Œ±Œπ ŒµŒπŒ¥ŒπŒ∫ŒøŒØ œÄœÅŒøœÑŒµŒØŒΩŒøœÖŒΩ œåœÑŒπ œÑŒ≠œÑŒøŒπŒ± œÉœÖŒºœÄœÑœéŒºŒ±œÑŒ± ŒµŒØŒΩŒ±Œπ Œ±œÄŒØŒ∏Œ±ŒΩŒø ŒΩŒ± ŒµŒºœÜŒ±ŒΩŒπœÉœÑŒøœçŒΩ, ŒµŒ∫œÑœåœÇ ŒµŒ¨ŒΩ Œø œáœÅŒÆœÉœÑŒ∑œÇ Œ≠œáŒµŒπ œÄœÅŒøœãœÄŒ¨œÅœáŒøœÖœÉŒµœÇ Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒπŒ∫Œ≠œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œåœÄœâœÇ œÑŒø Œ¨œÉŒ∏ŒºŒ± ŒÆ œáœÅœåŒΩŒπŒ± Œ±œÄŒøœÜœÅŒ±Œ∫œÑŒπŒ∫ŒÆ œÄŒΩŒµœÖŒºŒøŒΩŒøœÄŒ¨Œ∏ŒµŒπŒ± (COPD). Œü Œ∫ŒØŒΩŒ¥œÖŒΩŒøœÇ œÖœÄŒøŒæŒØŒ±œÇ Œ∫Œ±Œπ œÖœÄŒµœÅŒ∫Œ±œÄŒΩŒØŒ±œÇ (Œ¥Œ∑Œª. Œ∑ œçœÄŒ±œÅŒæŒ∑ œÖœÄŒµœÅŒ≤ŒøŒªŒπŒ∫Œøœç Œ¥ŒπŒøŒæŒµŒπŒ¥ŒØŒøœÖ œÑŒøœÖ Œ¨ŒΩŒ∏œÅŒ±Œ∫Œ± œÉœÑŒø Œ±ŒØŒºŒ±) ŒµŒØŒΩŒ±Œπ Œ±œÄŒØŒ∏Œ±ŒΩŒø ŒΩŒ± ŒµŒºœÜŒ±ŒΩŒπœÉœÑŒµŒØ ŒºŒµ œÖœÜŒ±œÉŒºŒ¨œÑŒπŒΩŒµœÇ Œ∫Œ±Œπ œáŒµŒπœÅŒøœÖœÅŒ≥ŒπŒ∫Œ≠œÇ ŒºŒ¨œÉŒ∫ŒµœÇ, Œ∫Œ±Œ∏œéœÇ Œ¥ŒµŒΩ ŒµœÜŒ±œÅŒºœåŒ∂ŒøœÖŒΩ œÉœÜŒπœáœÑŒ¨. Œ©œÉœÑœåœÉŒø, ŒµœÄŒπœÉŒ∑ŒºŒ±ŒØŒΩŒµœÑŒ±Œπ œåœÑŒπ Œ¥ŒµŒΩ œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± œÑŒøœÄŒøŒ∏ŒµœÑŒøœçŒΩœÑŒ±Œπ ŒºŒ¨œÉŒ∫ŒµœÇ œÄœÅŒøœÉœéœÄŒøœÖ œÉŒµ ŒºŒπŒ∫œÅŒ¨ œÄŒ±ŒπŒ¥ŒπŒ¨ Œ∫Œ¨œÑœâ œÑœâŒΩ Œ¥œçŒø ŒµœÑœéŒΩ, œÉŒµ Œ¨œÑŒøŒºŒ± ŒºŒµ Œ¥œÖœÉŒ∫ŒøŒªŒØŒ± œÉœÑŒ∑ŒΩ Œ±ŒΩŒ±œÄŒΩŒøŒÆ ŒÆ œåœÑŒ±ŒΩ Œ±Œ∏ŒªŒøœçŒΩœÑŒ±Œπ. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19 </a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li><li><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247414" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247414</a></li></ul></section>',5),sa=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"ŒìŒπŒ± œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ∑ ŒºŒµŒªŒ≠œÑŒ∑"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://youtu.be/npXP5wqNzaI?t=205",target:"_blank",rel:"noopener noreferrer"},"https://youtu.be/npXP5wqNzaI?t=205"),a(" ŒµœÄŒµŒæŒÆŒ≥Œ∑œÉŒ∑ œÑœâŒΩ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅœâŒΩ ŒºœçŒ∏œâŒΩ, œÄŒ±œÅŒøœÖœÉŒØŒ± œÄŒπŒ∏Œ±ŒΩŒÆœÇ œÖœÄŒøŒæŒØŒ±œÇ 3:24 - 6:39")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1rbdXeVTKT8oFFWyV0XZ00ewjdngvsuHF/view?usp=share_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1rbdXeVTKT8oFFWyV0XZ00ewjdngvsuHF/view?usp=share_link"),a(" ‚Äì Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± ŒºŒ¨œÉŒ∫Œ±œÇ œâœÇ œÄœÅœéœÇ œÑŒø œÜŒπŒªœÑœÅŒ¨œÅŒπœÉŒºŒ±")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1oNy89fCcFjaBuicacmlH1xiGHGsr--Is/view?usp=share_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1oNy89fCcFjaBuicacmlH1xiGHGsr--Is/view?usp=share_link"),a(" ‚Äì Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± ŒºŒ¨œÉŒ∫Œ±œÇ œâœÇ œÄœÅœéœÇ œÑŒ∑ŒΩ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± Œ±œÄœå Œ±œÅœÅœéœÉœÑŒπŒµœÇ")]),e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),ia=e("hr",{class:"mt-10 mb-40"},null,-1),ra={id:"s6"},na=i('<h2 id="s6t">6. ŒôŒøŒØ Œ∫Œ±Œπ œÖŒ≥ŒπŒµŒπŒΩŒÆ œáŒµœÅŒπœéŒΩ</h2><h3>ŒëœÄŒøŒªœÖŒºŒ±ŒΩœÑŒπŒ∫œå œáŒµœÅŒπœéŒΩ ŒÆ œÉŒ±œÄŒøœçŒΩŒπ;</h3><p> Œ§Œ± œáŒ≠œÅŒπŒ± ŒºŒ±œÇ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± Œ±œÄŒøœÑŒµŒªŒ≠œÉŒøœÖŒΩ Œ∫œÅŒØœÉŒπŒºŒø œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒ± œÉœÑŒ∑ ŒºŒµœÑŒ¨Œ¥ŒøœÉŒ∑ ŒªŒøŒπŒºœéŒæŒµœâŒΩ. ŒåœÑŒ±ŒΩ ŒµœÜŒ±œÅŒºœåŒ∂ŒøŒΩœÑŒ±Œπ œÉœáŒøŒªŒ±œÉœÑŒπŒ∫Œ¨ œÉœÑŒ± œáŒ≠œÅŒπŒ± Œ∫Œ±Œπ œÑœÅŒØŒ≤ŒøŒΩœÑŒ±Œπ Œ≥ŒπŒ± œÑŒøœÖŒªŒ¨œáŒπœÉœÑŒøŒΩ 20 Œ¥ŒµœÖœÑŒµœÅœåŒªŒµœÄœÑŒ±, œÑŒ± Œ±œÄŒøŒªœÖŒºŒ±ŒΩœÑŒπŒ∫Œ¨ œáŒµœÅŒπœéŒΩ Œ∫Œ±Œπ œÑŒø œÉŒ±œÄŒøœçŒΩŒπ ŒºŒµ Œ≤Œ¨œÉŒ∑ œÑŒø Œ±ŒªŒ∫ŒøœåŒª Œ∏Œ± œÉŒ∫ŒøœÑœéœÉŒøœÖŒΩ œÑŒøŒΩ Œ∫ŒøœÅŒøŒΩŒøœäœå. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, œÑŒø œÉŒ±œÄŒøœçŒΩŒπ Œ¥ŒπŒ±œÑŒ±œÅŒ¨œÉœÉŒµŒπ œÑŒøŒΩ Œ∫ŒøŒªŒªœéŒ¥Œ∑ Œ¥ŒµœÉŒºœå ŒºŒµœÑŒ±Œæœç œÑœâŒΩ œÄŒ±Œ∏ŒøŒ≥œåŒΩœâŒΩ Œ∫Œ±Œπ œÑŒøœÖ Œ¥Œ≠œÅŒºŒ±œÑœåœÇ œÉŒ±œÇ, ŒµœÄŒπœÑœÅŒ≠œÄŒøŒΩœÑŒ±œÇ œÉœÑŒ± œÄŒ±Œ∏ŒøŒ≥œåŒΩŒ± ŒΩŒ± Œ≥ŒªŒπœÉœÑœÅŒÆœÉŒøœÖŒΩ Œ±ŒºŒ≠œÉœâœÇ ŒºŒ±Œ∫œÅŒπŒ¨ Œ±œÄœå œÑŒ± œáŒ≠œÅŒπŒ± œÉŒ±œÇ. ŒúŒµ œÑŒø œÉœáŒøŒªŒ±œÉœÑŒπŒ∫œå œÄŒªœçœÉŒπŒºŒø, œåœáŒπ ŒºœåŒΩŒø ŒµŒæŒøœÖŒ¥ŒµœÑŒµœÅœéŒΩŒµœÑŒµ œÑŒøŒΩ Œπœå, Œ±ŒªŒªŒ¨ œÑŒøŒΩ Œ±œÄŒøŒºŒ±Œ∫œÅœçŒΩŒµœÑŒµ Œ∫Œ±Œπ Œ±œÄœå œÑŒ± œáŒ≠œÅŒπŒ± œÉŒ±œÇ. Œó œÄœÅŒ±Œ∫œÑŒπŒ∫ŒÆ œÑŒ∑œÇ Œ∫Œ±ŒªŒÆœÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ œÑœâŒΩ œáŒµœÅŒπœéŒΩ ŒµŒØŒΩŒ±Œπ ŒºŒπŒ± Œ±œÄŒªŒÆ œÄœÅŒøŒªŒ∑œÄœÑŒπŒ∫ŒÆ œÉœÑœÅŒ±œÑŒ∑Œ≥ŒπŒ∫ŒÆ œÄŒøœÖ ŒºœÄŒøœÅŒøœçŒΩ ŒµœçŒ∫ŒøŒªŒ± ŒΩŒ± Œ±Œ∫ŒøŒªŒøœÖŒ∏ŒÆœÉŒøœÖŒΩ ŒøŒπ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒøŒπ Œ¨ŒΩŒ∏œÅœâœÄŒøŒπ Œ∫Œ±Œπ œÄŒøŒªŒªŒ≠œÇ ŒºŒµŒªŒ≠œÑŒµœÇ Œ≠œáŒøœÖŒΩ Œ±œÄŒøŒ¥ŒµŒØŒæŒµŒπ œÑŒ∑ŒΩ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÑŒ∑œÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ œÑœâŒΩ œáŒµœÅŒπœéŒΩ œÉœÑŒ∑ŒΩ œÄœÅœåŒªŒ∑œàŒ∑ œÑŒ∑œÇ ŒºŒµœÑŒ¨Œ¥ŒøœÉŒ∑œÇ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫œéŒΩ œÄŒ±Œ∏ŒøŒ≥œåŒΩœâŒΩ, œÉœÖŒºœÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ±ŒΩŒøŒºŒ≠ŒΩœâŒΩ œÑŒøœÖ Œ∫ŒøœÅŒøŒΩŒøœäŒøœÖ œåœÄœâœÇ Œø SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>ŒëœÄŒøŒ¥œÖŒΩŒ¨ŒºœâœÉŒ∑ œÑŒøœÖ Œ∫ŒøœÅŒøŒΩŒøœäŒøœç ŒºŒµ œÉŒ±œÄŒøœçŒΩŒπ</h3><p> ŒüŒπ Œ∫ŒøœÅŒøŒΩŒøœäŒøŒØ œÄŒ±ŒØœÅŒΩŒøœÖŒΩ œÑŒø œåŒΩŒøŒºŒ¨ œÑŒøœÖœÇ Œ±œÄœå œÑŒ∑ŒΩ ¬´Œ∫ŒøœÅœéŒΩŒ±¬ª œÄŒøœÖ œÄŒµœÅŒπŒ≤Œ¨ŒªŒªŒµŒπ œÑŒøŒΩ Œπœå - Œ±ŒπœáŒºŒ≠œÇ œÄœÅœâœÑŒµŒêŒΩŒ∑œÇ œÄŒøœÖ ŒµŒØŒΩŒ±Œπ ŒµŒΩœÉœâŒºŒ±œÑœâŒºŒ≠ŒΩŒµœÇ œÉœÑŒ∑ŒΩ ŒµœÄŒπœÜŒ¨ŒΩŒµŒπŒ¨ œÑŒøœÖœÇ. ŒüŒπ Œ±ŒπœáŒºŒ≠œÇ, ŒøŒπ ŒøœÄŒøŒØŒµœÇ ŒµŒØŒΩŒ±Œπ œÖœÄŒµœçŒ∏œÖŒΩŒµœÇ Œ≥ŒπŒ± œÑŒ∑ ŒºœåŒªœÖŒΩœÉŒ∑ œÑŒøœÖ ŒæŒµŒΩŒπœÉœÑŒÆ, Œ≥Œ±ŒΩœÑŒ∂œéŒΩŒøœÖŒΩ œÉŒµ ŒºŒπŒ± ŒºŒµŒºŒ≤œÅŒ¨ŒΩŒ∑. Œó ŒºŒµŒºŒ≤œÅŒ¨ŒΩŒ∑ ŒµŒØŒΩŒ±Œπ œÑŒø ¬´Œ∫Œ≠ŒªœÖœÜŒøœÇ¬ª œÑŒøœÖ ŒπŒøœç, Œ±ŒªŒªŒ¨ Œ∫Œ±Œπ œÑŒø Œ±Œ¥œçŒΩŒ±ŒºŒø œÉŒ∑ŒºŒµŒØŒø œÑŒøœÖ ŒπŒøœç. </p><p> Œ§Œ± ŒºœåœÅŒπŒ± œÑŒøœÖ œÉŒ±œÄŒøœÖŒΩŒπŒøœç Œ≠œáŒøœÖŒΩ Œ¥œçŒø œáŒ∑ŒºŒπŒ∫Œ¨ Œ¥ŒπŒ±Œ∫œÅŒπœÑŒ¨ ŒºŒ≠œÅŒ∑: Œ≠ŒΩŒ± œÖŒ¥œÅœåœÜŒπŒªŒø (œÄŒøœÖ Œ±Œ≥Œ±œÄŒ¨ œÑŒø ŒΩŒµœÅœå) ¬´Œ∫ŒµœÜŒ¨ŒªŒπ¬ª Œ∫Œ±Œπ ŒºŒπŒ± œÖŒ¥œÅœåœÜŒøŒ≤Œ∑ (œÄŒøœÖ ŒºŒπœÉŒµŒØ œÑŒø ŒΩŒµœÅœå) ¬´ŒøœÖœÅŒ¨¬ª. Œ§Œø Œ∫ŒµœÜŒ¨ŒªŒπ Œ≤ŒøŒ∑Œ∏Œ¨ œÑŒø œÉŒ±œÄŒøœçŒΩŒπ ŒΩŒ± Œ±ŒΩŒ±ŒºŒπœáŒ∏ŒµŒØ ŒºŒµ œÑŒø ŒΩŒµœÅœå, ŒµŒΩœé Œ∑ ŒøœÖœÅŒ¨ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± Œ±ŒªŒªŒ∑ŒªŒµœÄŒπŒ¥œÅŒ¨œÉŒµŒπ ŒºŒµ Œ¨ŒªŒªŒ± œÖŒ¥œÅœåœÜŒøŒ≤Œ± ŒºœåœÅŒπŒ± œåœÄœâœÇ œÑŒ± ŒªŒπœÄŒØŒ¥ŒπŒ±. </p><p> ŒïœÖœÑœÖœáœéœÇ, Œ∑ ŒºŒµŒºŒ≤œÅŒ¨ŒΩŒ∑ œÑŒøœÖ Œ∫ŒøœÅŒøŒΩŒøœäŒøœç Œ±œÄŒøœÑŒµŒªŒµŒØœÑŒ±Œπ Œ∫œÖœÅŒØœâœÇ Œ±œÄœå ŒºœåœÅŒπŒ± ŒªŒπœÄŒπŒ¥ŒØœâŒΩ. ŒîŒπŒ±œÑŒ∑œÅŒµŒØœÑŒ±Œπ œáŒ¨œÅŒ∑ œÉŒµ Œ±œÉŒ∏ŒµŒΩŒµŒØœÇ œáŒ∑ŒºŒπŒ∫Œ≠œÇ Œ±ŒªŒªŒ∑ŒªŒµœÄŒπŒ¥œÅŒ¨œÉŒµŒπœÇ ŒºŒµœÑŒ±Œæœç ŒºŒµŒºŒøŒΩœâŒºŒ≠ŒΩœâŒΩ ŒºŒøœÅŒØœâŒΩ. ŒüŒπ œÖŒ¥œÅœåœÜŒøŒ≤ŒµœÇ (œÄŒøœÖ ŒºŒπœÉŒøœçŒΩ œÑŒø ŒΩŒµœÅœå) ¬´ŒøœÖœÅŒ≠œÇ¬ª œÑœâŒΩ ŒºŒøœÅŒØœâŒΩ œÑŒøœÖ œÉŒ±œÄŒøœÖŒΩŒπŒøœç ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œÉœÄŒ¨œÉŒøœÖŒΩ œÑŒπœÇ Œ±ŒªŒªŒ∑ŒªŒµœÄŒπŒ¥œÅŒ¨œÉŒµŒπœÇ ŒºŒµœÑŒ±Œæœç œÑœâŒΩ ŒºŒøœÅŒØœâŒΩ ŒªŒπœÄŒπŒ¥ŒØœâŒΩ œÉœÑŒ∑ ŒºŒµŒºŒ≤œÅŒ¨ŒΩŒ∑ œÑŒøœÖ Œ∫ŒøœÅŒøŒΩŒøœäŒøœç (Œ≤Œª. Œ£œáŒÆŒºŒ± 5). </p><p> Œó ŒøœÖœÅŒ¨ œÑŒøœÖ œÉŒ±œÄŒøœÖŒΩŒπŒøœç ŒºœÄŒøœÅŒµŒØ ŒΩŒ± Œ¥ŒπŒ±œÑŒ±œÅŒ¨ŒæŒµŒπ œÑŒπœÇ Œ±Œ¥œçŒΩŒ±ŒºŒµœÇ Œ±ŒªŒªŒ∑ŒªŒµœÄŒπŒ¥œÅŒ¨œÉŒµŒπœÇ ŒºŒµœÑŒ±Œæœç œÑœâŒΩ ŒºŒøœÅŒØœâŒΩ œÑœâŒΩ ŒªŒπœÄŒπŒ¥ŒØœâŒΩ œÉœÑŒ∑ ŒºŒµŒºŒ≤œÅŒ¨ŒΩŒ∑, œÉœáŒØŒ∂ŒøŒΩœÑŒ¨œÇ œÑŒ∑ŒΩ. ŒëœÇ œÖœÄŒøŒ∏Œ≠œÉŒøœÖŒºŒµ œåœÑŒπ Œø ŒπœåœÇ Œ≠œáŒµŒπ Œ¥ŒπŒ±œÉœÄŒ±œÉœÑŒµŒØ œÄœÅŒπŒΩ œÄœÅŒøœÉœÑŒ±œÑŒµœÖœÑŒµŒØ ŒºŒµ Œ±œÉœÜŒ¨ŒªŒµŒπŒ± œÉŒµ Œ≠ŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒø ŒæŒµŒΩŒπœÉœÑŒÆ. Œ£Œµ Œ±œÖœÑŒÆŒΩ œÑŒ∑ŒΩ œÄŒµœÅŒØœÄœÑœâœÉŒ∑, Œ¥ŒµŒΩ Œ∏Œ± ŒµŒØŒΩŒ±Œπ œÄŒªŒ≠ŒøŒΩ œÉŒµ Œ∏Œ≠œÉŒ∑ ŒΩŒ± Œ∫Œ¨ŒΩŒµŒπ œÑŒ∑ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫ŒÆ œÑŒøœÖ Œ¥ŒøœÖŒªŒµŒπŒ¨. Œ£œÑŒ∑ œÉœÖŒΩŒ≠œáŒµŒπŒ±, œÑŒ± ŒºœåœÅŒπŒ± œÑŒøœÖ œÉŒ±œÄŒøœÖŒΩŒπŒøœç œÄŒµœÅŒπŒ≤Œ¨ŒªŒªŒøœÖŒΩ Œ∏œÅŒ±œçœÉŒºŒ±œÑŒ± ŒπŒøœç ŒºŒµ œåŒªŒµœÇ œÑŒπœÇ ŒøœÖœÅŒ≠œÇ œÉœÑœÅŒ±ŒºŒºŒ≠ŒΩŒµœÇ œÄœÅŒøœÇ œÑŒ± ŒºŒ≠œÉŒ±. ŒëœÖœÑœå œÑŒø œÉœçŒºœÄŒªŒµŒ≥ŒºŒ± ŒøŒΩŒøŒºŒ¨Œ∂ŒµœÑŒ±Œπ ŒºŒπŒ∫Œ∫œçŒªŒπŒø (Œ≤Œª. Œ£œáŒÆŒºŒ± 6). ŒüŒπ œÖŒ¥œÅœåœÜŒπŒªŒµœÇ Œ∫ŒµœÜŒ±ŒªŒ≠œÇ œÄŒøœÖ Œ∫ŒøŒπœÑŒøœçŒΩ œÄœÅŒøœÇ œÑŒ± Œ≠Œæœâ ŒµœÄŒπœÑœÅŒ≠œÄŒøœÖŒΩ œÉœÑŒø ŒºŒπŒ∫Œ∫œçŒªŒπŒø ŒΩŒ± ŒæŒµœÄŒªœÖŒ∏ŒµŒØ œÉœÑŒ∑ŒΩ Œ±œÄŒøœáŒ≠œÑŒµœÖœÉŒ∑ ŒºŒµ ŒΩŒµœÅœå. Œ§Œø ŒΩŒµœÅœå, œáœâœÅŒØœÇ œÑŒø œÉŒ±œÄŒøœçŒΩŒπ, Œ¥ŒµŒΩ Œ∏Œ± ŒºœÄŒøœÅŒøœçœÉŒµ ŒΩŒ± Œ∫Œ¨ŒΩŒµŒπ Œ∫Œ¨œÑŒπ œÑŒ≠œÑŒøŒπŒø. </p>',9),oa={class:"grid gap-2 md:grid-cols-2 e-card"},la=e("b",null,"Œ£œáŒÆŒºŒ± 5.",-1),ca=e("b",null,"Œ£œáŒÆŒºŒ± 6.",-1),da=i('<p> ŒüŒπ œÄŒªŒ∑œÅŒøœÜŒøœÅŒØŒµœÇ œÄŒøœÖ Œ¥ŒØŒΩŒøŒΩœÑŒ±Œπ ŒπœÉœáœçŒøœÖŒΩ ŒµœÄŒØœÉŒ∑œÇ Œ∫Œ±Œπ Œ≥ŒπŒ± Œ¨ŒªŒªŒøœÖœÇ ŒπŒøœçœÇ ŒºŒµ œÄŒµœÅŒØŒ≤ŒªŒ∑ŒºŒ± (œÄ.œá. Œ≥œÅŒØœÄŒ∑, Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ± Œí Œ∫Œ±Œπ C Œ∫Œ±Œπ ŒΩœåœÉŒøœÇ œÑŒøœÖ ŒπŒøœç ŒàŒºœÄŒøŒªŒ±), Œ∫Œ±Œ∏œéœÇ ŒøŒπ œÜŒ¨Œ∫ŒµŒªŒøŒØ œÑŒøœÖœÇ Œ±œÄŒøœÑŒµŒªŒøœçŒΩœÑŒ±Œπ Œ±œÄœå œÜœâœÉœÜŒøŒªŒπœÄŒØŒ¥ŒπŒ±. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>ŒïœÄŒπŒªŒ≠Œ≥ŒøŒΩœÑŒ±œÇ Œ±œÄŒøŒªœÖŒºŒ±ŒΩœÑŒπŒ∫œå œáŒµœÅŒπœéŒΩ</h3><p> Œü Œ†Œ±Œ≥Œ∫œåœÉŒºŒπŒøœÇ ŒüœÅŒ≥Œ±ŒΩŒπœÉŒºœåœÇ Œ•Œ≥ŒµŒØŒ±œÇ (WHO) œÉœÖŒΩŒπœÉœÑŒ¨ Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫œå œáŒµœÅŒπœéŒΩ ŒºŒµ Œ≤Œ¨œÉŒ∑ œÑŒø ŒøŒπŒΩœåœÄŒΩŒµœÖŒºŒ± ŒµŒ¨ŒΩ Œ¥ŒµŒΩ Œ≠œáŒµœÑŒµ œÉŒ±œÄŒøœçŒΩŒπ œáŒµœÅŒπœéŒΩ. </p><p><b>Œ§Œ± Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫Œ¨ œáŒµœÅŒπœéŒΩ ŒºŒµ Œ≤Œ¨œÉŒ∑ œÑŒø Œ±ŒªŒ∫ŒøœåŒª œÄŒπœÉœÑŒµœçŒµœÑŒ±Œπ œåœÑŒπ ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒøœçŒΩ ŒµŒºœÄŒøŒ¥ŒØŒ∂ŒøŒΩœÑŒ±œÇ œÑŒπœÇ œÄœÅœâœÑŒµŒêŒΩŒµœÇ œÑœâŒΩ ŒºŒπŒ∫œÅŒøŒ≤ŒØœâŒΩ - œÉœÖŒºœÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ±ŒΩŒøŒºŒ≠ŒΩœâŒΩ œÑœâŒΩ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ Œ∫Œ±Œπ ŒøœÅŒπœÉŒºŒ≠ŒΩœâŒΩ ŒπœéŒΩ - ŒΩŒ± ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒÆœÉŒøœÖŒΩ Œ∫Œ±ŒΩŒøŒΩŒπŒ∫Œ¨.</b> Œ§Œ± Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫Œ¨ œáŒµœÅŒπœéŒΩ ŒºŒµ œÖœàŒ∑ŒªŒÆ œÄŒµœÅŒπŒµŒ∫œÑŒπŒ∫œåœÑŒ∑œÑŒ± œÉŒµ Œ±ŒªŒ∫ŒøœåŒª ŒºœÄŒøœÅŒøœçŒΩ ŒµœÄŒØœÉŒ∑œÇ ŒΩŒ± ŒµœÄŒ∑œÅŒµŒ¨œÉŒøœÖŒΩ œÑŒø ŒªŒπœÄŒπŒ¥ŒπŒ∫œå œÄŒµœÅŒØŒ≤ŒªŒ∑ŒºŒ± œÄŒøœÖ œÄŒµœÅŒπŒ≤Œ¨ŒªŒªŒµŒπ œÑŒøŒΩ Œ∫ŒøœÅŒøŒΩŒøœäœå. ŒìŒπŒ± ŒΩŒ± ŒµŒØŒΩŒ±Œπ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫Œ¨, œÑŒ± Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫Œ¨ œáŒµœÅŒπœéŒΩ œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ œÑŒøœÖŒªŒ¨œáŒπœÉœÑŒøŒΩ 60% Œ±ŒªŒ∫ŒøœåŒª. Œ§Œ± œÄœÅœåœÉŒ∏ŒµœÑŒ± œÉœÑŒø Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫œå ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒµŒºœÄŒøŒ¥ŒØœÉŒøœÖŒΩ œÑŒø Œ±ŒªŒ∫ŒøœåŒª ŒΩŒ± ŒµŒæŒ±œÑŒºŒπœÉœÑŒµŒØ œÄŒøŒªœç Œ≥œÅŒÆŒ≥ŒøœÅŒ±, Œ∫Œ¨ŒΩŒøŒΩœÑŒ±œÇ œÑŒøŒΩ Œπœå ŒΩŒ± ŒµŒºœÄŒøœÑŒπœÉœÑŒµŒØ Œ≥ŒπŒ± ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒø œáœÅŒøŒΩŒπŒ∫œå Œ¥ŒπŒ¨œÉœÑŒ∑ŒºŒ±. </p><p> Œ©œÉœÑœåœÉŒø, œÖœÄŒ¨œÅœáŒøœÖŒΩ ŒµœÄŒØœÉŒ∑œÇ ŒøœÅŒπœÉŒºŒ≠ŒΩŒøŒπ Œ∫ŒØŒΩŒ¥œÖŒΩŒøŒπ œÄŒøœÖ œÉœáŒµœÑŒØŒ∂ŒøŒΩœÑŒ±Œπ ŒºŒµ œÑŒ∑ œáœÅŒÆœÉŒ∑ Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫œéŒΩ ŒºŒµ Œ≤Œ¨œÉŒ∑ œÑŒø Œ±ŒªŒ∫ŒøœåŒª. Œ•œÄŒ¨œÅœáŒµŒπ Œ±œÖŒæŒ∑ŒºŒ≠ŒΩŒøœÇ Œ∫ŒØŒΩŒ¥œÖŒΩŒøœÇ Œ¥Œ∑ŒªŒ∑œÑŒ∑œÅŒØŒ±œÉŒ∑œÇ Œ±œÄœå Œ±ŒªŒ∫ŒøœåŒª Œ≥ŒπŒ± œÑŒ± œÄŒ±ŒπŒ¥ŒπŒ¨ Œ∫Œ±Œπ Œ∑ œÉœÖœáŒΩŒÆ œÑŒøœÖœÇ œáœÅŒÆœÉŒ∑ Œ∏Œ± ŒºœÄŒøœÅŒøœçœÉŒµ ŒΩŒ± ŒøŒ¥Œ∑Œ≥ŒÆœÉŒµŒπ œÉŒµ ŒºŒπŒ∫œÅŒøŒ≤ŒπŒ±Œ∫ŒÆ Œ±ŒΩœÑŒøœáŒÆ. Œ•œÄŒ¨œÅœáŒøœÖŒΩ ŒµŒΩŒ±ŒªŒªŒ±Œ∫œÑŒπŒ∫Œ¨ Œ±ŒΩœÑŒπœÉŒ∑œÄœÑŒπŒ∫Œ¨ œáŒµœÅŒπœéŒΩ œáœâœÅŒØœÇ Œ±ŒªŒ∫ŒøœåŒª, œåœÄŒøœÖ œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒµŒØœÑŒ±Œπ œÉœáŒµœÑŒπŒ∫Œ¨ œÉœÖœáŒΩŒ¨ œÑŒø Œ≤ŒµŒΩŒ∂Œ±ŒªŒ∫œåŒΩŒπŒø. Œ†œÅœåœÉœÜŒ±œÑŒµœÇ ŒºŒµŒªŒ≠œÑŒµœÇ Œ≠œáŒøœÖŒΩ Œ¥ŒµŒØŒæŒµŒπ œåœÑŒπ œÑŒø Œ±œÄŒøŒªœÖŒºŒ±ŒΩœÑŒπŒ∫œå œáŒµœÅŒπœéŒΩ œáœâœÅŒØœÇ Œ±ŒªŒ∫ŒøœåŒª ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒµŒØ ŒµŒæŒØœÉŒøœÖ Œ∫Œ±ŒªŒ¨ Œ∫Œ±Œπ Œ¥ŒµŒΩ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ œÑŒø Œ≥ŒΩœâœÉœÑœå Œ±ŒØœÉŒ∏Œ∑ŒºŒ± ¬´ŒµŒ≥Œ∫Œ±œçŒºŒ±œÑŒøœÇ¬ª œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØœÑŒ±Œπ Œ±œÄœå œÑŒ∑ œáœÅŒÆœÉŒ∑ Œ±œÄŒøŒªœÖŒºŒ±ŒΩœÑŒπŒ∫Œøœç œáŒµœÅŒπœéŒΩ ŒºŒµ Œ±ŒªŒ∫ŒøœåŒª. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ma=e("hr",{class:"mt-10 mb-40"},null,-1),ua={id:"s7"},ha=i('<h2 id="s7t" class="mt-40 text-5xl">7. ŒüŒπ ŒºœçŒ∏ŒøŒπ Œ≥ŒπŒ± œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±</h2><h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 1:</span> Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩ Œ±œÖœÑŒπœÉŒºœå/œÉŒøŒ≤Œ±œÅŒ≠œÇ œÄŒ±œÅŒµŒΩŒ≠œÅŒ≥ŒµŒπŒµœÇ </h3><p> Œü œÜœåŒ≤ŒøœÇ œåœÑŒπ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ±œÖŒæŒ¨ŒΩŒøœÖŒΩ œÑŒøŒΩ Œ∫ŒØŒΩŒ¥œÖŒΩŒø Œ±œÖœÑŒπœÉŒºŒøœç œÄœÅŒøŒÆŒªŒ∏Œµ Œ±œÄœå ŒºŒØŒ± ŒºŒµŒªŒ≠œÑŒ∑ œÑŒøœÖ 1997 Œ∑ ŒøœÄŒøŒØŒ± Œ¥Œ∑ŒºŒøœÉŒπŒµœçœÑŒ∑Œ∫Œµ Œ±œÄœå œÑŒøŒΩ Andrew Wakefield, Œ≠ŒΩŒ±ŒΩ ŒíœÅŒµœÑŒ±ŒΩœå œáŒµŒπœÅŒøœçœÅŒ≥Œø. Œ£œÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ±, Œ∑ ŒºŒµŒªŒ≠œÑŒ∑ Œ¥Œ∑ŒºŒøœÉŒπŒµœçŒ∏Œ∑Œ∫Œµ œÉœÑŒø The Lancet, Œ≠ŒΩŒ± ŒπŒ±œÑœÅŒπŒ∫œå œÄŒµœÅŒπŒøŒ¥ŒπŒ∫œå, Œ∫Œ±Œπ ŒπœÉœáœÖœÅŒπŒ∂œåœÑŒ±ŒΩ œåœÑŒπ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø ŒπŒªŒ±œÅŒ¨œÇ, œÄŒ±œÅœâœÑŒØŒ¥ŒπŒ¥Œ±œÇ Œ∫Œ±Œπ ŒµœÅœÖŒ∏œÅŒ¨œÇ (MMR) Œ±œçŒæŒ∑œÉŒµ œÑŒ∑ŒΩ ŒµŒºœÜŒ¨ŒΩŒπœÉŒ∑ Œ±œÖœÑŒπœÉŒºŒøœç œÉŒµ œÄŒøŒªŒªŒ¨ œÄŒ±ŒπŒ¥ŒπŒ¨ œÉœÑŒ∑ ŒíœÅŒµœÑŒ±ŒΩŒØŒ±. </p><p> ŒàŒ∫œÑŒøœÑŒµ, Œ∑ ŒºŒµŒªŒ≠œÑŒ∑ Œ±œÖœÑŒÆ Œ≠œáŒµŒπ Œ±œÄŒ±ŒæŒπœâŒ∏ŒµŒØ œÄŒªŒÆœÅœâœÇ ŒªœåŒ≥œâ œÉŒøŒ≤Œ±œÅœéŒΩ Œ¥ŒπŒ±Œ¥ŒπŒ∫Œ±œÉœÑŒπŒ∫œéŒΩ œÄŒµŒπœÅŒ±ŒºŒ±œÑŒπŒ∫œéŒΩ œÉœÜŒ±ŒªŒºŒ¨œÑœâŒΩ œÄŒøœÖ ŒµŒΩœÑŒøœÄŒØœÉœÑŒ∑Œ∫Œ±ŒΩ. Œ£œÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ± ŒøŒπ œÉœÖŒºŒºŒµœÑŒ≠œáŒøŒΩœÑŒµœÇ œÉœÑŒ∑ ŒºŒµŒªŒ≠œÑŒ∑ ŒÆœÑŒ±ŒΩ ŒºœåŒΩŒø 12. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, Œ±œÄŒøŒ∫Œ±ŒªœçœÜŒ∏Œ∑Œ∫Œ±ŒΩ œÉœÖŒ≥Œ∫œÅŒøœçœÉŒµŒπœÇ ŒøŒπŒ∫ŒøŒΩŒøŒºŒπŒ∫œéŒΩ œÉœÖŒºœÜŒµœÅœåŒΩœÑœâŒΩ Œ∫Œ±Œπ Œ∑Œ∏ŒπŒ∫Œ≠œÇ œÄŒ±œÅŒ±Œ≤Œ¨œÉŒµŒπœÇ. Œ©œÇ Œ±œÄŒøœÑŒ≠ŒªŒµœÉŒºŒ±, Œø Andrew Wakefield Œ≠œáŒ±œÉŒµ œÑŒ∑ŒΩ ŒπŒ±œÑœÅŒπŒ∫ŒÆ œÑŒøœÖ Œ¨Œ¥ŒµŒπŒ± Œ∫Œ±Œπ Œ∑ ŒºŒµŒªŒ≠œÑŒ∑ œÄŒøœÖ Œ¥Œ∑ŒºŒøœÉŒπŒµœçŒ∏Œ∑Œ∫Œµ Œ±ŒΩŒ±Œ∫ŒªŒÆŒ∏Œ∑Œ∫Œµ Œ±œÄœå œÑŒø œÄŒµœÅŒπŒøŒ¥ŒπŒ∫œå. </p><p> Œ£ŒÆŒºŒµœÅŒ±, œÖœÄŒ¨œÅœáŒøœÖŒΩ Œ±œÅŒ∫ŒµœÑŒ≠œÇ ŒºŒµŒªŒ≠œÑŒµœÇ œÄŒøœÖ Œ≠œáŒøœÖŒΩ ŒµŒΩœÑŒøœÄŒØœÉŒµŒπ œÉœÖŒºœÄœÑœéŒºŒ±œÑŒ± œÑŒøœÖ Œ±œÖœÑŒπœÉŒºŒøœç œÉŒµ œÄŒ±ŒπŒ¥ŒπŒ¨ œÄŒøŒªœç œÄœÅŒπŒΩ ŒªŒ¨Œ≤ŒøœÖŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø MMR Œ∫Œ±Œπ Œ±œÖœÑŒ≠œÇ Œ±œÄŒøœÑŒµŒªŒøœçŒΩ œÉœÑŒøŒπœáŒµŒØŒ± ŒµŒΩŒ¨ŒΩœÑŒπŒ± œÉœÑŒøŒΩ ŒºœçŒ∏Œø œÄŒøœÖ œÉœÖœÉœáŒµœÑŒØŒ∂ŒµŒπ œÑŒøŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºœå ŒºŒµ œÑŒøŒΩ Œ±œÖœÑŒπœÉŒºœå. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, œÄœÅœåœÉœÜŒ±œÑŒ∑ Œ≠œÅŒµœÖŒΩŒ± Œ±ŒΩŒ±œÜŒ≠œÅŒµŒπ œÉœÑŒøŒπœáŒµŒØŒ± œÄŒøœÖ œÖœÄŒøœÉœÑŒ∑œÅŒØŒ∂ŒøœÖŒΩ œåœÑŒπ Œø Œ±œÖœÑŒπœÉŒºœåœÇ Œ±ŒΩŒ±œÄœÑœçœÉœÉŒµœÑŒ±Œπ œÉœÑŒ∑ ŒºŒÆœÑœÅŒ±, Œ¥Œ∑ŒªŒ±Œ¥ŒÆ œÄŒøŒªœç œÄœÅŒπŒΩ Œ≥ŒµŒΩŒΩŒ∑Œ∏ŒµŒØ Œ≠ŒΩŒ± ŒºœâœÅœå Œ∫Œ±Œπ ŒæŒµŒ∫ŒπŒΩŒÆœÉŒµŒπ ŒΩŒ± Œ∫Œ¨ŒΩŒµŒπ ŒµŒºŒ≤œåŒªŒπŒ±. ŒöŒ±ŒºŒØŒ± Œ±œÄœå œÑŒπœÇ œÑŒµŒªŒµœÖœÑŒ±ŒØŒµœÇ ŒºŒµŒªŒ≠œÑŒµœÇ Œ¥ŒµŒΩ Œ≠œáŒµŒπ Œ±ŒΩŒ±œÜŒ≠œÅŒµŒπ Œ∫Œ¨œÄŒøŒπŒøœÖ ŒµŒØŒ¥ŒøœÖœÇ œÉœÖœÉœáŒ≠œÑŒπœÉŒ∑œÇ ŒºŒµœÑŒ±Œæœç ŒøœÄŒøŒπŒøœÖŒ¥ŒÆœÄŒøœÑŒµ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ Œ∫Œ±Œπ œÑŒ∑ŒΩ ŒµŒºœÜŒ¨ŒΩŒπœÉŒ∑ œÉœÖŒºœÄœÑœâŒºŒ¨œÑœâŒΩ Œ±œÖœÑŒπœÉŒºŒøœç. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),pa=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"ŒìŒπŒ± œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ∑ Œ≠œÅŒµœÖŒΩŒ±"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Here‚Äôs What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety",target:"_blank",rel:"noopener noreferrer"},"Coronavirus disease (COVID-19): Vaccines safety")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),va=i('<h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 2:</span> Œ§Œø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± œÑœâŒΩ Œ≤œÅŒµœÜœéŒΩ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œáŒµŒπœÅŒπœÉœÑŒµŒØ œÄŒøŒªŒªŒ±œÄŒªŒ¨ ŒµŒºŒ≤œåŒªŒπŒ± </h3><p> Œ§Œ± œÄŒ±ŒπŒ¥ŒπŒ¨ ŒµŒºŒ≤ŒøŒªŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ œÉŒµ ŒΩŒµŒ±œÅŒÆ Œ∑ŒªŒπŒ∫ŒØŒ± ŒµœÄŒµŒπŒ¥ŒÆ Œ¥ŒπŒ±œÑœÅŒ≠œáŒøœÖŒΩ ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒø Œ∫ŒØŒΩŒ¥œÖŒΩŒø ŒΩŒ± Œ±œÅœÅœâœÉœÑŒÆœÉŒøœÖŒΩ œÉŒøŒ≤Œ±œÅŒ¨ ŒÆ ŒΩŒ± œÄŒµŒ∏Œ¨ŒΩŒøœÖŒΩ ŒµŒ¨ŒΩ Œ∫ŒøŒªŒªŒÆœÉŒøœÖŒΩ Œ∫Œ¨œÄŒøŒπŒµœÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ. </p><p> Œ§Œ± ŒΩŒµŒøŒ≥Œ≠ŒΩŒΩŒ∑œÑŒ± Œ≠œáŒøœÖŒΩ Œ±ŒΩŒøœÉŒØŒ± œÉŒµ ŒøœÅŒπœÉŒºŒ≠ŒΩŒµœÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ (œÄ.œá. Œ±ŒΩŒµŒºŒøŒ≤ŒªŒøŒ≥ŒπŒ¨) ŒµœÄŒµŒπŒ¥ŒÆ ŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒΩ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± Œ±œÄœå œÑŒπœÇ ŒºŒ∑œÑŒ≠œÅŒµœÇ œÑŒøœÖœÇ Œ∫Œ±œÑŒ¨ œÑŒ∑ Œ¥ŒπŒ¨œÅŒ∫ŒµŒπŒ± œÑŒ∑œÇ Œ∫œçŒ∑œÉŒ∑œÇ. Œ©œÉœÑœåœÉŒø, Œ∑ Œ±ŒΩŒøœÉŒØŒ± Œ±œÖœÑŒÆ Œ¥ŒπŒ±œÅŒ∫ŒµŒØ ŒºœåŒΩŒø Œ≥ŒπŒ± ŒºŒµœÅŒπŒ∫ŒøœçœÇ ŒºŒÆŒΩŒµœÇ. </p><p> ŒåŒºœâœÇ œÑŒ± œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ± Œ≤œÅŒ≠œÜŒ∑ Œ¥ŒµŒΩ Œ≠œáŒøœÖŒΩ Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÉŒµ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œåœÄœâœÇ Œ∑ Œ¥ŒπœÜŒ∏ŒµœÅŒØœÅŒπŒ¥Œ± (diphtheria), Œø Œ∫ŒøŒ∫Œ∫œçœÑŒ∑œÇ (whooping cough), Œ∑ œÄŒøŒªŒπŒøŒºœÖŒµŒªŒØœÑŒπŒ¥Œ± (polio), Œø œÑŒ≠œÑŒ±ŒΩŒøœÇ (tetanus), Œ∑ Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ± Œí ŒÆ œÉœÑŒøŒΩ Œπœå Hib. </p><p> ŒìŒπŒ± ŒΩŒ± ŒºŒµŒπœâŒ∏ŒµŒØ Œø Œ±œÅŒπŒ∏ŒºœåœÇ œÑœâŒΩ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ œÄŒøœÖ ŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ Œ≠ŒΩŒ± œÄŒ±ŒπŒ¥ŒØ Œ∫Œ±œÑŒ¨ œÑŒ∑ŒΩ ŒµœÄŒØœÉŒ∫ŒµœàŒÆ œÑŒøœÖ œÉœÑŒøŒΩ Œ≥ŒπŒ±œÑœÅœå, ŒøœÅŒπœÉŒºŒ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄœÅŒøœÉœÜŒ≠œÅŒøŒΩœÑŒ±Œπ œâœÇ œÉœÖŒΩŒ¥œÖŒ±œÉŒºœåœÇ (œÉœÖŒΩŒ¥œÖŒ¨Œ∂ŒøŒΩœÑŒ±Œπ Œ¥œçŒø ŒÆ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ± Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ ŒµŒºŒ≤œåŒªŒπŒ± œÉŒµ Œ≠ŒΩŒ±). Œ†Œ±œÅŒ±Œ¥ŒµŒØŒ≥ŒºŒ±œÑŒ± œÑŒ≠œÑŒøŒπœâŒΩ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ ŒµŒØŒΩŒ±Œπ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œÑŒ∑œÇ Œ¥ŒπœÜŒ∏ŒµœÅŒØœÑŒπŒ¥Œ±œÇ, œÑŒøœÖ œÑŒµœÑŒ¨ŒΩŒøœÖ, œÑŒøœÖ Œ∫ŒøŒ∫Œ∫œçœÑŒ∑ (DTap), œÑŒ∑œÇ ŒôŒªŒ±œÅŒ¨œÇ, Œ†Œ±œÅœâœÑŒØœÑŒπŒ¥Œ±œÇ Œ±ŒªŒªŒ¨ Œ∫Œ±Œπ œÑŒ∑œÇ ŒïœÅœÖŒ∏œÅŒ¨œÇ (MMR). </p><p> ŒïœÄŒπœÉœÑŒ∑ŒºŒøŒΩŒπŒ∫Œ¨ Œ¥ŒµŒ¥ŒøŒºŒ≠ŒΩŒ± Œ¥ŒµŒØœáŒΩŒøœÖŒΩ œåœÑŒπ Œ∑ œÑŒ±œÖœÑœåœáœÅŒøŒΩŒ∑ ŒªŒÆœàŒ∑ œÄŒøŒªŒªœéŒΩ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ Œ¥ŒµŒΩ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ Œ∫Œ±ŒΩŒ≠ŒΩŒ± œÄœÅœåŒ≤ŒªŒ∑ŒºŒ± œÖŒ≥ŒµŒØŒ±œÇ. Œ§Œø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± œÑœâŒΩ Œ≤œÅŒµœÜœéŒΩ ŒµŒØŒΩŒ±Œπ œÄŒπŒø Œ±ŒΩŒ∏ŒµŒ∫œÑŒπŒ∫œå Œ±œÄœå œåœÉŒø œÄŒπœÉœÑŒµœçŒøœÖŒΩ ŒºŒµœÅŒπŒ∫ŒøŒØ. ŒúŒ¨ŒªŒπœÉœÑŒ± ŒºŒµ Œ≤Œ¨œÉŒ∑ œÑŒøŒΩ Œ±œÅŒπŒ∏Œºœå œÑœâŒΩ Œ±ŒΩœÑŒπœÉœâŒºŒ¨œÑœâŒΩ œÄŒøœÖ œÖœÄŒ¨œÅœáŒøœÖŒΩ œÉœÑŒø Œ±ŒØŒºŒ±, Œ∏ŒµœâœÅŒ∑œÑŒπŒ∫Œ¨ Œ≠ŒΩŒ± Œ≤œÅŒ≠œÜŒøœÇ Œ∏Œ± ŒµŒØœáŒµ œÑŒ∑ŒΩ ŒπŒ∫Œ±ŒΩœåœÑŒ∑œÑŒ± ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ œÉŒµ œÄŒøŒªœç ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒø Œ±œÅŒπŒ∏Œºœå ŒµŒºŒ≤ŒøŒªŒØœâŒΩ (œÑŒø ŒµœÅœéœÑŒ∑ŒºŒ± ŒµŒØŒΩŒ±Œπ ŒµŒ¨ŒΩ Œ∏Œ± œÄœÅŒ≠œÄŒµŒπ ŒΩŒ± Œ±ŒΩœÑŒ±œÄŒøŒ∫œÅŒπŒ∏ŒµŒØ œÉŒµ 1000, 10000 ŒÆ 100000 œÑŒ±œÖœÑœåœáœÅŒøŒΩŒ±). </p><p> ŒëŒ∫œåŒºŒ∑ Œ∫Œ±Œπ Œ±ŒΩ œåŒªŒ± œÑŒ± œÄœÅŒøŒ≥œÅŒ±ŒºŒºŒ±œÑŒπœÉŒºŒ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ± (Œ≤Œ¨œÉŒµŒπ œÑŒøœÖ ŒµŒ∏ŒΩŒπŒ∫Œøœç œÉœáŒµŒ¥ŒØŒøœÖ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœç) Œ≥ŒØŒΩŒøŒΩœÑŒ±ŒΩ œÑŒ±œÖœÑœåœáœÅŒøŒΩŒ±, Œ∏Œ± ŒµœÄŒπŒ≤Œ¨œÅœÖŒΩŒ±ŒΩ ŒºœåŒΩŒø Œ≠ŒΩŒ± ŒºŒπŒ∫œÅœå ŒºŒ≠œÅŒøœÇ œÑŒøœÖ Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫Œøœç œÉœÖœÉœÑŒÆŒºŒ±œÑŒøœÇ ŒµŒΩœåœÇ Œ≤œÅŒ≠œÜŒøœÖœÇ. </p><p> Œ£œÑŒ∑ŒΩ œÄœÅŒ±Œ≥ŒºŒ±œÑŒπŒ∫œåœÑŒ∑œÑŒ±, œÑŒ± Œ≤œÅŒ≠œÜŒ∑ ŒµŒ∫œÑŒØŒ∏ŒµŒΩœÑŒ±Œπ œÉŒµ Œ±ŒΩŒ±œÅŒØŒ∏ŒºŒ∑œÑŒ± Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± Œ∫Œ±Œπ ŒπŒøœçœÇ Œ∫Œ±Œ∏Œ∑ŒºŒµœÅŒπŒΩŒ¨, Œ∫Œ±Œπ Œ∑ ŒµœÄŒπŒ≤Œ¨œÅœÖŒΩœÉŒ∑ Œ±œÄœå œÑŒøœÖœÇ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœçœÇ ŒµŒØŒΩŒ±Œπ Œ±ŒºŒµŒªŒ∑œÑŒ≠Œ± œÉŒµ œÉœçŒ≥Œ∫œÅŒπœÉŒ∑ ŒºŒµ Œ±œÖœÑŒ¨. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, Œ≠œÅŒµœÖŒΩŒµœÇ Œ±œÄŒøŒ∫Œ±ŒªœçœÄœÑŒøœÖŒΩ œåœÑŒπ Œ∑ Œ≠Œ∫Œ∏ŒµœÉŒ∑ œÉŒµ œÄŒøŒªŒªŒ±œÄŒªŒ¨ ŒµŒºŒ≤œåŒªŒπŒ± Œ∫Œ±œÑŒ¨ œÑŒøœÖœÇ œÄœÅœéœÑŒøœÖœÇ 23 ŒºŒÆŒΩŒµœÇ Œ∂œâŒÆœÇ œÑŒøœÖœÇ œÉœÖœÉœáŒµœÑŒØŒ∂ŒµœÑŒ±Œπ ŒºŒµ œÑŒøŒΩ Œ±œÖŒæŒ∑ŒºŒ≠ŒΩŒø Œ∫ŒØŒΩŒ¥œÖŒΩŒø œÄŒ±œÅŒøœÖœÉŒØŒ±œÉŒ∑œÇ ŒªŒøŒπŒºœéŒæŒµœâŒΩ œÄŒøœÖ Œ¥ŒµŒΩ œÉœÑŒøœáŒµœçŒøŒΩœÑŒ±Œπ Œ±œÄœå œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ±œÖœÑŒ¨. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 3:</span> Œó Œ±ŒΩŒøœÉŒØŒ± œÄŒøœÖ Œ±œÄŒøŒ∫œÑŒ¨ Œ∫Œ¨œÄŒøŒπŒøœÇ œÄŒøœÖ ŒΩŒøœÉŒµŒØ ŒµŒØŒΩŒ±Œπ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ Œ±œÄœå œÑŒ∑ŒΩ Œ±ŒΩŒøœÉŒØŒ± œÄŒøœÖ Œ±œÄŒøŒ∫œÑŒ¨ ŒµŒ∫ŒµŒØŒΩŒøœÇ œÄŒøœÖ ŒµŒºŒ≤ŒøŒªŒπŒ¨Œ∂ŒµœÑŒ±Œπ</h3><p> Œ§Œø Œ≥ŒµŒ≥ŒøŒΩœåœÇ œåœÑŒπ Œ∑ œÜœÖœÉŒπŒ∫ŒÆ ŒªŒøŒØŒºœâŒæŒ∑ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ ŒπœÉœáœÖœÅœåœÑŒµœÅŒ∑ Œ±ŒΩŒøœÉŒØŒ± Œ≠ŒΩŒ±ŒΩœÑŒπ œÑŒ∑œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±œÇ Œ±œÄœå œÑŒøŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºœå ŒµŒØŒΩŒ±Œπ Œ±ŒªŒ∑Œ∏ŒÆœÇ. Œ©œÉœÑœåœÉŒø, ŒøŒπ Œ∫ŒØŒΩŒ¥œÖŒΩŒøŒπ Œ±œÖœÑŒÆœÇ œÑŒ∑œÇ œÄœÅŒøœÉŒ≠Œ≥Œ≥ŒπœÉŒ∑œÇ œÖœÄŒµœÅŒ≤Œ±ŒØŒΩŒøœÖŒΩ Œ∫Œ±œÑŒ¨ œÄŒøŒªœç œÑŒ± œÉœáŒµœÑŒπŒ∫Œ¨ ŒøœÜŒ≠ŒªŒ∑. </p><p> Œ§Œø œÑŒØŒºŒ∑ŒºŒ± ŒºŒµœÑŒ¨ Œ±œÄœå ŒºŒØŒ± œÜœÖœÉŒπŒ∫ŒÆ ŒºœåŒªœÖŒΩœÉŒ∑ Œ±ŒΩŒµŒºŒøŒ≤ŒªŒøŒ≥ŒπŒ¨œÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ ŒºŒ≠œáœÅŒπ Œ∫Œ±Œπ œÄŒΩŒµœÖŒºŒøŒΩŒØŒ± œÄŒøœÖ œÄœÅŒøŒ∫ŒªŒÆŒ∏Œ∑Œ∫Œµ Œ±œÄœå Œ±ŒΩŒµŒºŒøŒ≤ŒªŒøŒ≥ŒπŒ¨ ŒÆ œÄŒΩŒµœÖŒºŒøŒΩŒπœåŒ∫ŒøŒ∫Œø. ŒÜŒªŒªŒ± œÄŒ±œÅŒ±Œ¥ŒµŒØŒ≥ŒºŒ±œÑŒ± ŒµœÄŒπœÄœÑœéœÉŒµœâŒΩ Œ±œÄœå œÜœÖœÉŒπŒ∫ŒÆ ŒºœåŒªœÖŒΩœÉŒ∑ ŒµŒØŒΩŒ±Œπ Œ∑ Œ¥ŒπŒ±ŒΩŒøŒ∑œÑŒπŒ∫ŒÆ Œ±ŒΩŒ±œÄŒ∑œÅŒØŒ± ŒºŒµœÑŒ¨ Œ±œÄœå ŒΩœåœÉŒ∑œÉŒ∑ œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ Œø ŒπœåœÇ Hib, Œ≥ŒµŒΩŒµœÑŒπŒ∫Œ≠œÇ Œ±ŒΩœâŒºŒ±ŒªŒØŒµœÇ ŒºŒµœÑŒ¨ Œ±œÄœå ŒµœÅœÖŒ∏œÅŒ¨, Œ∫Œ±œÅŒ∫ŒØŒΩŒø œÑŒøœÖ ŒÆœÄŒ±œÑŒøœÇ ŒºŒµœÑŒ¨ Œ±œÄœå œÑŒøŒΩ Œπœå œÑŒ∑œÇ Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ±œÇ Œí ŒÆ ŒºŒ≠œáœÅŒπ Œ∫Œ±Œπ Œ∏Œ¨ŒΩŒ±œÑŒø ŒºŒµœÑŒ¨ Œ±œÄœå œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± ŒπŒªŒ±œÅŒ¨œÇ. </p><p> Œ†ŒπŒø œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ± ŒµŒ¨ŒΩ Œ∫Œ¨œÄŒøŒπŒøœÇ Œ∏ŒµŒªŒÆœÉŒµŒπ ŒΩŒ± Œ±œÄŒøŒ∫œÑŒÆœÉŒµŒπ Œ±ŒΩŒøœÉŒØŒ± œÉœÑŒ∑ŒΩ ŒπŒªŒ±œÅŒ¨ ŒºŒµœÑŒ¨ Œ±œÄœå œÜœÖœÉŒπŒ∫ŒÆ ŒΩœåœÉŒ∑œÉŒ∑, Œ∏Œ± Œ±ŒΩœÑŒπŒºŒµœÑœéœÄŒπŒ∂Œµ 1 œÉœÑŒπœÇ 500 œÄŒπŒ∏Œ±ŒΩœåœÑŒ∑œÑŒµœÇ Œ∏Œ±ŒΩŒ¨œÑŒøœÖ Œ±œÄœå œÑŒ± œÉœÖŒºœÄœÑœéŒºŒ±œÑŒ¨ œÑŒ∑œÇ. </p><p> ŒëŒΩœÑŒØŒ∏ŒµœÑŒ±, Œø Œ±œÅŒπŒ∏ŒºœåœÇ œÑœâŒΩ Œ±œÑœåŒºœâŒΩ œÄŒøœÖ ŒµŒØœáŒ±ŒΩ œÉŒøŒ≤Œ±œÅŒ≠œÇ Œ±ŒªŒªŒµœÅŒ≥ŒπŒ∫Œ≠œÇ Œ±ŒΩœÑŒπŒ¥œÅŒ¨œÉŒµŒπœÇ Œ±œÄœå Œ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒø MMR Œ≥ŒπŒ± œÑŒ∑ŒΩ ŒôŒªŒ±œÅŒ¨-Œ†Œ±œÅœâœÑŒØœÑŒπŒ¥Œ±-ŒïœÅœÖŒ∏œÅŒ¨, ŒµŒØŒΩŒ±Œπ ŒºŒπŒ∫œÅœåœÑŒµœÅŒøœÇ Œ±œÄœå 1 œÉŒµ 1.000.000.000. </p><p> Œ©œÉœÑœåœÉŒø, œÖœÄŒ¨œÅœáŒøœÖŒΩ ŒºŒµœÅŒπŒ∫Œ¨ ŒµŒºŒ≤œåŒªŒπŒ± œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ Œ±œÄœå œåœÑŒπ Œ∑ œÜœÖœÉŒπŒ∫ŒÆ ŒΩœåœÉŒ∑œÉŒ∑. ŒìŒπŒ± œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ±, œÑŒø ŒµŒºŒ≤œåŒªŒπŒø Œ≥ŒπŒ± œÑŒøŒΩ Œπœå œÑœâŒΩ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩœâŒΩ Œ∏Œ∑ŒªœâŒºŒ¨œÑœâŒΩ (HPV) œÄŒµœÅŒπŒ≠œáŒµŒπ œÖœàŒ∑ŒªŒÆ Œ∫Œ±Œ∏Œ±œÅœåœÑŒ∑œÑŒ± œÑŒ∑œÇ œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ∑œÇ œÄœÅœâœÑŒµŒêŒΩŒ∑œÇ, œÄŒøœÖ ŒøŒ¥Œ∑Œ≥ŒµŒØ œÉŒµ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ Œ±Œ∫œåŒºŒ± Œ∫Œ±Œπ Œ±œÄœå œÑŒ∑ œÜœÖœÉŒπŒ∫ŒÆ ŒΩœåœÉŒ∑œÉŒ∑. ŒÜŒªŒªŒ± œÄŒ±œÅŒ±Œ¥ŒµŒØŒ≥ŒºŒ±œÑŒ± œÄŒµœÅŒπŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø Œ∫Œ±œÑŒ¨ œÑŒøœÖ œÑŒµœÑŒ¨ŒΩŒøœÖ, œÑŒøœÖ ŒπŒøœç Hib, Œ∫Œ±Œπ œÑŒøœÖ œÄŒΩŒµœÖŒºŒøŒΩŒπœåŒ∫ŒøŒ∫Œ∫ŒøœÖ. ŒåœÉŒøŒΩ Œ±œÜŒøœÅŒ¨ œÑŒøŒΩ COVID-19, Œ¥ŒµŒΩ Œ≠œáŒµŒπ Œ¥ŒπŒµœÖŒ∫œÅŒπŒΩŒπœÉœÑŒµŒØ Œ±Œ∫œåŒºŒ∑. ŒàœáŒµŒπ Œ±œÄŒøŒ¥ŒµŒπœáŒ∏ŒµŒØ œåŒºœâœÇ œåœÑŒπ Œ∑ ŒºœåŒΩŒπŒºŒ∑ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± ŒºŒµœÑŒ¨ œÑŒ∑ ŒΩœåœÉŒ∑œÉŒ∑ ŒµŒØŒΩŒ±Œπ Œ±œÄŒØŒ∏Œ±ŒΩŒ∑. </p><p> Œ†Œ±œÅœåŒªŒø œÄŒøœÖ ŒøŒπ Œ±œÉŒ∏ŒµŒΩŒµŒØœÇ ŒºŒµ Œ∫ŒøœÅŒøŒΩŒøœäœå Œ±œÄŒ≠Œ∫œÑŒ∑œÉŒ±ŒΩ ¬´œÉŒ∑ŒºŒ±ŒΩœÑŒπŒ∫ŒÆ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ ŒºŒΩŒÆŒºŒ∑¬ª œÄŒøœÖ œÄŒµœÅŒπŒªŒ¨ŒºŒ≤Œ±ŒΩŒµ Œ∫Œ±Œπ œÑŒ± œÑŒ≠œÉœÉŒµœÅŒ± œÉŒ∑ŒºŒ±ŒΩœÑŒπŒ∫Œ¨ ŒºŒ≠œÅŒ∑ œÑŒøœÖ Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫Œøœç œÉœÖœÉœÑŒÆŒºŒ±œÑŒøœÇ, Œ∫œçœÑœÑŒ±œÅŒ± ŒºŒΩŒÆŒºŒ∑œÇ Œí, Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ±, Œ∫œçœÑœÑŒ±œÅŒ± ŒºŒΩŒÆŒºŒ∑œÇ CD4+Œ§Œ±, Œ∫œçœÑœÑŒ±œÅŒ± ŒºŒΩŒÆŒºŒ∑œÇ CD8+Œ§, Œ∑ œÄœÅŒøœÉœÑŒ±œÉŒØŒ± Œ¨œÅœáŒπœÉŒµ ŒΩŒ± ŒºŒµŒπœéŒΩŒµœÑŒ±Œπ ŒºŒµœÑŒ¨ Œ±œÄœå ŒºŒπœÉœå œáœÅœåŒΩŒø ŒÆ Œ∫Œ±Œπ ŒªŒπŒ≥œåœÑŒµœÅŒø. ŒïœÄŒØœÉŒ∑œÇ, ŒøŒπ ŒµœÄŒπœÉœÑŒÆŒºŒøŒΩŒµœÇ Œ≠œáŒøœÖŒΩ Œ¥ŒµŒØŒæŒµŒπ Œ≠ŒΩŒ± ¬´œÑŒµœÅŒ¨œÉœÑŒπŒø Œ¥œÖŒΩŒ±ŒºŒπŒ∫œå ŒµœçœÅŒøœÇ¬ª œÉœÑŒ∑ŒΩ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ ŒºŒµœÑŒ±Œæœç œÑœâŒΩ Œ±œÑœåŒºœâŒΩ, ŒºŒµ 200œÄŒªŒ¨œÉŒπŒ± Œ¥ŒπŒ±œÜŒøœÅŒ¨ œÉœÑŒ± ŒµœÄŒØœÄŒµŒ¥Œ± Œ±ŒΩœÑŒπœÉœâŒºŒ¨œÑœâŒΩ. </p><p> ŒÜŒªŒªŒµœÇ ŒºŒµŒªŒ≠œÑŒµœÇ Œ≠œáŒøœÖŒΩ Œ¥ŒµŒØŒæŒµŒπ œåœÑŒπ ŒµŒ∏ŒµŒªŒøŒΩœÑŒ≠œÇ œÄŒøœÖ Œ≠ŒªŒ±Œ≤Œ±ŒΩ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø Moderna (mRNA), Œ±œÄŒ≠Œ∫œÑŒ∑œÉŒ±ŒΩ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± ‚Äì Œ≠ŒΩŒ±œÇ Œ¥ŒµŒØŒ∫œÑŒ∑œÇ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆœÇ Œ±œÄœåŒ∫œÅŒπœÉŒ∑œÇ ‚Äì œÉœÑŒø Œ±ŒØŒºŒ± œÑŒøœÖœÇ Œ±œÄœå œÑŒøœÖœÇ Œ±ŒΩŒ∏œÅœéœÄŒøœÖœÇ œÄŒøœÖ ŒΩœåœÉŒ∑œÉŒ±ŒΩ ŒºŒµ œÑŒøŒΩ Œπœå COVID-19. Œ©œÉœÑœåœÉŒø, Œ±œÖœÑœå œÑŒø Œ≥ŒµŒ≥ŒøŒΩœåœÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± œÑœÅŒøœÄŒøœÄŒøŒπŒ∑Œ∏ŒµŒØ Œ±œÄœå œÑŒ∑ œÉŒøŒ≤Œ±œÅœåœÑŒ∑œÑŒ± œÑŒ∑œÇ ŒΩœåœÉŒøœÖ Œ∫Œ±Œ∏œéœÇ œÖœÄŒ¨œÅœáŒµŒπ œÉœÖœÉœáŒ≠œÑŒπœÉŒ∑ ŒºŒµœÑŒ±Œæœç Œ±œÖœÑŒÆœÇ Œ∫Œ±Œπ œÑŒ∑œÇ Œ¥ŒπŒ±œÅŒ∫ŒøœçœÇ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆœÇ Œ±œÄœåŒ∫œÅŒπœÉŒ∑œÇ. Œ£œÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ±, ŒøŒπ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒøŒπ œÉœÖŒºœÄœÑœâŒºŒ±œÑŒπŒ∫ŒøŒØ Œ±œÉŒ∏ŒµŒΩŒµŒØœÇ ŒµŒØœáŒ±ŒΩ œÄŒøŒªœç ŒªŒØŒ≥Œ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± ŒºŒµœÑŒ¨ Œ±œÄœå Œ≠ŒæŒπ ŒºŒÆŒΩŒµœÇ ŒºœåŒªœÖŒΩœÉŒ∑œÇ. </p><p> ŒëœÄœå œÑŒ± œÄŒπŒø œÄŒ¨ŒΩœâ œÉœÖŒºœÄŒµœÅŒ±ŒØŒΩŒøœÖŒºŒµ œåœÑŒπ Œ∑ œÜœÖœÉŒπŒ∫ŒÆ Œ±ŒΩŒøœÉŒØŒ± œÄŒøœÖ Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒµŒØœÑŒ±Œπ Œ±œÄœå ŒºŒØŒ± ŒºœåŒªœÖŒΩœÉŒ∑ SARS-CoV-2 ŒµŒØŒΩŒ±Œπ œÉœÖœáŒΩŒ¨ Œ±œÄœÅœåŒ≤ŒªŒµœÄœÑŒ∑. ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, œÑŒ± Œ±ŒΩœÑŒπœÉœéŒºŒ±œÑŒ± œÄŒøœÖ Œ±ŒΩŒ±œÄœÑœçœÉœÉŒøŒΩœÑŒ±Œπ ŒºŒ≠œÉœâ ŒµŒΩœåœÇ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ mRNA œÉœÑŒøœáŒµœçŒøœÖŒΩ Œ≠ŒΩŒ± ŒµœÖœÅœçœÑŒµœÅŒø œÜŒ¨œÉŒºŒ± Œ∏Œ≠œÉŒµœâŒΩ œÉœÑŒøŒΩ œÑŒøŒºŒ≠Œ± Œ¥Œ≠œÉŒºŒµœÖœÉŒ∑œÇ œÖœÄŒøŒ¥ŒøœáŒ≠œâŒΩ (RBD) Œ±œÄœå ŒµŒ∫ŒµŒØŒΩŒ± œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩœÑŒ±Œπ Œ±œÄœå œÜœÖœÉŒπŒ∫ŒÆ ŒºœåŒªœÖŒΩœÉŒ∑. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 4:</span> Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ ŒøœÖœÉŒØŒµœÇ Œ±œÄŒµŒπŒªŒ∑œÑŒπŒ∫Œ≠œÇ Œ≥ŒπŒ± œÑŒ∑ŒΩ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒ∑ Œ∂œâŒÆ</h3><p> Œ†ŒøŒªŒªŒøŒØ Œ¨ŒΩŒ∏œÅœâœÄŒøŒπ Œ±ŒΩŒ∑œÉœÖœáŒøœçŒΩ Œ≥ŒπŒ± œÑŒ∑ŒΩ œÄŒµœÅŒπŒµŒ∫œÑŒπŒ∫œåœÑŒ∑œÑŒ± ŒøœÖœÉŒπœéŒΩ œåœÄœâœÇ Œ∑ œÜŒøœÅŒºŒ±ŒªŒ¥ŒµŒ∞Œ¥Œ∑, Œø œÖŒ¥œÅŒ¨œÅŒ≥œÖœÅŒøœÇ ŒÆ œÑŒø Œ±ŒªŒøœÖŒºŒØŒΩŒπŒø ŒºŒ≠œÉŒ± œÉœÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±. ŒëœÖœÑŒ≠œÇ ŒøŒπ œáŒ∑ŒºŒπŒ∫Œ≠œÇ ŒøœÖœÉŒØŒµœÇ ŒµŒØŒΩŒ±Œπ œÑŒøŒæŒπŒ∫Œ≠œÇ Œ≥ŒπŒ± œÑŒøŒΩ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒø ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœå ŒºœåŒΩŒø œÉŒµ œÄŒøŒªœç ŒºŒµŒ≥Œ¨ŒªŒµœÇ œÉœÖŒ≥Œ∫ŒµŒΩœÑœÅœéœÉŒµŒπœÇ. ŒüŒπ œÄŒøœÉœåœÑŒ∑œÑŒµœÇ œÄŒøœÖ œÄŒµœÅŒπŒ≠œáŒøŒΩœÑŒ±Œπ œÉœÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± ŒµŒØŒΩŒ±Œπ œÉŒµ ŒµŒªŒ¨œáŒπœÉœÑŒµœÇ œÄŒøœÉœåœÑŒ∑œÑŒµœÇ, ŒºŒπŒ∫œÅœåœÑŒµœÅŒµœÇ Œ∫Œ±Œπ Œ±œÄœå œÑŒπœÇ œÄŒøœÉœåœÑŒ∑œÑŒµœÇ œÄŒøœÖ ŒªŒ±ŒºŒ≤Œ¨ŒΩŒøœÖŒºŒµ Œ±Œ∫œåŒºŒ± Œ∫Œ±Œπ Œ±œÄœå œÑŒ∑ Œ¥ŒπŒ±œÑœÅŒøœÜŒÆ ŒºŒ±œÇ. ŒúŒ¨ŒªŒπœÉœÑŒ± Œ∑ ŒøœÖœÉŒØŒ± œÑŒ∑œÇ œÜŒøœÅŒºŒ±ŒªŒ¥ŒµŒ∞Œ¥Œ∑œÇ œÄŒ±œÅŒ¨Œ≥ŒµœÑŒ±Œπ œÉŒµ œÖœàŒ∑ŒªœåœÑŒµœÅŒµœÇ œÉœÖŒ≥Œ∫ŒµŒΩœÑœÅœéœÉŒµŒπœÇ Œ±Œ∫œåŒºŒ± Œ∫Œ±Œπ Œ±œÄœå œÑŒøŒΩ ŒØŒ¥ŒπŒø œÑŒøŒΩ ŒºŒµœÑŒ±Œ≤ŒøŒªŒπœÉŒºœå ŒºŒ±œÇ. </p><p> ŒüœÅŒπœÉŒºŒ≠ŒΩŒ± œáŒ∑ŒºŒπŒ∫Œ¨ œÉœÑŒøŒπœáŒµŒØŒ± œåœÄœâœÇ ŒµŒØŒΩŒ±Œπ œÑŒ± Œ¨ŒªŒ±œÑŒ± Œ±ŒªŒøœÖŒºŒπŒΩŒØŒøœÖ (aluminium salts) œÄœÅŒøœÉœÑŒØŒ∏ŒµŒΩœÑŒ±Œπ œÉœÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ∫Œ±Œ∏œéœÇ ŒªŒµŒπœÑŒøœÖœÅŒ≥ŒøœçŒΩ œâœÇ Œ±ŒΩŒøœÉŒøŒµŒΩŒπœÉœáœÖœÑŒπŒ∫Œ¨. ŒëœÖœÑœå œÉŒ∑ŒºŒ±ŒØŒΩŒµŒπ œÄœâœÇ Œ∑ œÄŒ±œÅŒøœÖœÉŒØŒ± œÑŒøœÖœÇ œÉœÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± ŒµŒΩŒπœÉœáœçŒµŒπ œÑŒ∑ŒΩ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ œåœÑŒ±ŒΩ Œ∫Œ¨œÄŒøŒπŒøœÇ ŒµŒºŒ≤ŒøŒªŒπŒ¨Œ∂ŒµœÑŒ±Œπ. Œ†Œ±œÅœåŒªŒ± Œ±œÖœÑŒ¨, ŒºœåŒΩŒø œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ Œ¨ŒªŒ±œÑŒ± Œ±ŒªŒøœÖŒºŒπŒΩŒØŒøœÖ. ŒìŒπŒ± œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ± œÑŒ± œÄœÅœåœÉœÜŒ±œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ≥ŒπŒ± œÑŒøŒΩ Œπœå COVID-19 Œ¥ŒµŒΩ œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ Œ¨ŒªŒ±œÑŒ± Œ±ŒªŒøœÖŒºŒπŒΩŒØŒøœÖ. </p><p> ŒúŒµœÅŒπŒ∫Œ¨ ŒµŒºŒ≤œåŒªŒπŒ± ŒµœÄŒØœÉŒ∑œÇ ŒµŒºœÄŒµœÅŒπŒ≠œáŒøœÖŒΩ œÑŒ∑ŒΩ Œ∏ŒπŒºŒµœÅŒøœÉŒ¨ŒªŒ∑(thimerosal) œâœÇ œÉœÖŒΩœÑŒ∑œÅŒ∑œÑŒπŒ∫œå. Œ©œÉœÑœåœÉŒø, Œ∫Œ±ŒΩŒ≠ŒΩŒ± Œ±œÄœå œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄŒøœÖ Œ∫Œ¨ŒΩŒøœÖŒΩ œÑŒ± œÄŒ±ŒπŒ¥ŒπŒ¨ Œ¥ŒµŒΩ œÄŒµœÅŒπŒ≠œáŒµŒπ œÑŒø œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒø œÉœÖŒΩœÑŒ∑œÅŒ∑œÑŒπŒ∫œå. Œó Œ∏ŒπŒºŒµœÅŒøœÉŒ¨ŒªŒ∑ œÄŒµœÅŒπŒ≠œáŒµŒπ Œ±ŒπŒ∏œÖŒªœÖŒ¥œÅŒ¨œÅŒ≥œÖœÅŒø (ethylmercury), Œø ŒøœÄŒøŒØŒøœÇ Œ±œÄŒøŒºŒ±Œ∫œÅœçŒΩŒµœÑŒ±Œπ Œ≥œÅŒÆŒ≥ŒøœÅŒ± Œ±œÄœå œÑŒøŒΩ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒø ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœå œÉŒµ œÉœçŒ≥Œ∫œÅŒπœÉŒ∑ ŒºŒµ œÑŒøŒΩ ŒºŒµŒ∏œÖŒªœÖŒ¥œÅŒ¨œÅŒ≥œÖœÅŒø (methylmercury) Œø ŒøœÄŒøŒØŒøœÇ Œ≤ŒπŒøœÉœÖœÉœÉœâœÅŒµœçŒµœÑŒ±Œπ, œÉœÖŒΩŒµœÄœéœÇ œÖœÄŒ¨œÅœáŒµŒπ Œ¥ŒπŒ±œÜŒøœÅŒ¨ œÉœÑŒ∑ŒΩ œÑŒøŒæŒπŒ∫œåœÑŒ∑œÑŒ± œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØœÑŒ±Œπ œÉœÑŒøŒΩ Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒø ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºœå Œ±ŒΩŒ¨ŒªŒøŒ≥Œ± ŒºŒµ œÑŒ∑ ŒºŒøœÅœÜŒÆ œÑŒøœÖ ŒºŒµœÑŒ¨ŒªŒªŒøœÖ. Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± Œ≥ŒπŒ± œÑŒøŒΩ Œπœå COVID-19 Œ¥ŒµŒΩ œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ œÑŒøŒæŒπŒ∫Œ¨ ŒºŒ≠œÑŒ±ŒªŒªŒ±. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',24),ka=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"ŒìŒπŒ± œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒ∑ ŒºŒµŒªŒ≠œÑŒ∑"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.publichealth.org/public-awareness/understanding-vaccines/goes-vaccine/",target:"_blank",rel:"noopener noreferrer"},"What Goes Into A Vaccine?")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"What‚Äôs in Vaccines?")])])],-1),fa=i('<h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 5:</span> Œó Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ œÖŒ≥ŒπŒµŒπŒΩŒÆ Œ∫Œ±Œπ Œ±œÄŒøŒªœçŒºŒ±ŒΩœÉŒ∑ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒºŒµŒπœéœÉŒøœÖŒΩ œÑŒπœÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ Œ∫Œ±Œπ œåœáŒπ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ±</h3><p> Œó Œ±ŒªŒÆŒ∏ŒµŒπŒ± ŒµŒØŒΩŒ±Œπ œåœÑŒπ Œ∑ œáŒøœÅŒÆŒ≥Œ∑œÉŒ∑ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ Œ¥ŒµŒΩ Œ∏Œ± Œ≠œÄœÅŒµœÄŒµ ŒΩŒ± ŒªŒ±ŒºŒ≤Œ¨ŒΩŒµŒπ œåŒªŒ± œÑŒ± ŒµœçœÉŒ∑ŒºŒ± Œ≥ŒπŒ± œÑŒ∑ ŒºŒµŒØœâœÉŒ∑ ŒÆ ŒµŒæŒ¨ŒªŒµŒπœàŒ∑ œÑŒøœÖ œÄŒøœÉŒøœÉœÑŒøœç œÑœâŒΩ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫œéŒΩ Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ. ŒàœáŒµŒπ Œ±œÄŒøŒ¥ŒµŒπœáŒ∏ŒµŒØ œåœÑŒπ Œ∑ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑ œÖŒ≥ŒπŒµŒπŒΩŒÆ, Œ∑ Œ¥ŒπŒ±œÑœÅŒøœÜŒÆ Œ∫Œ±Œπ Œ∑ Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑ Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫œéŒΩ Œ≠œáŒøœÖŒΩ ŒµœÄŒØœÉŒ∑œÇ œÉœÖŒºŒ≤Œ¨ŒªŒµŒπ œÉœÑŒ∑ŒΩ ŒµŒæŒ¨ŒªŒµŒπœàŒ∑ ŒµŒΩœåœÇ œÄŒøœÉŒøœÉœÑŒøœç œÑœâŒΩ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫œéŒΩ Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ. ŒõŒøŒπŒºœéŒæŒµŒπœÇ œåœÄœâœÇ Œø œÑœçœÜŒøœÇ Œ∫Œ±Œπ Œ∑ œáŒøŒªŒ≠œÅŒ± œÄŒøœÖ ŒºŒµœÑŒ±Œ¥ŒØŒ¥ŒøŒΩœÑŒ±Œπ Œ±œÄœå ŒºŒøŒªœÖœÉŒºŒ≠ŒΩŒø ŒΩŒµœÅœå, Œ∫Œ±Œπ ŒºŒ¨ŒªŒπœÉœÑŒ± Œ±œÄŒøœÑŒµŒªŒøœçœÉŒ±ŒΩ ŒºŒØŒ± Œ∫œçœÅŒπŒ± Œ±ŒπœÑŒØŒ± Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ Œ∫Œ±Œπ Œ∏Œ±ŒΩŒ¨œÑŒøœÖ œÉœÑŒπœÇ Œ±œÅœáŒ≠œÇ œÑŒøœÖœÇ 20Œøœç Œ±ŒπœéŒΩŒ±, Œ≠œáŒøœÖŒΩ ŒºŒµŒπœâŒ∏ŒµŒØ Œ¥œÅŒ±ŒºŒ±œÑŒπŒ∫Œ¨ ŒªœåŒ≥œâ œÑŒ∑œÇ Œ∫Œ±ŒªœçœÑŒµœÅŒ∑œÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ. ŒúŒØŒ± œÄœÅœåœÉœÜŒ±œÑŒ∑ Œ±ŒΩŒ±œÉŒ∫œåœÄŒ∑œÉŒ∑ Œ∫Œ±œÑŒ≠ŒªŒ∑ŒæŒµ œÉœÑŒø œÉœÖŒºœÄŒ≠œÅŒ±œÉŒºŒ± œåœÑŒπ œÑŒø œÄŒªœçœÉŒπŒºŒø œÑœâŒΩ œáŒµœÅŒπœéŒΩ Œ±œÄŒøœÑœÅŒ≠œÄŒµŒπ œÑŒπœÇ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫Œ≠œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ. ŒàŒΩŒ± Œ¨ŒªŒªŒø œÄœÅœåœÉœÜŒ±œÑŒø œÉœÑŒøŒπœáŒµŒØŒø œÄœÅŒøŒ≠œÅœáŒµœÑŒ±Œπ Œ±œÄœå œÑŒø lockdown Œ≥ŒπŒ± œÑŒøŒΩ COVID-19 Œ∫Œ±Œπ œÑŒ∑ŒΩ œÄŒ±œÅŒ¨ŒªŒªŒ∑ŒªŒ∑ Œ≤ŒµŒªœÑŒØœâœÉŒ∑ œÑŒ∑œÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ Œ∑ ŒøœÄŒøŒØŒ± ŒºŒµŒØœâœÉŒµ Œ¥œÅŒ±ŒºŒ±œÑŒπŒ∫Œ¨ œÑŒ± œÄŒøœÉŒøœÉœÑŒ¨ ŒµœÄŒøœáŒπŒ∫ŒÆœÇ Œ≥œÅŒØœÄŒ∑œÇ. </p><p> Œ©œÉœÑœåœÉŒø, œåœÑŒ±ŒΩ Œ±œÖœÑŒøŒØ ŒøŒπ œÄŒ±œÅŒ¨Œ≥ŒøŒΩœÑŒµœÇ Œ±œÄŒøŒºŒøŒΩœâŒ∏ŒøœçŒΩ Œ∫Œ±Œπ Œ±ŒΩŒ±ŒªœÖŒ∏ŒøœçŒΩ œÑŒ± œÄŒøœÉŒøœÉœÑŒ¨ œÑœâŒΩ ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫œéŒΩ Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ, œÑœåœÑŒµ Œø œÅœåŒªŒøœÇ œÑœâŒΩ ŒµŒºŒ≤ŒøŒªŒØœâŒΩ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± Œ±ŒºœÜŒπœÉŒ≤Œ∑œÑŒ∑Œ∏ŒµŒØ. ŒàŒΩŒ± œÉœáŒµœÑŒπŒ∫œå œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ± Œ±œÄŒøœÑŒµŒªŒµŒØ œÑŒø ŒµŒºŒ≤œåŒªŒπŒø œÑŒ∑œÇ ŒπŒªŒ±œÅŒ¨œÇ œÉœÑŒπœÇ ŒóŒΩœâŒºŒ≠ŒΩŒµœÇ Œ†ŒøŒªŒπœÑŒµŒØŒµœÇ ŒëŒºŒµœÅŒπŒ∫ŒÆœÇ. Œ£œÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒ±, œåœÑŒ±ŒΩ ŒµŒπœÉŒÆœáŒ∏Œ∑ œÑŒø œÄœÅœéœÑŒø ŒµŒºŒ≤œåŒªŒπŒø ŒπŒªŒ±œÅŒ¨œÇ œÑŒø 1963, œÑŒ± œÄŒøœÉŒøœÉœÑŒ¨ ŒºœåŒªœÖŒΩœÉŒ∑œÇ ŒÆœÑŒ±ŒΩ œÉœÑŒ±Œ∏ŒµœÅŒ¨ œÉŒµ œÄŒµœÅŒØœÄŒøœÖ 40000 œÄŒµœÅŒπœÄœÑœéœÉŒµŒπœÇ ŒµœÑŒ∑œÉŒØœâœÇ. ŒïŒ∫ŒµŒØ Œ¥Œ∑ŒªŒ±Œ¥ŒÆ œÄŒøœÖ ŒøŒπ Œ∫Œ±ŒΩœåŒΩŒµœÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ Œ∫Œ±Œπ Œ±œÄŒøŒªœçŒºŒ±ŒΩœÉŒ∑œÇ Œ¥ŒµŒΩ Œ¨ŒªŒªŒ±ŒæŒ±ŒΩ Œ∫Œ±Œπ œÄŒøŒªŒªŒ¨ Œ≥ŒπŒ± œÄŒ¨ŒΩœâ Œ±œÄœå ŒºŒØŒ± Œ¥ŒµŒ∫Œ±ŒµœÑŒØŒ± Œ∑ ŒµŒπœÉŒ±Œ≥œâŒ≥ŒÆ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ ŒºŒµŒØœâœÉŒµ œÉŒ∑ŒºŒ±ŒΩœÑŒπŒ∫Œ¨ œÑŒø œÄŒøœÉŒøœÉœÑœå œÑœâŒΩ ŒºŒøŒªœçŒΩœÉŒµœâŒΩ Œ±œÄœå ŒπŒªŒ±œÅŒ¨ œÉŒµ œÄŒµœÅŒØœÄŒøœÖ 25.000 œÄŒµœÅŒπœÄœÑœéœÉŒµŒπœÇ ŒºŒ≠œáœÅŒπ œÑŒø 1970. </p><p> ŒëŒ∫œåŒºŒ∑ Œ≠ŒΩŒ± œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ± ŒµŒØŒΩŒ±Œπ Œ∑ ŒΩœåœÉŒøœÇ Hib. Œ£œçŒºœÜœâŒΩŒ± ŒºŒµ œÉœÑŒøŒπœáŒµŒØŒ± œÑŒøœÖ CDC, ŒøŒπ ŒºŒøŒªœçŒΩœÉŒµŒπœÇ Œ±œÄœå Œ±œÖœÑŒÆ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± ŒºŒµŒπœéŒ∏Œ∑Œ∫Œ±ŒΩ Œ±œÄœå 20.000 œÉŒµ 1.500 ŒºŒ≠œÉŒ± œÉŒµ 3 œáœÅœåŒΩŒπŒ± (Œ±œÄœå œÑŒø 1990 ŒºŒ≠œáœÅŒπ œÑŒø 1993), ŒºŒµœÑŒ¨ œÑŒ∑ŒΩ ŒµŒπœÉŒ±Œ≥œâŒ≥ŒÆ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ. </p><p> Œ§Œ≠ŒªŒøœÇ, Œ±Œ∫œåŒºŒ∑ Œ≠ŒΩŒ± œÄœÅœåœÉœÜŒ±œÑŒø œÉœÑŒøŒπœáŒµŒØŒø ŒµŒØŒΩŒ±Œπ œåœÑŒπ œÄŒ±œÅœåŒªŒø œÄŒøœÖ Œ¥ŒµŒΩ Œ≠Œ≥ŒπŒΩŒ±ŒΩ Œ¥œÅŒ±ŒºŒ±œÑŒπŒ∫Œ≠œÇ Œ±ŒªŒªŒ±Œ≥Œ≠œÇ œÉœÑŒøœÖœÇ Œ∫Œ±ŒΩœåŒΩŒµœÇ œÖŒ≥ŒπŒµŒπŒΩŒÆœÇ œÉœÑŒøŒΩ Œ±ŒΩŒµœÄœÑœÖŒ≥ŒºŒ≠ŒΩŒø Œ∫œåœÉŒºŒø, Œ≠Œ≥ŒπŒΩŒµ ŒºŒµŒØœâœÉŒ∑ œÑœâŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºœéŒΩ. ŒëœÖœÑŒÆ œÑŒ∑ œÉœÑŒπŒ≥ŒºŒÆ Œ±œÅŒ∫ŒµœÑŒ≠œÇ œáœéœÅŒµœÇ œåœÄœâœÇ Œ∑ ŒíœÅŒµœÑŒ±ŒΩŒØŒ±, ŒøŒπ ŒóŒΩœâŒºŒ≠ŒΩŒµœÇ Œ†ŒøŒªŒπœÑŒµŒØŒµœÇ ŒëŒºŒµœÅŒπŒ∫ŒÆœÇ, Œ∑ ŒìŒµœÅŒºŒ±ŒΩŒØŒ±, Œ∑ ŒôœÉœÄŒ±ŒΩŒØŒ± Œ∫.Œ¨., Œ≤ŒªŒ≠œÄŒøœÖŒΩ œÑŒ± œÄŒøœÉŒøœÉœÑŒ¨ ŒºœåŒªœÖŒΩœÉŒ∑œÇ Œ±œÄœå œÑŒ∑ŒΩ ŒπŒªŒ±œÅŒ¨ Œ∫Œ±Œπ Œ±œÄœå Œ¨ŒªŒªŒµœÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ œÄŒøœÖ Œ∏Œ± ŒºœÄŒøœÅŒøœçœÉŒ±ŒΩ ŒΩŒ± ŒµŒºœÄŒøŒ¥ŒπœÉœÑŒøœçŒΩ ŒºŒ≠œÉœâ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœç ŒΩŒ± Œ±œÖŒæŒ¨ŒΩŒøŒΩœÑŒ±Œπ. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 6:</span> Œ§Œ± ŒµŒºŒ≤œåŒªŒπŒ± ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± ŒºŒøŒªœçŒΩŒøœÖŒΩ œÑŒø œÄŒ±ŒπŒ¥ŒØ ŒºŒµ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± œÑŒ∑ŒΩ ŒøœÄŒøŒØŒ± œÄœÅŒøœÉœÄŒ±Œ∏ŒµŒØ ŒΩŒ± ŒµŒºœÄŒøŒ¥ŒØœÉŒµŒπ</h3><p> ŒúŒµœÅŒπŒ∫Œ¨ Œ±œÄœå œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± œÄŒµœÅŒπŒ≠œáŒøœÖŒΩ Œ∂œâŒΩœÑŒ±ŒΩŒøœçœÇ ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒøœÖœÇ ŒºŒπŒ∫œÅŒøŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœçœÇ/ŒπŒøœçœÇ ŒøŒπ ŒøœÄŒøŒØŒøŒπ ŒµŒæŒ±Œ∫ŒøŒªŒøœÖŒ∏ŒøœçŒΩ ŒΩŒ± ŒµŒØŒΩŒ±Œπ ŒπŒ∫Œ±ŒΩŒøŒØ ŒΩŒ± Œ±ŒΩŒ±œÄŒ±œÅŒ±œáŒ∏ŒøœçŒΩ œÉœÑŒøŒΩ ŒæŒµŒΩŒπœÉœÑŒÆ (œÉœÑŒøŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒ≠ŒΩŒø). ŒüŒπ ŒºŒπŒ∫œÅŒøŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøŒØ ŒµŒØŒΩŒ±Œπ ¬´Œ±œÄŒøŒ¥œÖŒΩŒ±ŒºœâŒºŒ≠ŒΩŒøŒπ¬ª, œÄŒøœÖ œÉŒ∑ŒºŒ±ŒØŒΩŒµŒπ œåœÑŒπ Œ≠œáŒøœÖŒΩ œáŒ¨œÉŒµŒπ œÑŒø ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒø ŒºŒ≠œÅŒøœÇ œÑŒ∑œÇ ŒπŒ∫Œ±ŒΩœåœÑŒ∑œÑŒ¨œÇ œÑŒøœÖœÇ ŒΩŒ± œÄœÅŒøŒ∫Œ±ŒªŒøœçŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒµœÇ, Œ±ŒªŒªŒ¨ ŒµŒæŒ±Œ∫ŒøŒªŒøœÖŒ∏ŒøœçŒΩ ŒΩŒ± Œ¥ŒπŒ±Œ∏Œ≠œÑŒøœÖŒΩ Œ±ŒΩŒøœÉŒøŒ≥ŒøŒΩŒπŒ∫Œ≠œÇ (immunogenic) ŒπŒ¥ŒπœåœÑŒ∑œÑŒµœÇ. ŒàœÑœÉŒπ Œ∑ ŒºœåŒªœÖŒΩœÉŒ∑ Œ±œÄœå Œ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒø ŒµŒØŒΩŒ±Œπ œÄŒøŒªœç ŒªŒπŒ≥œåœÑŒµœÅŒø œÉŒøŒ≤Œ±œÅŒÆ œÉŒµ œÉœáŒ≠œÉŒ∑ ŒºŒµ œÑŒ∑ ŒºœåŒªœÖŒΩœÉŒ∑ Œ±œÄœå œÑŒøŒΩ ŒØŒ¥ŒπŒø œÑŒøŒΩ Œπœå œÄŒøœÖ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±. Œ§Œ± ¬´Œ∂œâŒΩœÑŒ±ŒΩŒ¨¬ª ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ± ŒµŒØŒΩŒ±Œπ Œ±œÖœÑŒ¨ œÑŒ∑œÇ ŒπŒªŒ±œÅŒ¨œÇ-œÄŒ±œÅœâœÑŒØœÑŒπŒ¥Œ±œÇ-ŒµœÅœÖŒ∏œÅŒ¨œÇ(MMR), œÑŒøœÖ œÅŒøœÑŒ±œäŒøœç (rotavirus), œÑŒ∑œÇ ŒµœÖŒªŒøŒ≥ŒπŒ¨œÇ, œÑŒ∑œÇ Œ±ŒΩŒµŒºŒøŒ≤ŒªŒøŒ≥ŒπŒ¨œÇ Œ∫Œ±Œπ œÑŒøœÖ Œ∫ŒØœÑœÅŒπŒΩŒøœÖ œÄœÖœÅŒµœÑŒøœç. Œ£œÑŒπœÇ œÄŒµœÅŒπœÉœÉœåœÑŒµœÅŒµœÇ œÄŒµœÅŒπœÄœÑœéœÉŒµŒπœÇ, œÑŒ± ¬´Œ∂œâŒΩœÑŒ±ŒΩŒ¨¬ª ŒµŒºŒ≤œåŒªŒπŒ± Œ¥ŒµŒØœáŒΩŒøœÖŒΩ œÉŒ∑ŒºŒ±ŒΩœÑŒπŒ∫Œ¨ œÖœàŒ∑ŒªœåœÑŒµœÅŒ∑ Œ±ŒΩŒøœÉŒøŒ≥ŒøŒΩŒπŒ∫œåœÑŒ∑œÑŒ± Œ±œÄœå œÑŒ± Œ±Œ¥œÅŒ±ŒΩŒøœÄŒøŒπŒ∑ŒºŒ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒ±, Œ∫Œ±Œ∏œéœÇ ŒºŒπŒºŒøœçŒΩœÑŒ±Œπ œÉœáŒµŒ¥œåŒΩ œÑŒ≠ŒªŒµŒπŒ± œÑŒ∑ œÜœÖœÉŒπŒ∫ŒÆ ŒºœåŒªœÖŒΩœÉŒ∑ œÄœÅŒøŒ∫Œ±ŒªœéŒΩœÑŒ±œÇ Œ≠ŒΩŒ± œÄŒπŒø ŒøŒªŒøŒ∫ŒªŒ∑œÅœâŒºŒ≠ŒΩŒø œÜŒ¨œÉŒºŒ± Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫œéŒΩ Œ±œÄŒøŒ∫œÅŒØœÉŒµœâŒΩ. Œ©œÉœÑœåœÉŒø, Œ±œÖœÑŒ¨ œÑŒ± ŒµŒºŒ≤œåŒªŒπŒ± Œ¥ŒµŒΩ œÉœÖœÉœÑŒÆŒΩŒøŒΩœÑŒ±Œπ Œ≥ŒπŒ± œÄŒ±ŒπŒ¥ŒπŒ¨ ŒºŒµ ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ±, œåœÄœâœÇ Œ≥ŒπŒ± œÄŒ±œÅŒ¨Œ¥ŒµŒπŒ≥ŒºŒ± Œ±œÖœÑŒ¨ œÄŒøœÖ œÖœÄŒøŒ≤Œ¨ŒªŒªŒøŒΩœÑŒ±Œπ œÉŒµ Œ∏ŒµœÅŒ±œÄŒµŒØŒ± Œ≥ŒπŒ± Œ∫Œ±œÅŒ∫ŒØŒΩŒø. </p><p> ŒïœÄŒØœÉŒ∑œÇ, œÑŒ± ¬´Œ∂œâŒΩœÑŒ±ŒΩŒ¨¬ª ŒµŒºŒ≤œåŒªŒπŒ± ŒºœÄŒøœÅŒøœçŒΩ œÄœÅŒ¨Œ≥ŒºŒ±œÑŒπ ŒΩŒ± œÄœÅŒøŒ∫Œ±ŒªŒ≠œÉŒøœÖŒΩ ŒÆœÄŒπŒ± œÉœÖŒºœÄœÑœéŒºŒ±œÑŒ± œÄŒøœÖ ŒºŒøŒπŒ¨Œ∂ŒøœÖŒΩ ŒºŒµ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± Œ±œÄœå œÑŒ∑ŒΩ ŒøœÄŒøŒØŒ± œÑŒøœÖœÇ œÄœÅŒøœÉœÑŒ±œÑŒµœçŒøœÖŒΩ. Œ©œÉœÑœåœÉŒø, ŒøŒπ ŒªŒÆœÄœÑŒµœÇ œÑŒøœÖ ŒµŒºŒ≤ŒøŒªŒØŒøœÖ Œ≤ŒπœéŒΩŒøœÖŒΩ œÑŒ∑ŒΩ Œ±ŒΩŒøœÉŒøŒªŒøŒ≥ŒπŒ∫ŒÆ Œ±œÄœåŒ∫œÅŒπœÉŒ∑ œÑŒøœÖ ŒøœÅŒ≥Œ±ŒΩŒπœÉŒºŒøœç œÉœÑŒø ŒµŒºŒ≤œåŒªŒπŒø Œ∫Œ±Œπ œåœáŒπ œÑŒ∑ŒΩ ŒØŒ¥ŒπŒ± œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±. Œ•œÄŒ¨œÅœáŒµŒπ ŒºœåŒΩŒø ŒºŒØŒ± Œ∫Œ±œÑŒ±Œ≥ŒµŒ≥œÅŒ±ŒºŒºŒ≠ŒΩŒ∑ œÄŒµœÅŒØœÄœÑœâœÉŒ∑ Œ∫Œ±œÑŒ¨ œÑŒ∑ŒΩ ŒøœÄŒøŒØŒ± Œ≠ŒΩŒ± ŒµŒºŒ≤œåŒªŒπŒø Œ±œÄŒøŒ¥ŒµŒØœáŒ∏Œ∑Œ∫Œµ œåœÑŒπ œÄœÅŒøŒ∫Œ±ŒªŒµŒØ œÑŒ∑ŒΩ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±. ŒëœÖœÑœå ŒÆœÑŒ±ŒΩ œÑŒø Œ±œÄœå œÑŒøœÖ œÉœÑœåŒºŒ±œÑŒøœÇ ŒµŒºŒ≤œåŒªŒπŒø œÑŒ∑œÇ œÄŒøŒªŒπŒøŒºœÖŒµŒªŒØœÑŒπŒ¥Œ±œÇ (POV) œÑŒø ŒøœÄŒøŒØŒø Œ¥ŒµŒΩ œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒµŒØœÑŒ±Œπ œÄŒªŒ≠ŒøŒΩ Œ∫Œ±Œπ Œ≠œáŒµŒπ Œ±ŒΩœÑŒπŒ∫Œ±œÑŒ±œÉœÑŒ±Œ∏ŒµŒØ œÄœÅŒøœÇ œÑŒø œÄŒ±œÅœåŒΩ ŒºŒµ ŒºŒØŒ± ŒºŒøœÅœÜŒÆ ŒΩŒµŒ∫œÅŒøœç ŒπŒøœç, Œ≥ŒΩœâœÉœÑŒÆ œâœÇ Œ±Œ¥œÅŒ±ŒΩŒøœÄŒøŒπŒ∑ŒºŒ≠ŒΩŒø ŒµŒºŒ≤œåŒªŒπŒø œÄŒøŒªŒπŒøŒºœÖŒµŒªŒØœÑŒπŒ¥Œ±œÇ (IPV). </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">ŒúœçŒ∏ŒøœÇ 7:</span> ŒîŒµŒΩ ŒµŒØŒΩŒ±Œπ Œ±œÄŒ±œÅŒ±ŒØœÑŒ∑œÑŒø ŒΩŒ± ŒµŒºŒ≤ŒøŒªŒπŒ±œÉœÑŒøœçŒºŒµ ŒªœåŒ≥œâ œÑŒøœÖ œåœÑŒπ œÄŒøŒªŒªŒ≠œÇ œáœéœÅŒµœÇ Œ≠œáŒøœÖŒΩ œáŒ±ŒºŒ∑ŒªŒ¨ œÄŒøœÉŒøœÉœÑŒ¨ ŒºŒøŒªœçŒΩœÉŒµœâŒΩ</h3><p> Œó ¬´Œ±ŒΩŒøœÉŒØŒ± œÑŒ∑œÇ Œ±Œ≥Œ≠ŒªŒ∑œÇ¬ª ŒµŒºœÜŒ±ŒΩŒØŒ∂ŒµœÑŒ±Œπ œåœÑŒ±ŒΩ Œ≠ŒΩŒ± ŒºŒµŒ≥Œ¨ŒªŒø ŒºŒ≠œÅŒøœÇ ŒºŒØŒ±œÇ Œ∫ŒøŒπŒΩœåœÑŒ∑œÑŒ±œÇ (Œ∑ Œ±Œ≥Œ≠ŒªŒ∑) Œ±œÄŒøŒ∫œÑŒ¨ Œ±ŒΩŒøœÉŒØŒ± œÉŒµ ŒºŒØŒ± Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±, Œ∫Œ±Œ∏ŒπœÉœÑœéŒΩœÑŒ±œÇ Œ±œÄŒØŒ∏Œ±ŒΩŒ∑ œÑŒ∑ŒΩ ŒµŒæŒ¨œÄŒªœâœÉŒ∑ œÑŒ∑œÇ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±œÇ Œ±œÄœå Œ¨œÑŒøŒºŒø œÉŒµ Œ¨œÑŒøŒºŒø. ŒßŒ¨œÅŒ∑ œÉœÑŒ∑ŒΩ ¬´Œ±ŒΩŒøœÉŒØŒ± œÑŒ∑œÇ Œ±Œ≥Œ≠ŒªŒ∑œÇ¬ª, œÄŒøŒªŒªŒøŒØ Œ¨ŒΩŒ∏œÅœâœÄŒøŒπ Œ¥ŒµŒΩ Œ≤ŒªŒ≠œÄŒøœÖŒΩ œÑŒ∑ŒΩ Œ±ŒΩŒ¨Œ≥Œ∫Œ∑ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœç. ŒïŒ¨ŒΩ Œ∑ œÄŒªŒµŒπŒøœàŒ∑œÜŒØŒ± œÑœâŒΩ Œ±ŒΩŒ∏œÅœéœÄœâŒΩ ŒµŒØŒΩŒ±Œπ Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑ŒºŒ≠ŒΩŒ∑, Œ∑ ŒºŒ∑ Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑ŒºŒ≠ŒΩŒ∑ ŒºŒµŒπŒøŒΩœåœÑŒ∑œÑŒ± Œ∏Œ± œÄœÅŒøœÉœÑŒ±œÑŒµœçŒµœÑŒ±Œπ ŒµœÄŒØœÉŒ∑œÇ. ŒëœÖœÑœå ŒµŒØŒΩŒ±Œπ œÉŒ∑ŒºŒ±ŒΩœÑŒπŒ∫œå Œ¥ŒπœåœÑŒπ œÖœÄŒ¨œÅœáŒµŒπ Œ≠ŒΩŒ± ŒºŒ≠œÅŒøœÇ œÑŒøœÖ œÄŒªŒ∑Œ∏œÖœÉŒºŒøœç, œÑŒ± Œ≤œÅŒ≠œÜŒ∑, ŒµŒ≥Œ∫œÖŒºŒøŒΩŒøœçœÉŒµœÇ, Œ∑ŒªŒπŒ∫ŒπœâŒºŒ≠ŒΩŒøŒπ Œ∫Œ±Œπ Œ¨œÑŒøŒºŒ± ŒºŒµ ŒµŒæŒ±œÉŒ∏ŒµŒΩŒ∑ŒºŒ≠ŒΩŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± œÄŒøœÖ ŒºŒµœÅŒπŒ∫Œ≠œÇ œÜŒøœÅŒ≠œÇ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± ŒªŒ¨Œ≤ŒµŒπ ŒµŒºŒ≤œåŒªŒπŒ±. Œ©œÉœÑœåœÉŒø, Œ±œÇ œÖœÄŒøŒ∏Œ≠œÉŒøœÖŒºŒµ œåœÑŒπ œÄŒøŒªŒªŒøŒØ Œ¨ŒΩŒ∏œÅœâœÄŒøŒπ Œ¥ŒµŒΩ ŒµŒºŒ≤ŒøŒªŒπŒ¨Œ∂ŒøŒΩœÑŒ±Œπ ŒøœçœÑŒµ ŒøŒπ ŒØŒ¥ŒπŒøŒπ ŒøœçœÑŒµ Œ∫Œ±Œπ œÑŒ± œÄŒ±ŒπŒ¥ŒπŒ¨ œÑŒøœÖœÇ. Œ£Œµ Œ±œÖœÑŒÆ œÑŒ∑ŒΩ œÄŒµœÅŒØœÄœÑœâœÉŒ∑, Œ∑ ¬´Œ±ŒΩŒøœÉŒØŒ± œÑŒ∑œÇ Œ±Œ≥Œ≠ŒªŒ∑œÇ¬ª ŒµŒæŒ±œÜŒ±ŒΩŒØŒ∂ŒµœÑŒ±Œπ, Œ±ŒΩŒøŒØŒ≥ŒøŒΩœÑŒ±œÇ ŒµœÖŒ∫Œ±ŒπœÅŒØŒµœÇ œÉŒµ ŒπŒøœçœÇ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒÆœÅŒπŒ± ŒΩŒ± ŒµŒ≥Œ∫Œ±œÑŒ±œÉœÑŒ±Œ∏ŒøœçŒΩ Œ∫Œ±Œπ ŒΩŒ± ŒµŒæŒ±œÄŒªœâŒ∏ŒøœçŒΩ. ŒúŒµ œÑœåœÉŒøœÖœÇ œÄŒøŒªŒªŒøœçœÇ Œ±ŒΩŒ∏œÅœéœÄŒøœÖœÇ ŒºŒµ Œ±ŒΩŒøœÉŒØŒ± ŒºŒØŒ± ŒºŒøŒªœÖœÉŒºŒ±œÑŒπŒ∫ŒÆ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± Œ¥ŒµŒΩ Œ∏Œ± Œ≠œáŒµŒπ œÄŒøœÑŒ≠ œÑŒ∑ŒΩ ŒµœÖŒ∫Œ±ŒπœÅŒØŒ± ŒΩŒ± ŒµŒ≥Œ∫Œ±œÑŒ±œÉœÑŒ±Œ∏ŒµŒØ Œ∫Œ±Œπ ŒΩŒ± ŒµŒæŒ±œÄŒªœâŒ∏ŒµŒØ. </p><p> ŒïœÄŒπœÄŒªŒ≠ŒøŒΩ, ŒøŒπ Œ¥ŒπŒµŒ∏ŒΩŒµŒØœÇ ŒºŒµœÑŒ±Œ∫ŒπŒΩŒÆœÉŒµŒπœÇ œÉœÖœáŒΩŒ¨ ŒºŒµœÑŒ±œÜŒ≠œÅŒøœÖŒΩ ŒºŒØŒ± Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ± Œ±œÄœå œÑŒø ŒµŒæœâœÑŒµœÅŒπŒ∫œå ŒºŒ≠œÉŒ± œÉŒµ ŒºŒπŒ± œáœéœÅŒ±, ŒµŒΩœé Œ≠ŒΩŒ± ŒºŒ∑ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒ≠ŒΩŒø Œ¨œÑŒøŒºŒø Œ¥ŒπŒ±œÑœÅŒ≠œáŒµŒπ œÄŒøŒªœç ŒºŒµŒ≥Œ±ŒªœçœÑŒµœÅŒø Œ∫ŒØŒΩŒ¥œÖŒΩŒø ŒΩŒ± Œ±œÅœÅœâœÉœÑŒÆœÉŒµŒπ ŒÆ ŒΩŒ± ŒºŒøŒªœÖŒΩŒ∏ŒµŒØ ŒµŒΩœé œÑŒ±ŒæŒπŒ¥ŒµœçŒµŒπ. Œó Œ±œÖŒæŒ∑ŒºŒ≠ŒΩŒ∑ œÉœÖœáŒΩœåœÑŒ∑œÑŒ± œÑŒ∑œÇ ŒπŒªŒ±œÅŒ¨œÇ œÑŒø Œ∫Œ±œÑŒ±Œ¥ŒµŒπŒ∫ŒΩœçŒµŒπ Œ±œÖœÑœå œÉœÑŒπœÇ ŒóŒΩœâŒºŒ≠ŒΩŒµœÇ Œ†ŒøŒªŒπœÑŒµŒØŒµœÇ ŒëŒºŒµœÅŒπŒ∫ŒÆœÇ œÑŒ± œÑŒµŒªŒµœÖœÑŒ±ŒØŒ± œáœÅœåŒΩŒπŒ±. ŒåœÉŒø œÖœÄŒ¨œÅœáŒµŒπ Œ∑ Œ±œÉŒ∏Œ≠ŒΩŒµŒπŒ±, œÑœåœÑŒµ œÖœÄŒ¨œÅœáŒµŒπ Œ∫Œ±Œπ Œø Œ∫ŒØŒΩŒ¥œÖŒΩŒøœÇ ŒΩŒ± ŒºŒøŒªœÖŒΩŒ∏ŒøœçŒºŒµ. </p><section class="e-card"><h4 class="mt-0">ŒëŒΩŒ±œÜŒøœÅŒ≠œÇ / Œ†Œ∑Œ≥Œ≠œÇ Œ†ŒªŒ∑œÅŒøœÜœåœÅŒ∑œÉŒ∑œÇ</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',14),ga=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function ba(h,d){const l=v,c=k,r=f,n=g;return o(),u("div",je,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",xe,[t(c,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),qe,Ve,e("section",Se,[Ae,Ie,Me,De,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Œ†Œ∑Œ≥ŒÆ: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[Ce,a(" ŒîŒøŒºŒπŒ∫Œ≠œÇ Œ¥ŒπŒ±œÜŒøœÅŒ≠œÇ ŒπœéŒΩ Œ∫Œ±Œπ Œ≤Œ±Œ∫œÑŒ∑œÅŒØœâŒΩ ")]),_:1}),Oe,t(n,{class:"mb-8"},{default:s(()=>[ze,a(" ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± Œ≤ŒøŒ∑Œ∏ŒÆœÉŒøœÖŒΩ œÑŒø Œ±ŒΩŒøœÉŒøœÄŒøŒπŒ∑œÑŒπŒ∫œå œÉœçœÉœÑŒ∑ŒºŒ± ŒΩŒ± ŒµŒæŒøŒΩœÑœéœÉŒµŒπ œÑŒπœÇ Œ≤Œ±Œ∫œÑŒ∑œÅŒπŒ±Œ∫Œ≠œÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ, Œ±ŒªŒªŒ¨ Œ¥ŒµŒΩ ŒºœÄŒøœÅŒøœçŒΩ ŒΩŒ± œáœÅŒ∑œÉŒπŒºŒøœÄŒøŒπŒ∑Œ∏ŒøœçŒΩ Œ≠ŒΩŒ±ŒΩœÑŒπ œÑœâŒΩ ŒπŒøŒ≥ŒµŒΩœéŒΩ ŒªŒøŒπŒºœéŒæŒµœâŒΩ. Œ§Œ± "),Fe,a(" Œ¥œÅŒøœÖŒΩ Œ¥ŒπŒ±œÜŒøœÅŒµœÑŒπŒ∫Œ¨ Œ±œÄœå œÑŒ± Œ±ŒΩœÑŒπŒ≤ŒπŒøœÑŒπŒ∫Œ¨ Œ∫Œ±Œπ ŒµœÄŒØ œÑŒøœÖ œÄŒ±œÅœåŒΩœÑŒøœÇ ŒµŒØŒΩŒ±Œπ Œ±œÄŒøœÑŒµŒªŒµœÉŒºŒ±œÑŒπŒ∫Œ¨ ŒºœåŒΩŒø Œ≠ŒΩŒ±ŒΩœÑŒπ ŒøœÅŒπœÉŒºŒ≠ŒΩœâŒΩ ŒπŒøŒ≥ŒµŒΩœéŒΩ Œ±œÉŒ∏ŒµŒΩŒµŒπœéŒΩ, œåœÄœâœÇ Œ∑ Œ≥œÅŒØœÄŒ∑, Œø Œ≠œÅœÄŒ∑œÇ, Œ∑ Œ∑œÄŒ±œÑŒØœÑŒπŒ¥Œ± Œí Œ∫Œ±Œπ C Œ∫Œ±Œπ Œø HIV. ŒüŒπ ŒπŒøŒ≥ŒµŒΩŒµŒØœÇ ŒªŒøŒπŒºœéŒæŒµŒπœÇ ŒºœÄŒøœÅŒµŒØ ŒΩŒ± ŒµŒØŒΩŒ±Œπ œÄŒøŒªœç œÄŒπŒø Œ¥œçœÉŒ∫ŒøŒªŒø ŒΩŒ± Œ±ŒΩœÑŒπŒºŒµœÑœâœÄŒπœÉŒ∏ŒøœçŒΩ, ŒµœÄŒµŒπŒ¥ŒÆ Œø ŒπœåœÇ ŒµŒπœÉœáœâœÅŒµŒØ œÉœÑŒ± Œ±ŒΩŒ∏œÅœéœÄŒπŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒ±. Œ§Œø "),Ne,a(" ŒºœÄŒøœÅŒµŒØ ŒºŒµœÅŒπŒ∫Œ≠œÇ œÜŒøœÅŒ≠œÇ ŒΩŒ± œÉŒ∫ŒøœÑœéœÉŒµŒπ œÑŒ± ŒºŒøŒªœÖœÉŒºŒ≠ŒΩŒ± Œ∫œçœÑœÑŒ±œÅŒ± œÄœÅŒπŒΩ ŒºœÄŒøœÅŒ≠œÉŒµŒπ ŒΩŒ± Œ±ŒΩŒ±œÄŒ±œÅŒ±œáŒ∏ŒµŒØ Œø ŒπœåœÇ. Œ©œÉœÑœåœÉŒø, Œ∫Œ±Œ∏œéœÇ Œø ŒπœåœÇ Œ±ŒΩŒ±œÄŒ±œÅŒ¨Œ≥ŒµœÑŒ±Œπ, œÉœÖœáŒΩŒ¨ œÉŒ∫ŒøœÑœéŒΩŒµŒπ œÑŒø ŒºŒøŒªœÖœÉŒºŒ≠ŒΩŒø Œ∫œçœÑœÑŒ±œÅŒø œÑŒµŒºŒ±œáŒØŒ∂ŒøŒΩœÑŒ±œÇ œÑŒø Œ∫Œ±Œπ Œ¥ŒπŒ±œÉŒ∫ŒøœÅœÄŒØŒ∂ŒøŒΩœÑŒ±œÇ œÑŒø, Œ≥ŒµŒ≥ŒøŒΩœåœÇ œÄŒøœÖ ŒµœÄŒπœÑœÅŒ≠œÄŒµŒπ œÉœÑŒøŒΩ Œπœå ŒΩŒ± ŒµŒæŒ±œÄŒªœâŒ∏ŒµŒØ Œ∫Œ±Œπ œÉŒµ Œ¨ŒªŒªŒ± Œ∫œçœÑœÑŒ±œÅŒ± œÑŒøœÖ œÉœéŒºŒ±œÑŒøœÇ. ")]),_:1}),Pe]),$e,e("section",Be,[Te,Ee,Re,He,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Œ†Œ∑Œ≥ŒÆ: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[We,a(" ŒìŒπŒ± Œ∫Œ¨Œ∏Œµ ŒΩŒ≠Œø Œ±ŒΩœÑŒπŒ≥œåŒΩŒø, œÑŒø œÉœéŒºŒ± ŒºŒ±œÇ œáœÅŒµŒπŒ¨Œ∂ŒµœÑŒ±Œπ ŒΩŒ± Œ¥Œ∑ŒºŒπŒøœÖœÅŒ≥ŒÆœÉŒµŒπ Œ≠ŒΩŒ± œÉœÖŒ≥Œ∫ŒµŒ∫œÅŒπŒºŒ≠ŒΩŒø Œ±ŒΩœÑŒØœÉœâŒºŒ± ")]),_:1}),Ke,Ye,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Œ†Œ∑Œ≥ŒÆ: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Ue,a(" ŒëŒΩŒ¨œÄœÑœÖŒæŒ∑ Œ±ŒΩœÑŒπœÉœâŒºŒ¨œÑœâŒΩ ŒºŒ≠œÉœâ ŒµŒºŒ≤ŒøŒªŒπŒ±œÉŒºŒøœç ")]),_:1}),Je]),Le,e("section",Ge,[Qe,Xe,Ze,ea,e("div",aa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" ŒßŒµŒπœÅŒøœÖœÅŒ≥ŒπŒ∫ŒÆ ŒºŒ¨œÉŒ∫Œ± ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" ŒúŒ¨œÉŒ∫Œ± FFP2 (Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒπŒ∫ŒÆ œÉœÖœÉŒ∫ŒµœÖŒÆ) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" ŒúŒ¨œÉŒ∫Œ± FFP3 (Œ±ŒΩŒ±œÄŒΩŒµœÖœÉœÑŒπŒ∫ŒÆ œÉœÖœÉŒ∫ŒµœÖŒÆ) ŒºŒµ Œ≤Œ±ŒªŒ≤ŒØŒ¥Œ± ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" ŒúŒ¨œÉŒ∫Œ± œÜŒπŒªœÑœÅŒ±œÅŒØœÉŒºŒ±œÑŒøœÇ ")]),_:1})]),ta,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[sa]),_:1})]),ia,e("section",ra,[na,e("div",oa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Œ†Œ∑Œ≥ŒÆ: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[la,a(" Soap molecules destroying the virus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Œ†Œ∑Œ≥ŒÆ: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ca,a(" Micelle consisting of soap molecules and virus fragment ")]),_:1})]),da]),ma,e("section",ua,[ha,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[pa]),_:1}),va,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ka]),_:1}),fa]),t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" ŒÜŒªŒªŒøŒπ ŒºœçŒ∏ŒøŒπ œÉœáŒµœÑŒπŒ∫Œ¨ ŒºŒµ œÑŒøŒΩ Œπœå COVID-19 Œ∫Œ±Œπ Œ¨ŒªŒªŒµœÇ ŒµœÄŒπœÉœÑŒ∑ŒºŒøŒΩŒπŒ∫Œ≠œÇ œÄŒªŒ∑œÅŒøœÜŒøœÅŒØŒµœÇ ŒºœÄŒøœÅŒµŒØœÑŒµ ŒΩŒ± Œ≤œÅŒµŒØœÑŒµ œÉŒµ Œ±œÖœÑœå œÑŒøŒΩ œÉœçŒΩŒ¥ŒµœÉŒºŒø: "),ga]),_:1})])])}const wa=b(ye,[["render",ba]]),_a={},ya={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},ja={class:"e-article",lang:"pt",style:{hyphens:"auto"}},xa=e("h1",{class:"mb-0"},"V√≠rus",-1),qa=e("h5",{class:"font-normal uppercase leading-tight"},"INFORMA√á√ÉO CIENT√çFICA",-1),Va={id:"s1"},Sa=e("h2",{id:"s1t"},"1. V√≠rus versus bact√©rias",-1),Aa=e("p",{class:"font-bold"}," Bact√©rias e v√≠rus podem causar muitas infe√ß√µes comuns. Mas quais s√£o as diferen√ßas entre estes dois tipos de organismos infeciosos? ",-1),Ia=e("p",null,[e("span",{class:"e-term font-Heading"},"Bact√©rias"),a(" s√£o pequenos microrganismos que s√£o compostos por uma √∫nica c√©lula. As bact√©rias s√£o microorganismos min√∫sculos constitu√≠dos por uma √∫nica c√©lula. S√£o muito diversas e podem ter muitas formas e caracter√≠sticas estruturais. As bact√©rias podem viver em quase todos os ambientes poss√≠veis, incluindo dentro ou sobre o corpo humano. Apenas um pequeno n√∫mero de bact√©rias causa infec√ß√µes nos seres humanos. Estas bact√©rias s√£o designadas por bact√©rias patog√©nicas. ")],-1),Ma=e("p",null,[a(" Os "),e("span",{class:"e-term font-Heading"},"virus"),a(" s√£o outro tipo de microorganismo min√∫sculo, ainda mais pequeno do que as bact√©rias. Tal como as bact√©rias, s√£o muito diversos e t√™m uma diversidade de formas e caracter√≠sticas. Os v√≠rus s√£o parasitas. Isto significa que necessitam de c√©lulas ou tecidos vivos para se desenvolverem. Os v√≠rus podem invadir as c√©lulas do seu corpo, utilizando os componentes das suas c√©lulas para crescer e multiplicar-se. Alguns v√≠rus chegam mesmo a matar as c√©lulas hospedeiras como parte do seu ciclo de vida. As diferen√ßas entre v√≠rus e bact√©rias podem ser vistas na figura 1 e encontradas na tabela 1. ")],-1),Da=e("b",null,"Figura 1.",-1),Ca=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabela 1.</b> Diferen√ßas entre bact√©rias e v√≠rus</caption><thead><tr><th></th><th>Bact√©ria</th><th>V√≠rus</th></tr></thead><tbody><tr><th class="align-baseline"> Viver </th><td><b>Organismo vivo.</b><br>As bact√©rias s√£o organismos vivos com uma √∫nica c√©lula que pode gerar energia, fazer os seus pr√≥prios alimentos, mover-se e reproduzir-se (tipicamente por fiss√£o bin√°ria). Isto permite que as bact√©rias vivam em muitos lugares ‚Äì solo, √°gua, plantas e o corpo humano e servem muitos prop√≥sitos. <br> As bact√©rias incluem parasitas e n√£o parasitas. </td><td><b>Sem vida.</b><br> Os v√≠rus s√≥ crescem e reproduzem-se dentro das c√©lulas hospedeiras que infetam. Quando encontrados fora destas c√©lulas vivas, os v√≠rus est√£o adormecidos. A sua &quot;vida&quot;, portanto, requer o sequestro das atividades bioqu√≠micas de uma c√©lula viva. <br> Todos os v√≠rus s√£o parasitas intracelulares. </td></tr><tr><th class="align-baseline">N√∫mero de c√©lulas</th><td>Unicelular, uma c√©lula</td><td>Sem c√©lulas, n√£o vive</td></tr><tr><th class="align-baseline">Reprodu√ß√£o</th><td>Divide-se em 2</td><td>Invade uma c√©lula hospedeira e toma conta da c√©lula fazendo com que fa√ßa c√≥pias do ADN/RNA viral. Destr√≥i a c√©lula hospedeira libertando novos v√≠rus</td></tr><tr><th class="align-baseline">Tamanho</th><td>As bact√©rias s√£o muito maiores, variando de 800 nm a 1000 nm. As bact√©rias podem ser vistas sob um microsc√≥pio leve.</td><td>O tamanho dos v√≠rus √© entre 20 nm a 400 nm. Os v√≠rus s√≥ s√£o vis√≠veis ao microsc√≥pio electr√≥nico</td></tr><tr><th class="align-baseline">Benef√≠cios</th><td>Algumas bact√©rias s√£o ben√©ficas, por exemplo, certas bact√©rias s√£o necess√°rias no intestino.</td><td>Os v√≠rus n√£o s√£o ben√©ficos. V√≠rus podem ser √∫teis na engenharia gen√©tica.</td></tr><tr><th class="align-baseline">Infe√ß√£o</th><td>A infe√ß√£o bacteriana √© geralmente confinada a uma parte do corpo, descrita como uma infe√ß√£o localizada. As infe√ß√µes podem ser causadas por bact√©rias ou por toxinas (endotoxinas) produzidas.</td><td>Uma infe√ß√£o viral √© sist√©mica. Os v√≠rus infetam uma c√©lula hospedeira e multiplicam-se aos milhares, deixando a c√©lula hospedeira e infetando outras c√©lulas do corpo.</td></tr><tr><th class="align-baseline">Doen√ßa</th><td>As doen√ßas bacterianas incluem pneumonia, tuberculose, t√©tano e intoxica√ß√£o alimentar.</td><td>As doen√ßas sist√©micas causadas por infe√ß√µes virais incluem a gripe, o sarampo, a poliomielite, a SIDA e o COVID-19.</td></tr><tr><th class="align-baseline">Tratamento</th><td>Antibi√≥ticos e vacinas previnem a doen√ßa.</td><td>As vacinas previnem a propaga√ß√£o e os medicamentos antivirais ajudam a retardar a reprodu√ß√£o, mas n√£o podem det√™-lo completamente.</td></tr></tbody></table>',1),Oa=i(`<section class="e-card"><h4 class="mt-4">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),za=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Porque √© que os antibi√≥ticos n√£o matam os v√≠rus?</h2><p> Os antibi√≥ticos visam a maquinaria de crescimento em bact√©rias (n√£o v√≠rus) para matar ou inibir essas bact√©rias em particular. Os antibi√≥ticos n√£o podem matar v√≠rus porque os v√≠rus t√™m estruturas diferentes e replicam-se de forma diferente das bact√©rias. Al√©m disso, o uso excessivo e a prescri√ß√£o inadequada de antibi√≥ticos em todo o mundo est√£o a levar ao problema global de sa√∫de da <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">resist√™ncia aos antibi√≥ticos</a>. Consulte o quadro 2 em que condi√ß√µes os antibi√≥ticos podem ser √∫teis (NB! A decis√£o sobre a sua utiliza√ß√£o ser√° tomada pelo seu m√©dico). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabela 2.</b> Necessidade de antibi√≥ticos por infe√ß√µes respirat√≥rias comuns </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respi¬≠ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>anti¬≠biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Fonte: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Refer√™ncia</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Fa={id:"s3"},Na=e("h2",{id:"s3t"},"3. Como funcionam as vacinas",-1),Pa=e("h3",null,"A resposta natural do corpo",-1),$a=e("p",null,[a(" Um "),e("span",{class:"e-term font-Heading"},"agente patog√©nico"),a(" √© uma bact√©ria, v√≠rus, parasita ou fungo que pode causar doen√ßas dentro do corpo. Cada agente patog√©nico √© composto por v√°rias subpartes, geralmente √∫nicas a esse agente patog√©nico espec√≠fico e √† doen√ßa que causa. A subparte de um agente patog√©nico que causa a forma√ß√£o de anticorpos √© chamada de antig√©nio. Os anticorpos produzidos em resposta ao antig√©nio do agente patog√©nico s√£o essenciais para o sistema imunit√°rio. Pode considerar os anticorpos como soldados no sistema de defesa do seu corpo. Cada anticorpo, ou soldado, no nosso sistema, √© treinado para reconhecer um antig√©nio espec√≠fico. Temos milhares de anticorpos diferentes nos nossos corpos. Quando o corpo humano √© exposto a um antig√©nio pela primeira vez, leva tempo para o sistema imunol√≥gico responder e produzir anticorpos espec√≠ficos desse antig√©nio (Fig. 2). ")],-1),Ba=e("p",null," Os anticorpos de um agente patog√©nico geralmente n√£o protegem contra outro agente patog√©nico, exceto quando dois agentes patog√©nicos s√£o muito semelhantes uns aos outros, como primos. Uma vez produzidos os anticorpos espec√≠ficos do antig√©nio, trabalham com o resto do sistema imunit√°rio para destruir o agente patog√©nico e parar a doen√ßa. Uma vez que o corpo produz anticorpos na sua resposta prim√°ria a um ant√≠geno, tamb√©m cria c√©lulas de mem√≥ria produtoras de anticorpos, que permanecem vivas mesmo ap√≥s os anticorpos derrotarem o agente patog√©nico. Suponha que o corpo seja exposto ao mesmo agente patog√©nico mais de uma vez. Nesse caso, a resposta do anticorpo √© muito mais r√°pida e eficaz do que a primeira vez, porque as c√©lulas de mem√≥ria est√£o prontas para bombear anticorpos contra esse antig√©nio. Isto significa que se a pessoa for exposta a um agente patog√©nico perigoso no futuro, o seu sistema imunol√≥gico ser√° capaz de responder imediatamente, protegendo contra doen√ßas. ",-1),Ta=e("b",null,"Figura 2.",-1),Ea=e("h3",null,"Como as vacinas ajudam?",-1),Ra=e("p",null," As vacinas reduzem os riscos de obter uma doen√ßa trabalhando com as defesas naturais do seu corpo para construir prote√ß√£o. Quando se recebe uma vacina, o seu sistema imunol√≥gico responde. ",-1),Ha=e("p",null," As vacinas cont√™m partes enfraquecidas ou inativas de um determinado organismo (ant√≠geno) que desencadeia uma resposta imune dentro do corpo (Fig. 3). As vacinas mais recentes cont√™m a planta para produzir antig√©nios em vez do pr√≥prio antig√©nio. Independentemente de a vacina ser constitu√≠da pelo pr√≥prio antig√©nio ou pela planta para que o corpo produza o antig√©nio, esta vers√£o enfraquecida n√£o causar√° a doen√ßa na pessoa que recebe a vacina. No entanto, vai levar o seu sistema imunol√≥gico a responder tanto quanto teria na sua primeira rea√ß√£o ao agente patog√©nico real. ",-1),Wa=e("b",null,"Figura 3.",-1),Ka=i('<p> As vacinas funcionam expondo os seus gl√≥bulos brancos √† prote√≠na estranha de um v√≠rus. Depois de o corpo ter encontrado um v√≠rus e ter dado uma resposta imunit√°ria (produzindo c√©lulas B e T) ao v√≠rus, guarda as c√©lulas B e T para que, se o mesmo v√≠rus ou bact√©ria voltar a infetar o corpo, o sistema imunit√°rio possa encenar uma guerra total, impedindo que o agente patog√©nico volte a fazer-nos sentir doentes. As vacinas apresentam o v√≠rus ao organismo para que este possa poupar as c√©lulas B e T sem nunca ficar doente. </p><h3>Imuniza√ß√£o e desafios relacionados</h3><p> Temos agora vacinas para prevenir mais de 20 doen√ßas que amea√ßam a vida, ajudando pessoas de todas as idades a viverem vidas mais longas e saud√°veis. Atualmente, a imuniza√ß√£o previne 2 a 3 milh√µes de mortes por ano de doen√ßas como difteria, t√©tano, pert√∫ssis/tosse convulsa, gripe e sarampo. </p><p> Temos vacina√ß√£o contra muitas infe√ß√µes virais graves (sarampo, papeira, hepatite A, hepatite B e alguns v√≠rus ‚Äì como aqueles que causam a constipa√ß√£o comum). Ainda assim, o problema continua a ser que podem mudar de uma pessoa para outra. Quando o v√≠rus sofre muta√ß√µes, muda o suficiente para que o sistema imunol√≥gico j√° n√£o o reconhe√ßa. As c√©lulas imunit√°rias armazenadas para matar o v√≠rus, j√° n√£o o reconhecem como a mesma doen√ßa e n√£o sabem como mat√°-lo. √â assim que uma infe√ß√£o com o mesmo v√≠rus pode continuar a esquivar-se do sistema imunit√°rio. A vacina√ß√£o para estes v√≠rus √© dif√≠cil porque j√° mudaram o seu formato at√© ao momento em que as vacinas s√£o desenvolvidas. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ya=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Processo de desenvolvimento de vacinas, seguran√ßa das vacinas</h2><h3>Desenvolvimento</h3><p> O desenvolvimento da vacina come√ßa normalmente num laborat√≥rio de investiga√ß√£o localizado numa universidade, num centro m√©dico ou numa pequena empresa de biotecnologia. Durante o desenvolvimento da vacina, os cientistas desenvolvem diferentes reagentes para testar e medir o seu efeito (ou falta dele). Muitas vezes s√£o necess√°rios anos de investiga√ß√£o para encontrar ideias que funcionem. </p><p> Diferentes cientistas ou grupos de investiga√ß√£o podem trabalhar para os mesmos objetivos durante o desenvolvimento da vacina. O progresso do trabalho √© apresentado em diferentes reuni√µes e artigos publicados em revistas cient√≠ficas, revistos pelos pares. Se algum trabalho parecer promissor, os cientistas farmac√™uticos podem contactar os que est√£o a trabalhar nele para expandir a sua investiga√ß√£o para o desenvolvimento de f√°rmacos. </p><h3>Ensaios/testes</h3><p> Se for encontrada uma vacina candidata promissora, tem de ser testada em animais. Esta √© a chamada fase pr√©-cl√≠nica. Primeiro s√£o usados pequenos animais como ratos, coelhos e outros. Se a vacina candidata afetar pequenos animais, normalmente o efeito tem de ser comprovado em animais maiores, como macacos. Se a vacina desencadear uma resposta imunit√°ria, √© testada em tr√™s fases de ensaios cl√≠nicos em seres humanos (OMS, 2021). </p><p> Na fase 1, a vacina √© inoculada em alguns volunt√°rios para avaliar a sua seguran√ßa, confirmar que gera uma resposta imune, e determinar a dose adequada. Geralmente, nesta fase, as vacinas s√£o testadas num pequeno grupo de jovens volunt√°rios adultos saud√°veis. </p><p> Na fase 2, a vacina √© dada a v√°rias centenas de volunt√°rios para avaliar a sua seguran√ßa e capacidade para gerar uma resposta imune. Os participantes nesta fase t√™m as mesmas caracter√≠sticas (como a idade e o sexo) que aqueles para os quais a vacina se destina. Geralmente existem m√∫ltiplos ensaios nesta fase para avaliar v√°rias faixas et√°rias (idosos, adultos, crian√ßas) e diferentes formula√ß√µes de vacinas. Al√©m disso, um grupo que n√£o recebe a vacina √© geralmente inclu√≠do para determinar se as altera√ß√µes no grupo vacinado s√£o atribu√≠das √† vacina ou se ocorreram por acaso. </p><p> Na fase 3, a vacina √© administrada a milhares de volunt√°rios ‚Äì comparada com um grupo semelhante de pessoas que n√£o receberam a vacina mas receberam um produto de compara√ß√£o. Isto visa determinar se a vacina √© eficaz contra a doen√ßa que se destina a proteger. Al√©m disso, pretende estudar a sua seguran√ßa num grupo muito maior de pessoas. Os ensaios de fase 3 s√£o frequentemente realizados em pa√≠ses e v√°rios locais dentro dos pa√≠ses, para garantir que os resultados do desempenho da vacina se aplicam a popula√ß√µes diferentes. </p><p> Durante os ensaios de fase 2 e 3, os volunt√°rios e os cientistas que conduzem o estudo s√£o impedidos de saber quais os volunt√°rios que receberam a vacina em teste ou o produto de compara√ß√£o. A isto chama-se ‚Äúensaio cego‚Äù e √© necess√°rio para garantir que nem os volunt√°rios nem os cientistas sejam influenciados na sua avalia√ß√£o de efic√°cia ou seguran√ßa por saberem quem recebeu qual produto. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Autoriza√ß√£o e monitoriza√ß√£o</h3><p> Quando os resultados de todos estes ensaios cl√≠nicos est√£o dispon√≠veis, √© necess√°ria uma s√©rie de passos. Os funcion√°rios da Ag√™ncia Europeia de Medicamentos e, mais tarde, em cada pa√≠s, analisam de perto os dados do estudo e decidem se autorizam a vacina. Todos os ensaios t√™m de ser correctamente realizados e bem documentados. Antes de ser aprovada, uma vacina tem de ser comprovadamente segura e eficaz numa popula√ß√£o alargada. A fasquia para a seguran√ßa e efic√°cia das vacinas √© excecionalmente elevada. Isto inclui an√°lises de efic√°cia e seguran√ßa para aprova√ß√µes regulamentares e pol√≠ticas de sa√∫de p√∫blica. </p><p> Durante a utiliza√ß√£o das vacinas, √© efectuada uma monitoriza√ß√£o adicional da seguran√ßa e da efic√°cia. Isto permite aos cientistas acompanhar o impacto e a seguran√ßa das vacinas, mesmo quando estas s√£o utilizadas em muitas pessoas durante um longo per√≠odo de tempo. Estes dados s√£o utilizados para ajustar as pol√≠ticas de utiliza√ß√£o das vacinas. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Ua={id:"s5"},Ja=e("h2",{id:"s5t"},"5. M√°scaras contra v√≠rus e bact√©rias",-1),La=e("p",null," As m√°scaras s√£o frequentemente usadas para proteger contra v√≠rus e bact√©rias. Elas espalharam-se no sentido de prote√ß√£o contra o v√≠rus SARS-CoV-2. Entre os diferentes tipos de m√°scaras, as m√°scaras cir√∫rgicas est√£o entre as coberturas faciais mais usadas na pandemia de COVID-19. Normalmente, s√£o de cor azul de um lado, que deve ser mantido como uma camada externa (Fig. 4). O principal objetivo das m√°scaras cir√∫rgicas √© proteger os doentes de um potencial contato com bact√©rias e v√≠rus exalados por quem usa a m√°scara. Portanto, eles impedem a propaga√ß√£o do coronav√≠rus pelo ar, mas s√£o meios menos eficazes para proteger o portador do v√≠rus. ",-1),Ga=e("p",null," As m√°scaras FFP2 ou FFP3 (frequentemente designadas por respiradores) devem ser utilizadas para filtrar e inalar melhor o ar. O sistema de numera√ß√£o (FFP1, FPP2, FFP3) indica a efici√™ncia de filtragem destes dispositivos (certificados como cumprindo a norma EN 149-2001). FFP2 e FPP3 t√™m uma efici√™ncia de filtragem de part√≠culas transportadas pelo ar (incluindo as que cont√™m o v√≠rus) de 92% e 98%, respetivamente. Ambas as m√°scaras t√™m tamb√©m uma pequena fuga para o interior: <8% e <2%, respetivamente. Na FFP2, √© frequentemente utilizada borracha especial na camada exterior da m√°scara. Se, em ambientes profissionais, foi permitida uma v√°lvula (que facilita a expira√ß√£o), no caso do SARS-CoV-2, apenas devem ser utilizados respiradores sem v√°lvula para filtrar tamb√©m o ar expirado. ",-1),Qa=e("p",null," Com a pandemia de COVID-19, foi introduzida uma nova m√°scara facial: a m√°scara filtrante. Este tipo de m√°scara √© feito de tecido multicamadas (uma delas tem de ser um filtro de nanofibras que garante uma capacidade de filtragem de bact√©rias e poeiras finas nocivas de, pelo menos, 90%). Esta m√°scara combina uma elevada capacidade de filtragem com a possibilidade de reutiliza√ß√£o, uma vez que pode ser lavada na m√°quina a 60 graus. ",-1),Xa={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Za=i('<p><i><b>Figura 4.</b> Diferentes tipos de m√°scaras</i></p><p> A efic√°cia das m√°scaras foi testada em laborat√≥rios especiais, por exemplo, na c√¢mara de exposi√ß√£o. Nesses estudos, um transportador de v√≠rus. Subsequentemente, as concentra√ß√µes de part√≠culas por detr√°s do gerador de part√≠culas enchem a c√¢mara de exposi√ß√£o com pequenas part√≠culas; √† semelhan√ßa dos aeross√≥is, as m√°scaras s√£o medidas e comparadas com a concentra√ß√£o na atmosfera geral da c√¢mara de exposi√ß√£o. </p><p> No entanto, as evid√™ncias mais fortes baseiam-se em dados epidemiol√≥gicos de situa√ß√µes da vida real. Por exemplo, a taxa de crescimento di√°ria do COVID-19 est√° a abrandar ap√≥s imosi√ß√£o de m√°scaras em 15 estados e no distrito de Columbia nos EUA. Um outro estudo analisou as mortes de coronav√≠rus em 198 pa√≠ses e concluiu que os pa√≠ses com normas culturais ou pol√≠ticas governamentais que favorecem o uso de m√°scaras tinham taxas de mortalidade mais baixas. </p><p> Muitos utilizadores do Facebook e das redes sociais t√™m partilhado publica√ß√µes enganosas sobre a utiliza√ß√£o prolongada de m√°scaras faciais que provocam uma defici√™ncia de oxig√©nio no corpo - hipoxia. No entanto, artigos de investiga√ß√£o e especialistas sugerem que √© pouco prov√°vel que esses sintomas ocorram na maioria das pessoas, a menos que o utilizador tenha doen√ßas respirat√≥rias pr√©-existentes, como asma ou doen√ßa pulmonar obstrutiva cr√≥nica (DPOC). O risco de hipoxia e hipercapnia (excesso de di√≥xido de carbono na corrente sangu√≠nea) √© improv√°vel com as m√°scaras de tecido e cir√∫rgicas, uma vez que n√£o s√£o justas. No entanto, alerta-se para o facto de as m√°scaras faciais n√£o deverem ser colocadas em crian√ßas com menos de dois anos de idade, em pessoas com dificuldades respirat√≥rias ou durante a pr√°tica de exerc√≠cio f√≠sico. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),et=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),at=e("hr",{class:"mt-10 mb-40"},null,-1),tt={id:"s6"},st=i('<h2 id="s6t">6. V√≠rus e higiene das m√£os</h2><h3>Desinfetante para as m√£os ou sabonete?</h3><p> As nossas m√£os podem ser um elemento cr√≠tico na transmiss√£o de infe√ß√µes. Quando aplicados nas m√£os cuidadosamente e esfregados durante pelo menos 20 segundos, os desinfectantes para as m√£os √† base de √°lcool e o sab√£o travam o coronav√≠rus. No entanto, o sab√£o rompe a liga√ß√£o entre os agentes patog√©nicos e a sua pele, permitindo que os agentes patog√©nicos deslizem imediatamente. N√£o s√≥ est√° a neutralizar o v√≠rus, como tamb√©m o est√° a eliminar fisicamente das suas m√£os. A pr√°tica de uma boa higiene das m√£os √© uma estrat√©gia preventiva simples que a maioria das pessoas pode facilmente adotar, e muitos estudos demonstraram a efic√°cia da higiene das m√£os na preven√ß√£o da transmiss√£o de agentes patog√©nicos infecciosos, incluindo coronav√≠rus como o SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Enfraquecer o corona v√≠rus com sab√£o</h3><p> Os coronav√≠rus recebem o seu nome da &quot;coroa&quot; que rodeia o v√≠rus - os picos de prote√≠nas incorporados na sua superf√≠cie. Os picos, respons√°veis pela infe√ß√£o do hospedeiro, est√£o ancorados numa membrana. A membrana √© o &quot;inv√≥lucro&quot; do v√≠rus e o seu ponto fraco. </p><p> As mol√©culas de sab√£o t√™m duas partes quimicamente distintas: uma &quot;cabe√ßa&quot; hidrof√≠lica (que adora √°gua) e uma &quot;cauda&quot; hidrof√≥bica (que odeia √°gua). A cabe√ßa ajuda o sab√£o a misturar-se com a √°gua, enquanto a cauda pode interagir com outras mol√©culas hidrof√≥bicas, como os l√≠pidos. </p><p> Felizmente, a membrana do coronav√≠rus √© constitu√≠da principalmente por mol√©culas de l√≠pidos. Estas s√£o mantidas juntas por interac√ß√µes qu√≠micas fracas entre mol√©culas individuais. As &quot;caudas&quot; hidrof√≥bicas (que odeiam a √°gua) das mol√©culas de sab√£o podem quebrar as interac√ß√µes entre as mol√©culas lip√≠dicas na membrana do coronav√≠rus (ver Fig. 5). </p><p> A ‚Äúcauda‚Äù do sab√£o pode romper as interac√ß√µes fracas entre as mol√©culas lip√≠dicas da membrana, rasgando-a. Suponhamos que o v√≠rus se fragmenta antes de ser abrigado em seguran√ßa numa c√©lula hospedeira. Nesse caso, o v√≠rus deixa de ser capaz de fazer o seu trabalho infecioso - como uma m√°quina cujas pe√ßas se desintegram. As mol√©culas de sab√£o envolvem ent√£o os fragmentos de v√≠rus com todas as caudas viradas para o interior. Este aglomerado √© designado por micela (ver Fig. 6). As cabe√ßas hidrof√≠licas voltadas para o exterior permitem que a micela seja levada pela √°gua. A √°gua, por si s√≥, n√£o √© suficiente. </p>',9),it={class:"grid gap-2 md:grid-cols-2 e-card"},rt=e("b",null,"Figura 5.",-1),nt=e("b",null,"Figura 6.",-1),ot=i('<p> A informa√ß√£o dada tamb√©m √© v√°lida para os outros v√≠rus envolvidos (Gripe, Hepatite B e C e Doen√ßa do V√≠rus do √âbola) uma vez que na sua estrutura tamb√©m t√™m fosfol√≠pidos. </p><section class="e-card"><h4 class="mt-0">Refer√™ncia</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Escolher desinfetante para as m√£os</h3><p> A Organiza√ß√£o Mundial de Sa√∫de (OMS) recomenda desinfetantes √† base de √°lcool se n√£o tiver sab√£o √† m√£o. </p><p><b>Acredita-se que os desinfetantes para as m√£os √† base de √°lcool funcionem impedindo que as prote√≠nas dos micr√≥bios ‚Äì incluindo bact√©rias e alguns v√≠rus ‚Äì funcionem normalmente. Desinfetantes para as m√£os com alto teor de √°lcool tamb√©m podem interferir na camada lip√≠dica que envolve o coronav√≠rus.</b> Para serem eficazes, os desinfetantes para as m√£os devem conter pelo menos 60% de √°lcool. Os aditivos no desinfetante podem impedir que o √°lcool evapore muito r√°pido, permitindo que o v√≠rus fique encharcado por mais tempo. </p><p> No entanto, existem tamb√©m certos riscos relacionados com a utiliza√ß√£o de desinfetantes manuais √† base de √°lcool. Existe um aumento do risco de intoxica√ß√£o alco√≥lica para as crian√ßas, e o uso frequente de desinfetantes manuais pode resultar em resist√™ncia antimicrobiana. Existem desinfetantes manuais alternativos sem √°lcool, onde o benzalc√≥nio √© mais utilizado. Estudos recentes indicaram que o desinfetante manual sem √°lcool funciona t√£o bem e n√£o causa a sensa√ß√£o familiar de &quot;queimadura&quot; conhecida pelo uso de desinfetante de m√£os alco√≥licas. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),lt=e("hr",{class:"mt-10 mb-40"},null,-1),ct={id:"s7"},dt=i('<h2 id="s7t" class="mt-40 text-5xl">7. Mitos da Vacina</h2><h3><span class="text-rose-400">Mito 1:</span> As vacinas causam autismo/efeitos secund√°rios graves.</h3><p> O medo generalizado de que as vacinas aumentam o risco de autismo teve origem num estudo de 1997 publicado por Andrew Wakefield, um cirurgi√£o brit√¢nico. O artigo foi publicado na The Lancet, uma prestigiada revista m√©dica, sugerindo que a vacina contra o sarampo, a papeira e a rub√©ola (MMR) aumentava o autismo nas crian√ßas brit√¢nicas. </p><p> Desde ent√£o, o artigo foi completamente desacreditado devido a erros processuais graves, ao facto de o estudo ter contado com apenas 12 participantes, a conflitos de interesses financeiros n√£o revelados e a viola√ß√µes √©ticas. Andrew Wakefield perdeu a sua licen√ßa m√©dica e o artigo foi retirado da revista The Lancet. </p><p> Atualmente, contra a teoria da liga√ß√£o entre autismo e vacina√ß√£o, v√°rios estudos identificaram sintomas de autismo em crian√ßas muito antes de estas receberem a vacina MMR. Al√©m disso, investiga√ß√µes recentes fornecem provas de que o autismo se desenvolve no √∫tero, muito antes de um beb√© nascer ou receber vacinas. Nenhum dos √∫ltimos estudos relatou uma liga√ß√£o entre qualquer vacina e a probabilidade de desenvolver autismo. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),mt=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Here‚Äôs What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety",target:"_blank",rel:"noopener noreferrer"},"Coronavirus disease (COVID-19): Vaccines safety")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ut=i('<h3><span class="text-rose-400">Mito 2:</span> Os sistemas imunol√≥gicos infantis n√£o conseguem lidar com v√°rias vacinas</h3><p> As crian√ßas recebem vacinas em tenra idade porque correm o maior risco de adoecer ou morrer se contra√≠rem estas doen√ßas. Mesmo os rec√©m-nascidos s√£o imunes a algumas doen√ßas (por exemplo, varicela) porque recebem anticorpos das m√£es; esta imunidade dura apenas alguns meses. Al√©m disso, a maioria dos beb√©s n√£o obt√©m anticorpos protetores contra difteria, tosse convulsa, poliomielite, t√©tano, hepatite B ou Hib das suas m√£es. </p><p> Para reduzir o n√∫mero de vacinas que uma crian√ßa recebe numa visita ao m√©dico, algumas vacinas s√£o oferecidas como uma combina√ß√£o (duas ou mais vacinas diferentes foram combinadas numa √∫nica inje√ß√£o). Exemplos de vacinas combinadas s√£o difteria-t√©tano-pertussis (DTap) e o sarampo-papeira-rub√©ola (MMR). </p><p> Dados cient√≠ficos demonstram que a administra√ß√£o de v√°rias vacinas em simult√¢neo n√£o causa quaisquer problemas de sa√∫de. O sistema imunol√≥gico infantil √© mais resistente do que se possa pensar. Com base no n√∫mero de anticorpos presentes no sangue, um beb√© teria, teoricamente a capacidade de responder a um n√∫mero muito maior de vacinas do que as que s√£o administradas (a quest√£o que se coloca √© se s√£o 1.000, 10.000 ou 100.000 de uma s√≥ vez). Mesmo que todas as cerca de 10 (dependendo do plano nacional de vacina√ß√£o) vacinas programadas fossem administradas de uma s√≥ vez, isso utilizaria apenas uma fra√ß√£o da capacidade imunit√°ria de um beb√©. Na realidade, os beb√©s est√£o expostos a in√∫meras bact√©rias e v√≠rus todos os dias, e as imuniza√ß√µes s√£o insignificantes em compara√ß√£o. Al√©m disso, os estudos n√£o demonstraram que a exposi√ß√£o a m√∫ltiplas vacinas durante os primeiros 23 meses de vida estaria associada a um risco acrescido de infec√ß√µes n√£o visadas pelas vacinas. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Mito 3:</span> A imunidade adquirida atrav√©s de uma doen√ßa √© melhor do que a imunidade adquirida atrav√©s da vacina√ß√£o</h3><p> √â verdade que a infe√ß√£o natural resulta quase sempre numa imunidade mais forte √† doen√ßa do que uma vacina√ß√£o. No entanto, os perigos desta abordagem superam em muito os benef√≠cios relativos. O pre√ßo da imunidade ap√≥s a infe√ß√£o natural pode ser pneumonia de varicela ou pneumococcus, incapacidade intelectual de Haemophilus influenzae tipo b (Hib), defeitos cong√©nitos de rub√©ola, cancro do f√≠gado devido ao v√≠rus da hepatite B, morte por sarampo, etc. Se quisesse ganhar imunidade ao sarampo, por exemplo, ao contrair a doen√ßa, enfrentaria uma em cada 500 hip√≥teses de morte devido aos seus sintomas. Em contraste, o n√∫mero de pessoas que tiveram rea√ß√µes al√©rgicas severas de uma vacina MMR √© inferior a um em um milh√£o. </p><p> No entanto, poucas vacinas induzem uma melhor resposta imunol√≥gica do que a infe√ß√£o natural. Por exemplo, a vacina do papilomav√≠rus humano (HPV) cont√©m uma alta pureza da prote√≠na espec√≠fica, conduzindo a uma melhor resposta imunol√≥gica do que a infe√ß√£o natural. Outros exemplos incluem o t√©tano, o haemophilus influenzae tipo b (Hib) e a vacina pneumoc√≥cica. </p><p> No que diz respeito ao COVID-19, tem de ser esclarecido. Foi demonstrado que a prote√ß√£o permanente ap√≥s a infe√ß√£o √© improv√°vel. Apesar de os doentes com coronav√≠rus terem adquirido uma &quot;mem√≥ria imunit√°ria substancial&quot; que envolveu as quatro partes significativas do sistema imunit√°rio: c√©lulas B da mem√≥ria, anticorpos, c√©lulas CD4+ T de mem√≥ria e c√©lulas CD8+ T de mem√≥ria, a prote√ß√£o come√ßou a reduzir ap√≥s meio ano. Al√©m disso, os cientistas mostraram uma &quot;gama din√¢mica massiva&quot; na resposta imunit√°ria entre indiv√≠duos, com uma diferen√ßa de 200 vezes nos n√≠veis de anticorpos. </p><p> Outros estudos mostraram que os volunt√°rios que receberam a vacina Moderna (mRNA) tinham mais anticorpos - um marcador de resposta imune - no sangue do que as pessoas que estavam doentes com COVID-19. No entanto, este facto pode ser modificado pela gravidade da doen√ßa, uma vez que existe uma correla√ß√£o entre a gravidade da doen√ßa e a resposta imunol√≥gica duradoura ‚Äì a maioria dos pacientes assintom√°ticos tinha muito poucos anticorpos ap√≥s seis meses de infe√ß√£o. Assim, a imunidade natural gerada por uma infe√ß√£o SARS-CoV-2 √© muitas vezes imprevis√≠vel. Al√©m disso, os anticorpos provocados pela vacina do mRNA tinham como alvo uma gama mais ampla de locais no Dom√≠nio de Liga√ß√£o ao Recetor (do ingl√™s Receptor Binding Domain, RBD) do que os provocados por infe√ß√µes naturais. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Mito 4:</span> As vacinas cont√™m subst√¢ncias que podem p√¥r a vida em risco.</h3><p> As pessoas est√£o preocupadas com o uso de formalde√≠do, merc√∫rio ou alum√≠nio nas vacinas. Por um lado, estes qu√≠micos s√£o t√≥xicos para o corpo humano a certos n√≠veis. Por outro lado, apenas pequenas quantidades destes produtos qu√≠micos podem ser encontradas em vacinas. Essas quantidades s√£o menores do que obtemos da nutri√ß√£o ou o formalde√≠do √© produzido a taxas mais elevadas pelos nossos pr√≥prios sistemas metab√≥licos. </p><p> Certos elementos, como sais de alum√≠nio, s√£o adicionados √†s vacinas porque funcionam como adjuvantes, o que significa que sua presen√ßa aumenta a resposta imune quando voc√™ √© vacinado. Al√©m disso, apenas algumas vacinas cont√™m sais de alum√≠nio e as novas vacinas COVID-19 n√£o os cont√™m. Algumas vacinas cont√™m timerosal como conservante; no entanto, nenhuma das vacinas usadas em crian√ßas atualmente cont√©m isso. O timerosal cont√©m etilmerc√∫rio, que √© eliminado do corpo humano rapidamente em compara√ß√£o com o metilmerc√∫rio, que se bioacumula - portanto, tamb√©m h√° uma diferen√ßa na forma de metal t√≥xico. No entanto, as vacinas COVID-19 n√£o cont√™m toxinas (por exemplo). </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),ht=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.publichealth.org/public-awareness/understanding-vaccines/goes-vaccine/",target:"_blank",rel:"noopener noreferrer"},"What Goes Into A Vaccine?")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"What‚Äôs in Vaccines?")])])],-1),pt=i('<h3><span class="text-rose-400">Mito 5:</span> Uma melhor higiene e um melhor saneamento s√£o respons√°veis pela diminui√ß√£o das infe√ß√µes, n√£o as vacinas</h3><p> Em parte, √© verdade que as vacinas n√£o merecem todo o cr√©dito pela redu√ß√£o ou elimina√ß√£o das taxas de doen√ßas infecciosas. Est√° provado que a melhoria do saneamento b√°sico, da nutri√ß√£o e o desenvolvimento de antibi√≥ticos tamb√©m ajudaram muito. Infec√ß√µes como a febre tifoide e a c√≥lera, transmitidas por √°gua contaminada, uma das principais causas de doen√ßa e morte no in√≠cio do s√©culo XX, foram drasticamente reduzidas por um melhor saneamento. Uma an√°lise recente concluiu que a lavagem das m√£os contribui para evitar doen√ßas infecciosas. Outra prova recente vem do confinamento devido √† COVID-19 e da melhoria da higiene, com uma redu√ß√£o dr√°stica das taxas de gripe sazonal. </p><p> No entanto, quando estes fatores s√£o isolados e as taxas de doen√ßas infeciosas s√£o analisadas, o papel das vacinas n√£o pode ser negado. Um exemplo √© o sarampo nos Estados Unidos. Quando a primeira vacina contra o sarampo foi introduzida em 1963, as taxas de infe√ß√£o tinham sido constantes em cerca de 400.000 casos por ano. E embora os h√°bitos higi√©nicos e o saneamento n√£o tenham mudado muito na d√©cada seguinte, a taxa de infe√ß√µes por sarampo diminuiu precipitadamente ap√≥s a introdu√ß√£o da vacina, com apenas cerca de 25.000 casos at√© 1970. Outro exemplo √© a doen√ßa hib. De acordo com os dados do CDC, a taxa de incid√™ncia desta doen√ßa baixou de 20.000 em 1990 para cerca de 1.500 em 1993, ap√≥s a introdu√ß√£o da vacina. </p><p> Outra prova vem das √∫ltimas d√©cadas. N√£o houve altera√ß√µes na higiene no mundo desenvolvido, mas houve uma diminui√ß√£o das taxas de vacina√ß√£o. Al√©m disso, v√°rios pa√≠ses, como o Reino Unido, os EUA, a Alemanha, a Espanha, etc., est√£o a assistir a um aumento do n√∫mero de sarampo, e outras doen√ßas evit√°veis pela vacina√ß√£o, identificadas como uma doen√ßa emergente &quot;pontos quentes&quot;. </p><section class="e-card"><h4 class="mt-0">Refer√™ncia</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Mito 6:</span> As vacinas podem infetar a crian√ßa com a doen√ßa que est√° a tentar prevenir</h3><p> Algumas das vacinas s√£o vacinas vivas que cont√™m microrganismos/v√≠rus atenuados vivos, que ainda s√£o capazes de se replicar dentro do hospedeiro (vacina). Os microrganismos est√£o &quot;enfraquecidos&quot;, o que significa que perderam a maior parte da sua capacidade causadora de doen√ßas, mas ainda possuem propriedades imunog√©nicas. Assim, √© sempre muito menos grave do que se uma crian√ßa for infetada com o v√≠rus causador da doen√ßa em si. As vacinas vivas atenuadas s√£o para o sarampo, papeira, rub√©ola (vacina combinada MMR), rotav√≠rus, var√≠ola, varicela e febre amarela. Na maioria dos casos, as vacinas vivas mostram uma imunogenicidade significativamente maior do que as vacinas inativadas, uma vez que a infe√ß√£o natural √© imitada quase na perfei√ß√£o, provocando uma gama mais abrangente de respostas imunol√≥gicas. No entanto, estas vacinas n√£o s√£o recomendadas para crian√ßas com sistemas imunit√°rios enfraquecidos, como as que est√£o a ser tratadas com cancro. </p><p> As vacinas vivas podem, de facto, causar sintomas leves que se assemelham √† doen√ßa contra a qual protegem. No entanto, os recetores da vacina est√£o a experimentar a resposta imune do corpo √† vacina, e n√£o √† doen√ßa em si. H√° apenas um caso registado em que se demonstrou que uma vacina causa doen√ßas. Esta foi a Vacina contra a Poliomielite Oral (OPV) que j√° n√£o √© utilizada e atualmente √© substitu√≠da por uma forma de v√≠rus morto conhecida como a vacina contra a poliomielite inativada (IPV). </p><section class="e-card"><h4 class="mt-0">Refer√™ncia</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Mito 7:</span> N√£o precisamos de vacinar porque muitos pa√≠ses t√™m baixas taxas de infe√ß√£o</h3><p> A imunidade de grupo ocorre quando uma grande parte de uma comunidade (o grupo) se torna imune a uma doen√ßa, tornando improv√°vel a propaga√ß√£o da doen√ßa de pessoa para pessoa. Gra√ßas √† &quot;imunidade de grupo&quot;, muitas pessoas n√£o v√™em a necessidade de vacina√ß√£o. Desde que uma grande maioria de pessoas esteja imunizada numa popula√ß√£o, a minoria n√£o imunizada tamb√©m estar√° protegida. Isto √© importante porque h√° uma parte da popula√ß√£o - beb√©s, mulheres gr√°vidas, idosos e pessoas com sistemas imunit√°rios enfraquecidos - que por vezes n√£o pode receber vacinas. No entanto, suponhamos que muitas pessoas n√£o se vacinam nem vacinam os seus filhos. Nesse caso, a &quot;imunidade de grupo&quot; desaparece, abrindo oportunidades para que os v√≠rus e as bact√©rias se estabele√ßam e se espalhem. Com tantas pessoas resistentes, uma doen√ßa infecciosa nunca ter√° hip√≥tese de se estabelecer e propagar. </p><p> Al√©m disso, as viagens internacionais transportam muitas vezes uma doen√ßa do estrangeiro e um indiv√≠duo n√£o vacinado corre um risco muito maior de ficar doente ou as pessoas que foram infectadas durante a viagem. O aumento da incid√™ncia do sarampo ilustra este facto nos EUA nos √∫ltimos anos. Enquanto existirem doen√ßas, corremos o risco de ser infectados. </p><section class="e-card"><h4 class="mt-0">Refer√™ncias</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),vt=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function kt(h,d){const l=v,c=k,r=f,n=g;return o(),u("div",ya,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",ja,[t(c,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),xa,qa,e("section",Va,[Sa,Aa,Ia,Ma,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Fonte: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[Da,a(" Diferen√ßas estruturais entre v√≠rus e bact√©rias ")]),_:1}),Ca,t(n,{class:"mb-8"},{default:s(()=>[a(" Os antibi√≥ticos podem ajudar o sistema imunol√≥gico a eliminar infe√ß√µes bacterianas, mas s√£o in√∫teis contra infe√ß√µes virais. Os f√°rmacos antivirais funcionam de forma diferente dos antibi√≥ticos e atualmente s√≥ s√£o eficazes contra algumas doen√ßas virais, tais como a gripe, herpes, hepatite B e C, e HIV. Infe√ß√µes virais podem ser muito mais dif√≠ceis de matar do que infe√ß√µes bacterianas porque o v√≠rus vai para as c√©lulas humanas. O sistema imunol√≥gico pode por vezes matar as c√©lulas infetadas antes que o v√≠rus se reproduza. No entanto, √† medida que o v√≠rus se reproduz, muitas vezes mata a c√©lula infetada explodindo, o que permite que o v√≠rus se espalhe para outras c√©lulas do corpo. ")]),_:1}),Oa]),za,e("section",Fa,[Na,Pa,$a,Ba,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[Ta,a(" Para cada novo antig√©nio, o nosso corpo precisa de construir um anticorpo espec√≠fico. ")]),_:1}),Ea,Ra,Ha,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Fonte: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Wa,a(" Desenvolvimento de anticorpos atrav√©s da vacina√ß√£o ")]),_:1}),Ka]),Ya,e("section",Ua,[Ja,La,Ga,Qa,e("div",Xa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" M√°scara cir√∫rgica ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" M√°scara FFP2 (respirador) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" M√°scara FFP3 (respirador) com v√°lvula ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" M√°scara de filtragem ")]),_:1})]),Za,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[et]),_:1})]),at,e("section",tt,[st,e("div",it,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[rt,a(" Mol√©culas de sab√£o a destruir o v√≠rus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[nt,a(" Micela composta por mol√©culas de sab√£o e fragmento de v√≠rus ")]),_:1})]),ot]),lt,e("section",ct,[dt,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[mt]),_:1}),ut,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ht]),_:1}),pt,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Mais mitos COVID-19 e investiga√ß√£o cient√≠fica relacionada podem ser encontrados a partir de: "),vt]),_:1})])])])}const ft=b(_a,[["render",kt]]),gt={},bt={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},wt={class:"e-article",lang:"sv",style:{hyphens:"auto"}},_t=e("h1",{class:"mb-0"},"Virus",-1),yt=e("h5",{class:"font-normal uppercase leading-tight"},"Vetenskaplig bakgrundsinformation",-1),jt={id:"s1"},xt=e("h2",{id:"s1t"},"1. Virus kontra bakterier",-1),qt=e("p",{class:"font-bold"},"Bakterier och virus kan orsaka m√•nga vanliga infektioner. Men vad √§r skillnaden mellan dessa tv√• typer av smittsamma organismer?",-1),Vt=e("p",null,[e("span",{class:"e-term font-Heading"},"Bakterier"),a(" √§r sm√• mikroorganismer som best√•r av en enda cell. De √§r v√§ldigt olika och kan ha m√•nga former och strukturella egenskaper. Bakterier kan leva i n√§stan alla t√§nkbara milj√∂er, inklusive i eller p√• m√§nniskokroppen. Endast en handfull bakterier orsakar infektioner hos m√§nniskor. Dessa bakterier kallas patogena bakterier.")],-1),St=e("p",null,[e("span",{class:"e-term font-Heading"},"Virus"),a(" √§r en annan typ av sm√• mikroorganismer, till och med mindre √§n bakterier. Liksom bakterier √§r de v√§ldigt olika och har en m√§ngd olika former och egenskaper. Virus √§r parasit√§ra. Det betyder att de kr√§ver levande celler eller v√§vnad att v√§xa i. Virus kan invadera cellerna i din kropp och anv√§nda komponenterna i dina celler f√∂r att v√§xa och f√∂r√∂ka sig. Vissa virus d√∂dar till och med v√§rdceller som en del av deras livscykel. Skillnader mellan virus och bakterier kan ses i figur 1 och finns i tabell 1.")],-1),At=e("b",null,"Figur 1.",-1),It=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabell 1.</b> Skillnader mellan bakterier och virus</caption><thead><tr><th></th><th>Bakterie</th><th>Virus</th></tr></thead><tbody><tr><th class="align-baseline"> Levande </th><td><b>Levande organism.</b><br>Bakterier √§r levande organismer med en enda cell som kan generera energi, r√∂ra sig och f√∂r√∂ka sig (vanligtvis genom bin√§r fission). Detta g√∂r att bakterier kan leva p√• m√•nga st√§llen ‚Äì jord, vatten, v√§xter och m√§nniskokroppen ‚Äì och tj√§na m√•nga syften.<br>Bakterier inkluderar b√•de parasiter och icke-parasiter. </td><td><b>Icke levande.</b><br>Virus v√§xer och fortplantar sig bara inuti v√§rdcellerna som infekteras. N√§r virus hittas utanf√∂r dessa levande celler √§r virus vilande. Deras &quot;liv&quot; kr√§ver d√§rf√∂r kapning av en levande cells biokemiska aktiviteter.<br>Alla virus √§r intracellul√§ra parasiter. </td></tr><tr><th class="align-baseline">Antal celler</th><td>Encellig, en cell</td><td>Inga celler, inte levande</td></tr><tr><th class="align-baseline">Fortplantning</th><td>Delas upp i 2</td><td>Invaderar en v√§rdcell och tar √∂ver cellen och g√∂r kopior av virusets DNA/RNA. F√∂rst√∂r v√§rdcellen och sl√§pper ut nya virus</td></tr><tr><th class="align-baseline">Storlek</th><td>Bakterier √§r mycket st√∂rre √§n virus, fr√•n 800 nm till 1000 nm. Bakterier kan ses i ljusmikroskop.</td><td>Storleken p√• virus √§r mellan 20 nm och 400 nm. Virus √§r bara synliga i elektronmikroskop.</td></tr><tr><td class="align-baseline">Vissa bakterier kan vara nyttiga, t.ex. vissa bakterier beh√∂vs i tarmen.</td><td>Virus √§r inte nyttiga f√∂r kroppen. Virus kan vara till hj√§lp vid genteknik.</td></tr><tr><th class="align-baseline">Infektion</th><td>Bakteriell infektion √§r vanligtvis begr√§nsad till en del av kroppen, beskriven som en lokaliserad infektion. Infektioner kan orsakas av bakterier eller av toxiner (endotoxiner) som produceras.</td><td>En virusinfektion √§r systemisk (som drabbar hela kroppen). Virus infekterar en v√§rdcell och f√∂r√∂kar sig i tusental, l√§mnar v√§rdcellen och infekterar andra kroppsceller.</td></tr><tr><th class="align-baseline">Sjukdom</th><td>Bakteriesjukdomar inkluderar lunginflammation, tuberkulos, stelkramp och matf√∂rgiftning.</td><td>Systemiska sjukdomar orsakade av virusinfektion inkluderar influensa, m√§ssling, polio, AIDS och covid-19.</td></tr><tr><th class="align-baseline">Behandling</th><td>Antibiotika och vacciner f√∂rebygger sjukdomen.</td><td>Vacciner f√∂rhindrar spridningen och antivirala l√§kemedel hj√§lper till att bromsa reproduktionen men kan inte stoppa den helt.</td></tr></tbody></table>',1),Mt=i(`<section class="e-card"><h4 class="mt-4">Referenser</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),Dt=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Varf√∂r d√∂dar inte antibiotika virus?</h2><p>Antibiotika riktar in sig p√• tillv√§xtmaskineriet i bakterier (inte virus) f√∂r att d√∂da eller h√§mma just dessa bakterier. Antibiotika kan inte d√∂da virus eftersom virus har olika strukturer och replikerar annorlunda √§n bakterier. Dessutom leder √∂veranv√§ndning av antibiotika √∂ver hela v√§rlden till √∂kningen av den globala <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiotikaresistensen</a>. Se Tabell 2 under vilka tillst√•nd antibiotika kan vara till hj√§lp (OBS! Beslutet om dess anv√§ndning tas av behandlande l√§kare).</p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabell 2.</b> Behov av antibiotika vid vanliga luftv√§gsinfektioner </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respi¬≠ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>anti¬≠biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">K√§lla: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Ct={id:"s3"},Ot=e("h2",{id:"s3t"},"3. Hur vacciner fungerar",-1),zt=e("h3",null,"Kroppens naturliga svar",-1),Ft=e("p",null,[a("En "),e("span",{class:"e-term font-Heading"},"patogen"),a(" √§r en bakterie, virus, parasit eller svamp som kan orsaka sjukdom i kroppen. Varje patogen best√•r av flera delar, vanligtvis unika f√∂r den specifika patogenen och sjukdom den orsakar. Den del av en patogen som orsakar bildandet av antikroppar kallas antigen. Antikropparna som produceras som svar p√• patogenens antigen √§r v√§sentliga f√∂r immunsystemet. Du kan betrakta antikroppar som soldaterna i din kropps f√∂rsvarssystem. Varje antikropp, eller soldat, i v√•rt system, √§r tr√§nad att k√§nna igen ett specifikt antigen. Vi har tusentals olika antikroppar i v√•ra kroppar. N√§r m√§nniskokroppen exponeras f√∂r ett antigen f√∂r f√∂rsta g√•ngen tar det tid f√∂r immunsystemet att svara och producera antikroppar specifika mot det antigenet (fig. 2).")],-1),Nt=e("p",null,"Antikroppar mot en patogen skyddar i allm√§nhet inte mot en annan patogen f√∂rutom n√§r tv√• patogener √§r v√§ldigt lika varandra, som kusiner. N√§r de antigenspecifika antikropparna v√§l har producerats arbetar de med resten av immunsystemet f√∂r att f√∂rst√∂ra patogenen och stoppa sjukdomen. N√§r kroppen v√§l producerar antikroppar i sitt prim√§ra svar p√• ett antigen, skapar den ocks√• antikroppsproducerande minnesceller, som f√∂rblir vid liv √§ven efter att antikropparna besegrat patogenen. Anta att kroppen uts√§tts f√∂r samma patogen mer √§n en g√•ng. I s√• fall √§r antikroppssvaret mycket snabbare och mer effektivt √§n f√∂rsta g√•ngen eftersom minnescellerna √§r redo att pumpa ut antikroppar mot det antigenet. Detta inneb√§r att om personen uts√§tts f√∂r en farlig patogen i framtiden, kommer immunf√∂rsvaret att kunna reagera omedelbart och skydda personen mot sjukdomar.",-1),Pt=e("b",null,"Figur 2.",-1),$t=e("h3",null,"Hur hj√§lper vacciner?",-1),Bt=e("p",null,"Vacciner minskar riskerna f√∂r att f√• en sjukdom genom att arbeta med din kropps naturliga f√∂rsvar f√∂r att bygga skydd. N√§r du f√•r ett vaccin svarar ditt immunf√∂rsvar.",-1),Tt=e("p",null,"Vaccin inneh√•ller f√∂rsvagade eller inaktiva delar av en viss organism (antigen) som utl√∂ser ett immunsvar i kroppen (fig. 3). Nyare vacciner inneh√•ller ‚Äùritningen‚Äù f√∂r att producera antigener snarare √§n sj√§lva antigenet. Oavsett om vaccinet best√•r av sj√§lva antigenet eller ritningen s√• att kroppen ska producera antigenet, kommer denna f√∂rsvagade version inte att orsaka sjukdomen hos den som f√•r vaccinet. Det kommer dock att f√• deras immunsystem att svara ungef√§r som det skulle ha gjort p√• sin f√∂rsta reaktion p√• den faktiska patogenen.",-1),Et=e("b",null,"Figur 3.",-1),Rt=i('<p>Vaccin fungerar genom att introducera/uts√§tta dina vita blodkroppar f√∂r det fr√§mmande proteinet i ett virus. N√§r din kropp har st√∂tt p√• ett virus och byggt upp ett immunsvar (producerat B- och T-celler) mot viruset, sparas B- och T-celler s√• att om samma virus eller bakterier n√•gonsin infekterar kroppen igen, kan immunsystemet snabbt komma ig√•ng och f√∂rhindra att patogenen g√∂r dig sjuk.</p><h3>Immunisering och relaterade utmaningar</h3><p>Vi har nu vacciner f√∂r att f√∂rhindra spridningen av mer √§n 20 livshotande sjukdomar, vilket hj√§lper m√§nniskor i alla √•ldrar att leva l√§ngre och h√§lsosammare liv. Immunisering f√∂rhindrar f√∂r n√§rvarande 2-3 miljoner d√∂dsfall √•rligen fr√•n sjukdomar som difteri, stelkramp, kikhosta, influensa och m√§ssling.</p><p>Vi har vaccinationer mot m√•nga allvarliga virusinfektioner (m√§ssling, p√•ssjuka, hepatit A, hepatit B och vissa virus ‚Äì som de som orsakar f√∂rkylning). √Ñnd√• kvarst√•r problemet att virus kan mutera fr√•n en person till en annan. N√§r viruset muterar f√∂r√§ndras det tillr√§ckligt mycket f√∂r att immunsystemet inte l√§ngre k√§nner igen det. Immuncellerna som lagras f√∂r att d√∂da viruset k√§nner inte l√§ngre igen det som samma sjukdom och vet inte hur de ska f√∂rg√∂ra det. Det √§r s√• en infektion med ursprungligen samma men aningen muterat virus kan forts√§tta att undvika immunf√∂rsvaret. Vaccination mot dessa virus √§r sv√•rt eftersom de redan har √§ndrat sin uppbyggnad n√§r vaccinerna utvecklas.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ht=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Vaccinutveckling och vaccin s√§kerhet</h2><h3>Utveckling</h3><p>Vaccinutveckling b√∂rjar vanligtvis i ett forskningslaboratorium bel√§get p√• ett universitet, v√•rdcentral eller ett bioteknikf√∂retag. Under vaccinutvecklingsprocessen utvecklar forskare olika reagenser f√∂r att testa och m√§ta deras effekt (eller brist p√• s√•dan). Ofta beh√∂vs flera √•r av forskning f√∂r att hitta id√©er som fungerar.</p><p>Olika forskare eller forskargrupper kan arbeta mot samma m√•l under vaccinutvecklingen. Arbetets framsteg presenteras i olika m√∂ten och refereegranskade artiklar i tidskrifter. Om n√•got arbete verkar lovande, kan l√§kemedelsforskare v√§nda sig till dem som arbetar med det f√∂r att ut√∂ka sin forskning mot produktutveckling.</p><h3>Testning</h3><p>Om en lovande vaccinkandidat har hittats m√•ste den testas p√• djur. Detta kallas den prekliniska fasen. F√∂rst anv√§nds sm√• djur som m√∂ss, r√•ttor, kaniner och andra. Om vaccinkandidaten visar effekt p√• sm√• djur, m√•ste effekten vanligtvis bevisas p√• st√∂rre djur som apor. Om vaccinet utl√∂ser ett immunsvar testas det i tre faser i kliniska pr√∂vningar p√• m√§nniskor (WHO, 2021).</p><p>I fas 1 ges vaccinet till n√•gra frivilliga f√∂r att bed√∂ma dess s√§kerhet, bekr√§fta att det genererar ett immunsvar och man beh√∂ver best√§mma r√§tt dos. Generellt i denna fas testas vacciner p√• en liten grupp unga, friska vuxna frivilliga.</p><p>I fas 2 ges vaccinet till flera hundra frivilliga f√∂r att bed√∂ma dess s√§kerhet och f√∂rm√•ga att ytterligare generera ett immunsvar. Deltagare i denna fas har samma egenskaper (s√•som √•lder och k√∂n) som de som vaccinet √§r avsett f√∂r. Det finns vanligtvis flera f√∂rs√∂k i denna fas f√∂r att utv√§rdera olika √•ldersgrupper (√§ldre, vuxna, barn). En grupp som inte f√•r vaccinet brukar ocks√• inkluderas i bed√∂mningen om f√∂r√§ndringarna i den vaccinerade gruppen tillskrivs vaccinet eller har skett av en slump.</p><p>I fas 3 ges vaccinet till tusentals frivilliga ‚Äì j√§mf√∂rt med en liknande grupp m√§nniskor som inte fick vaccinet utan fick placebo. Detta syftar till att avg√∂ra om vaccinet √§r effektivt mot sjukdomen det √§r designat f√∂r att skydda mot. Det syftar ocks√• till att studera dess s√§kerhet i en mycket st√∂rre grupp m√§nniskor. Fas 3-pr√∂vningar genomf√∂rs ofta √∂ver flera l√§nder och platser inom ett land f√∂r att s√§kerst√§lla att resultaten av vaccinets prestanda g√§ller m√•nga olika populationer.</p><p>Under fas 2- och 3-pr√∂vningar vet inte de frivilliga och inte heller forskarna som genomf√∂r studien vilka frivilliga som hade f√•tt det vaccin som testas eller en placebo. Detta kallas &quot;blindning&quot; och √§r n√∂dv√§ndigt f√∂r att s√§kerst√§lla att varken frivilliga eller forskarna p√•verkas i sin bed√∂mning av effektivitet eller s√§kerhet genom att veta vem som fick vilken produkt.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Auktorisation och √∂vervakning</h3><p>N√§r resultaten av alla dessa kliniska pr√∂vningar √§r tillg√§ngliga kr√§vs en rad steg. Tj√§nstem√§n vid Europeiska l√§kemedelsmyndigheten och senare i varje land granskar noggrant studiedata och beslutar om vaccinet ska godk√§nnas. Alla f√∂rs√∂k m√•ste vara korrekt utf√∂rda och v√§ldokumenterade. Ett vaccin m√•ste bevisas s√§kert och effektivt i en bred population innan det godk√§nns. Ribban f√∂r vaccinets s√§kerhet och effektivitet √§r exceptionellt h√∂g. Detta inkluderar granskning av effektivitet och s√§kerhet f√∂r godk√§nnanden av regulatoriska och folkh√§lsopolicyer.</p><p>Ytterligare √∂vervakning av s√§kerhet och effektivitet sker under anv√§ndningen av vacciner. Detta g√∂r det m√∂jligt f√∂r forskare att h√•lla reda p√• vaccinets effekt och s√§kerhet √§ven om de anv√§nds av m√•nga m√§nniskor under en l√•ng tidsram. Dessa data anv√§nds f√∂r att justera policyerna f√∂r vaccinanv√§ndning.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Wt={id:"s5"},Kt=e("h2",{id:"s5t"},"5. Ansiktsmasker mot virus och bakterier",-1),Yt=e("p",null,"Ansiktsmasker anv√§nds ofta f√∂r att skydda mot virus och bakterier. Dess anv√§ndning √∂kade betydligt eftersom de anv√§ndes som skydd mot SARS-CoV-2-viruset. Bland olika typer av ansiktsmasker √§r kirurgiska ansiktsmasker bland de mest anv√§nda ansiktsskydden i COVID-19-pandemin. Vanligtvis √§r de bl√•f√§rgade fr√•n ena sidan, vilket √§r det yttre lagret (fig. 4). Huvudsyftet med kirurgiska ansiktsmasker √§r att skydda patienter fr√•n potentiell kontakt med bakterier och virus som andas ut av b√§raren. De f√∂rhindrar v√§l spridningen av coronaviruset genom luften men √§r mindre effektivt p√• att skydda b√§raren fr√•n viruset.",-1),Ut=e("p",null,"FFP2- eller FFP3-masker (ofta kallade andningsskydd) b√∂r anv√§ndas f√∂r att filtrera och b√§ttre andas in luft. Numreringssystemet (FFP1, FPP2, FFP3) indikerar dessa enheters filtreringseffektivitet (certifierade enligt EN 149-2001-standarden). FFP2 och FPP3 har en filtreringseffektivitet f√∂r luftburna partiklar (inklusive de som inneh√•ller viruset) p√• 92 % respektive 98 %. B√•da maskerna har √§ven litet in√•tl√§ckage: <8% respektive <2%. I FFP2 anv√§nds ofta specialgummi p√• andningsskyddets yttre skikt. Om en ventil (som underl√§ttar utandning) i yrkesmilj√∂er har till√•tits, i fallet med SARS-CoV-2, b√∂r endast andningsskydd utan ventil anv√§ndas f√∂r att √§ven filtrera utandningsluft.",-1),Jt=e("p",null,"Med covid-19-pandemin har en ny ansiktsmask introducerats: filtreringsmasken. Denna typ av mask √§r gjord av flerskiktstyg (ett m√•ste vara ett nanofiberfilter som garanterar en bakteriell och skadlig finfilterkapacitet p√• minst 90%). Denna mask kombinerar h√∂g filtreringskapacitet med √•teranv√§ndbarhet d√• den kan tv√§ttas i maskin i 60 grader.",-1),Lt={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Gt=i('<p><i><b>Figur 4</b>. Olika typer av ansiktsmasker</i></p><p>Ansiktsmaskernas effektivitet har testats i speciella laboratorier, t.ex. i exponeringskammaren. I dessa studier, b√§r en person p√• virus. D√§refter fyller partikelkoncentrationerna bakom partikelgeneratorn exponeringskammaren med sm√• partiklar; i likhet med aerosoler m√§ts maskerna och j√§mf√∂rs med koncentrationen i den allm√§nna atmosf√§ren i exponeringskammaren.</p><p>Det starkaste beviset √§r dock baserat p√• epidemiologiska data fr√•n verkliga situationer. Till exempel avtar den dagliga tillv√§xttakten f√∂r COVID-19 efter krav p√• ansiktsmask i 15 delstater och District of Columbia i USA. En annan studie unders√∂kte d√∂dsfall i coronavirus i 198 l√§nder och fann att de med kulturella normer eller regeringspolitik som gynnar anv√§ndning av ansiktsmasker hade l√§gre d√∂dsfrekvens.</p><p>M√•nga Facebook- och sociala medieranv√§ndare har delat vilseledande inl√§gg ang√•ende l√•ngvarig anv√§ndning av ansiktsmasker som orsakar syrebrist i kroppen - hypoxi. √Ñnd√• antyder forskningsartiklar och experter att s√•dana symtom √§r osannolikt f√∂rekommande hos de flesta m√§nniskor om inte b√§raren har redan existerande luftv√§gssjukdomar som astma eller kronisk obstruktiv lungsjukdom (KOL). Risken f√∂r hypoxi och hyperkapni (att ha f√∂r mycket koldioxid i blodomloppet ) √§r osannolikt med tyg- och kirurgiska ansiktsmasker eftersom de inte sitter t√§tt. √Ñnd√• varnas det f√∂r att ansiktsmasker inte ska placeras p√• sm√• barn under tv√• √•r, de med andningssv√•righeter eller vid tr√§ning.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),Qt=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"F√∂r elever att studera vidare"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://www.youtube.com/watch?v=npXP 5wqNzaI&ab_channel=BeSmart",target:"_blank",rel:"noopener noreferrer"},"F√∂r att f√∂rklara m√•nga av de presenterade myterna kan man se p√• film under n√•gra minuter: 3:24 - 6:39")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1ziN9u4ukz-FZR3jz5JSBxZPSnnBzZgWK/view?usp=drive_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1ziN9u4ukz-FZR3jz5JSBxZPSnnBzZgWK/view?usp=drive_link"),a(" - om effektiviteten hos maskerna f√∂r att filtrera partiklar ")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1ZXOhGczMUQ4Ec5spEjx24MYcRj4GR1xz/view?usp=drive_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1ZXOhGczMUQ4Ec5spEjx24MYcRj4GR1xz/view?usp=drive_link"),a(" - om maskernas effektivitet f√∂r att f√∂rebygga sjukdomar ")]),e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"https://www.sciencedirect.com/science/article/pii/S2452199X20301481")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/")])])],-1),Xt=e("hr",{class:"mt-10 mb-40"},null,-1),Zt={id:"s6"},es=i('<h2 id="s6t">6. Virus och handhygien</h2><h3>Handdesinfektionsmedel eller tv√•l?</h3><p>V√•ra h√§nder kan vara en viktig faktor f√∂r √∂verf√∂ring av infektioner. N√§r de appliceras p√• h√§nderna och noggrant <a href="https://www.cdc.gov/handwashing/when-how-handwashing.html" target="_blank" rel="noopener noreferrer">skrubbas i minst 20 sekunder</a>, kommer alkoholbaserade handdesinfektionsmedel och tv√•l att stoppa coronaviruset. Tv√•l st√∂r dock det klibbiga bandet mellan patogener och din hud, vilket g√∂r att patogenerna kan direkt glida av huden. Du neutraliserar inte bara viruset, utan du f√•r ocks√• fysiskt bort det fr√•n dina h√§nder. Att ut√∂va god handhygien √§r en enkel f√∂rebyggande strategi som de flesta enkelt kan genomf√∂ra, och m√•nga studier har visat effektiviteten av handhygien f√∂r att f√∂rhindra √∂verf√∂ring av smittsamma patogener, inklusive coronavirus som SARS-CoV-2.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>F√∂rsvagar coronaviruset med tv√•l</h3><p>Coronaviruset har f√•tt sitt namn fr√•n &quot;corona&quot;- proteintopparna som √§r inb√§ddade p√• virusets yta. Spikarna, som √§r ansvariga f√∂r att infektera v√§rden, √§r f√∂rankrade i ett membran. Membranet √§r virusets &quot;skal&quot; och virusets svaga punkt.</p><p>Tv√•lens molekyler har tv√• kemiskt distinkta delar: ett hydrofilt (‚Äùvatten√§lskande‚Äù) &#39;huvud&#39; och en hydrofob (‚Äùvattenhatande‚Äù) &#39;svans&#39;. Huvudet hj√§lper tv√•len att blandas med vatten, medan svansen kan interagera med andra hydrofoba molekyler som lipider.</p><p>Lyckligtvis best√•r coronavirusets membran huvudsakligen av lipidmolekyler. De h√•lls samman av svaga kemiska interaktioner mellan enskilda molekyler. De hydrofoba (vattenhatande) &quot;svansarna&quot; av tv√•lens molekyler kan bryta interaktionerna mellan lipidmolekylerna i coronavirusmembranet (se fig. 5).</p><p>Tv√•lens svans kan st√∂ra de svaga interaktionerna mellan lipidmolekyler i membranet och slita is√§r det. Antag att viruset bryts upp innan det skyddas s√§kert i en v√§rdcell. I s√• fall kommer det inte l√§ngre att kunna spridas till andra celler. Tv√•lmolekyler omger sedan virusfragmentet med alla svansar v√§nda in√•t. Detta kluster kallas en micell (se fig. 6). De ut√•tv√§nda hydrofila huvudena g√∂r att micellen kan sk√∂ljas ner i avloppet med vatten. Enbart vatten r√§cker inte.</p>',9),as={class:"grid gap-2 md:grid-cols-2 e-card"},ts=e("b",null,"Figur 5.",-1),ss=e("b",null,"Figur 6.",-1),is=i('<p>Den givna informationen g√§ller √§ven f√∂r andra h√∂ljef√∂rsedda virus (influensa, hepatit B och C och Ebolavirus) eftersom deras h√∂lje best√•r av fosfolipider.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Att v√§lja handsprit</h3><p>V√§rldsh√§lsoorganisationen (WHO) rekommenderar alkoholbaserade handdesinfektionsmedel om du inte har tv√•l till hands.</p><p><b>Alkoholbaserade handdesinfektionsmedel tros fungera genom att f√∂rhindra normal funktionalitet hos proteiner fr√•n mikrober ‚Äì inklusive bakterier och vissa virus. Handdesinfektionsmedel med h√∂g alkoholhalt kan ocks√• f√∂rst√∂ra lipidskalet som omger coronaviruset.</b> F√∂r att vara effektivt m√•ste handsprit inneh√•lla minst 60 procent alkohol. Tillsatser i desinfektionsmedlet kan hindra alkoholen fr√•n att avdunsta f√∂r snabbt, vilket g√∂r att viruset kan dr√§nkas l√§ngre.</p><p>Det finns dock vissa risker med att anv√§nda alkoholbaserade handdesinfektionsmedel. Det finns en √∂kad risk f√∂r alkoholf√∂rgiftning hos barn, och frekvent anv√§ndning av handsprit kan resultera i antimikrobiell resistens. Det finns alternativa alkoholfria handdesinfektionsmedel, d√§r bensalkonium √§r vanligast. Nyligen genomf√∂rda studier har visat att alkoholfritt handdesinfektionsmedel fungerar lika bra och inte orsakar den v√§lbekanta svidande k√§nslan man k√§nner vid anv√§ndande av alkoholhandsprit.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),rs=e("hr",{class:"mt-10 mb-40"},null,-1),ns={id:"s7"},os=i('<h2 id="s7t" class="mt-40 text-5xl">7. Vaccinmyter</h2><h3><span class="text-rose-400">Myt 1:</span> Vacciner orsakar autism/allvarliga biverkningar.</h3><p>Den utbredda r√§dslan f√∂r att vacciner √∂kar risken f√∂r autism har sitt ursprung i en studie fr√•n 1997 publicerad av den brittiske kirurgen Andrew Wakefield. Artikeln publicerades i The Lancet, en prestigefylld medicinsk tidskrift, som tyder p√• att vaccinet mot m√§ssling, p√•ssjuka och r√∂da hund (MMR) √∂kade autism hos brittiska barn.</p><p>Uppsatsen har sedan dess misskrediterats grundligt p√• grund av allvarliga procedurfel, med endast 12 deltagare i studien, hemliga ekonomiska intressekonflikter och etiska kr√§nkningar. Andrew Wakefield f√∂rlorade sin medicinska licens och artikeln drogs tillbaka fr√•n The Lancet.</p><p>F√∂r n√§rvarande, mot teorin om autism-vaccination, har flera studier nu identifierat symtom p√• autism hos barn l√•ngt innan de f√•r MMR-vaccinet. Dessutom ger ny forskning bevis f√∂r att autism utvecklas i livmodern, l√•ngt innan ett barn f√∂ds eller f√•r vaccinationer. Ingen av de senare studierna har rapporterat ett samband mellan n√•got vaccin och sannolikheten f√∂r att utveckla autism.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ls=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"F√∂r ytterligare studie"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Here‚Äôs What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety",target:"_blank",rel:"noopener noreferrer"},"Coronavirus disease (COVID-19): Vaccines safety")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),cs=i('<h3><span class="text-rose-400">Myt 2:</span> Sp√§dbarns immunsystem kan inte hantera flera vacciner</h3><p>Barn f√•r vaccin i unga √•r eftersom de l√∂per st√∂rst risk att bli sjuka eller d√∂ om de f√•r dessa sjukdomar. √Ñven nyf√∂dda barn √§r immuna mot vissa sjukdomar (t.ex. vattkoppor) eftersom de f√•r antikroppar fr√•n sina m√∂drar; denna immunitet varar bara n√•gra m√•nader. Dessutom f√•r de flesta sp√§dbarn inte skyddande antikroppar mot difteri, kikhosta, polio, stelkramp, hepatit B eller Hib fr√•n sina m√∂drar.</p><p>F√∂r att minska antalet sprutor ett barn f√•r vid ett l√§karbes√∂k erbjuds vissa vacciner som en kombination (tv√• eller flera olika vacciner har kombinerats till en enda spruta). Exempel p√• kombinationsvaccin √§r difteri-stelkramp-kikhosta (DTap) och m√§ssling-p√•ssjuka-r√∂da hund (MMR).</p><p>Vetenskapliga data visar att f√• flera vacciner samtidigt inte orsakar n√•gra h√§lsoproblem. Sp√§dbarns immunf√∂rsvar √§r tuffare √§n man tror. Baserat p√• antalet antikroppar som finns i blodet, skulle ett barn teoretiskt ha f√∂rm√•ga att svara p√• ett mycket st√∂rre antal vacciner √§n vad som n√•gonsin anv√§nts (fr√•gan √§r om det skulle vara 1 000, 10 000 eller 100 000 p√• en g√•ng). √Ñven om alla ~10 (beroende p√• nationell vaccinationsplan) schemalagda vacciner gavs p√• en g√•ng, skulle det bara anv√§nda en br√•kdel av ett barns immunf√∂rsvar. I verkligheten uts√§tts sp√§dbarn f√∂r otaliga bakterier och virus varje dag, och immuniseringar √§r f√∂rsumbara i j√§mf√∂relse. Studier har inte heller visat att exponering f√∂r flera vacciner under de f√∂rsta 23 levnadsm√•naderna skulle vara associerad med en √∂kad risk f√∂r infektioner som inte riktas mot vaccin.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Myt 3:</span> Immunitet f√∂rv√§rvad genom en sjukdom √§r b√§ttre √§n immunitet f√∂rv√§rvad genom vaccination</h3><p>Det √§r sant att en naturlig infektion n√§stan alltid resulterar i en starkare immunitet mot sjukdomen √§n en vaccination. Farorna med detta tillv√§gag√•ngss√§tt √∂verv√§ger dock vida de relativa f√∂rdelarna. Priset f√∂r immunitet efter naturlig infektion kan vara lunginflammation fr√•n vattkoppor eller pneumokocker, intellektuell funktionsneds√§ttning fr√•n Haemophilus influenzae typ b (Hib), fosterskador fr√•n r√∂da hund, levercancer fr√•n hepatit B-virus, d√∂d i m√§ssling, etc. Om du √∂nskade f√• immunitet mot exempelvis m√§ssling, genom att insjukna i sjukdomen, skulle du ha en chans p√• 1 p√• 500 att d√∂ av dina symtom. D√§remot √§r antalet personer som har haft sv√•ra allergiska reaktioner fr√•n ett MMR-vaccin mindre √§n en p√• en miljon.</p><p>√Ñnd√• √§r det f√• vaccin som inducerar ett b√§ttre immunsvar √§n naturlig infektion. Till exempel inneh√•ller humant papillomvirus(HPV)-vaccinet en h√∂g renhet av det specifika proteinet, vilket leder till ett b√§ttre immunsvar √§n naturlig infektion. Andra exempel inkluderar stelkramp, Haemophilus influenzae typ b (Hib) och pneumokockvaccin.</p><p>N√§r det g√§ller covid-19 m√•ste vissa saker klarg√∂ras. Det har visat sig att ett permanent skydd efter infektion √§r osannolikt. √Ñven om coronapatienter fick &quot;avsev√§rt immunminne&quot; som involverade alla fyra viktiga delar av immunsystemet: minnes B-celler, antikroppar, minnes CD4+ T-celler och minnes CD8+ T-celler, b√∂rjade skyddet minska efter ett halv√•r. Dessutom har forskare visat ett &quot;massivt dynamiskt omr√•de&quot; i immunsvaret mellan individer, med en 200-faldig skillnad i antikroppsniv√•er.</p><p>Andra studier har visat att frivilliga som fick Moderna-vaccinet (mRNA) hade fler antikroppar ‚Äì en mark√∂r f√∂r immunsvar ‚Äì i blodet √§n personer som hade varit sjuka med covid-19. Detta faktum kan dock modifieras av sjukdomens sv√•righetsgrad eftersom det finns en korrelation mellan sjukdomens sv√•righetsgrad och best√•ende immunsvar ‚Äì de flesta asymtomatiska patienter hade mycket f√• antikroppar efter sex m√•naders infektion. S√•ledes √§r den naturliga immuniteten som genereras fr√•n en SARS-CoV-2-infektion ofta of√∂ruts√§gbar. Antikropparna som framkallades av mRNA-vaccinet riktade sig dessutom mot ett bredare spektrum av platser p√• den receptorbindande dom√§nen (RBD) √§n de som framkallades av naturlig infektion.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Myt 4:</span> Vacciner inneh√•ller livshotande √§mnen.</h3><p>M√§nniskor √§r oroade √∂ver f√∂rekomsten av formaldehyd, kvicksilver eller aluminium i vacciner. √Ö ena sidan √§r dessa kemikalier giftiga f√∂r m√§nniskokroppen i vissa niv√•er. √Ö andra sidan kan endast sm√• m√§ngder av dessa kemikalier hittas i vacciner. Dessa m√§ngder √§r mindre √§n vad vi f√•r naturligt fr√•n n√§ring eller den formaldehyd som produceras i h√∂gre hastighet av v√•ra egna metabola system.</p><p>Vissa grund√§mnen, s√•som aluminiumsalter, tills√§tts i vacciner eftersom de fungerar som en adjuvans, vilket inneb√§r att deras n√§rvaro √∂kar immunsvaret n√§r du vaccineras. Dessutom inneh√•ller endast vissa vacciner aluminiumsalter, och nya covid-19-vacciner inneh√•ller dem inte alls. Ett f√•tal vacciner har inneh√•llit tiomersal som konserveringsmedel; dock inneh√•ller inget av de vacciner som anv√§nds till barn f√∂r n√§rvarande detta. Tiomersal inneh√•ller etylkvicksilver, som snabbt avl√§gsnas fr√•n m√§nniskokroppen j√§mf√∂rt med metylkvicksilver, som bioackumuleras ‚Äì s√• det √§r ocks√• skillnad i vilken form den giftiga metallen finns. √Ñnd√• inneh√•ller covid-19-vaccin inte gifter (t.ex.).</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),ds=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"F√∂r vidare studier"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.publichealth.org/public-awareness/understanding-vaccines/goes-vaccine/",target:"_blank",rel:"noopener noreferrer"},"What Goes Into A Vaccine?")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"What‚Äôs in Vaccines?")])])],-1),ms=i('<h3><span class="text-rose-400">Myt 5:</span> B√§ttre hygien och sanitet leder till minskade infektioner, inte vacciner</h3><p>Det √§r delvis sant att vacciner inte f√∂rtj√§nar all √§ra f√∂r att minska eller eliminera andelen infektionssjukdomar. Det har visat sig att b√§ttre sanitet, n√§ring och utveckling av antibiotika har hj√§lpt till mycket. Infektioner som tyfus och kolera som √∂verf√∂rs av f√∂rorenat vatten, en viktig orsak till sjukdom och d√∂d i b√∂rjan av 1900-talet, har minskat dramatiskt genom b√§ttre sanitet. En nyligen genomf√∂rd granskning drog slutsatsen att handtv√§tt bidrar till att avv√§rja infektionssjukdomar. Ytterligare ett nytt bevis kommer fr√•n covid-19-karant√§n (lockdown) och f√∂rb√§ttrad hygien med dramatiskt minskade s√§songsinfluensafrekvenser.</p><p>Men n√§r dessa faktorer isoleras och antalet infektionssjukdomar analyseras kan vaccinernas roll inte f√∂rnekas. Ett exempel √§r m√§ssling i USA. N√§r det f√∂rsta m√§sslingsvaccinet introducerades 1963 hade infektionssiffrorna legat konstant p√• cirka 400 000 fall per √•r. Och √§ven om hygieniska vanor och sanitet inte f√∂r√§ndrades mycket under det f√∂ljande decenniet, sj√∂nk frekvensen av m√§sslingsinfektioner hastigt efter vaccinets introduktion, med endast cirka 25 000 fall 1970. Ett annat exempel √§r Hib-sjukdomen. Enligt CDC-data sj√∂nk incidensen f√∂r denna sjukdom fr√•n 20 000 1990 till cirka 1 500 1993 efter vaccinets introduktion.</p><p>Ytterligare ett bevis kommer fr√•n de senaste decennierna. Det har inte skett n√•gra f√∂r√§ndringar i hygienen i den utvecklade v√§rlden, men det har skett en minskning av vaccinationsfrekvensen. Nu ser flera l√§nder, s√•som Storbritannien, USA, Tyskland, Spanien, etc., ett √∂kande antal m√§ssling och andra sjukdomar som kan f√∂rebyggas med vaccin, identifierade som en framv√§xande sjukdom &quot;hot spots&quot;.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Myt 6:</span> Vacciner kan infektera barnet med sjukdomen det f√∂rs√∂ker f√∂rebygga</h3><p>Vissa av vaccinerna √§r levande vacciner som inneh√•ller levande f√∂rsvagade mikroorganismer/virus, som fortfarande kan replikera i den vaccinerade v√§rden. Mikroorganismerna √§r &quot;f√∂rsvagade&quot;, vilket betyder att de har f√∂rlorat det mesta av sin sjukdomsframkallande f√∂rm√•ga men har fortfarande immunogena egenskaper. Det √§r allts√• alltid mycket mindre allvarligt √§n om ett barn skulle bli infekterat med sj√§lva det sjukdomsframkallande viruset. Levande f√∂rsvagade vacciner √§r f√∂r vaccin mot m√§ssling, p√•ssjuka, r√∂da hund (MMR-kombinerat vaccin), rotavirus, smittkoppor, vattkoppor och gula febern. I de flesta fall visar levande vacciner signifikant h√∂gre immunogenicitet √§n inaktiverade vacciner eftersom naturlig infektion imiteras n√§stan perfekt genom att framkalla ett mer omfattande spektrum av immunologiska svar. Dessa vacciner √§r dock inte gynnade f√∂r barn med f√∂rsvagat immunf√∂rsvar, s√•som de som behandlas f√∂r cancer.</p><p>Levande vacciner kan verkligen orsaka milda symtom som liknar den sjukdom de skyddar mot. De som tagit vaccin upplever dock kroppens immunsvar mot vaccinet, inte sj√§lva sjukdomen. Det finns bara ett registrerat fall d√§r ett vaccin visade sig orsaka sjukdom. Detta var det orala poliovaccinet (OPV) som inte l√§ngre anv√§nds och f√∂r n√§rvarande ers√§tts med en d√∂dad virusform som kallas det inaktiverade poliovaccinet (IPV).</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Myt 7:</span> Vi beh√∂ver inte vaccinera eftersom m√•nga l√§nder har l√•ga infektionsfrekvenser</h3><p>Flockimmunitet uppst√•r n√§r en stor del av ett samh√§lle (flocken) blir immun mot en sjukdom, vilket g√∂r osannolikt att sjukdomen sprids fr√•n person till person. Tack vare &quot;flockimmunitet&quot; ser m√•nga m√§nniskor inte behovet av vaccination. S√• l√§nge en stor majoritet av m√§nniskor √§r immuniserade i n√•gon befolkning, kommer den oimmuniserade minoriteten ocks√• att skyddas. Detta √§r viktigt eftersom det finns en del av befolkningen ‚Äì sp√§dbarn, gravida kvinnor, √§ldre och de med f√∂rsvagat immunf√∂rsvar ‚Äì som s√• ofta inte kan f√• vaccin. Anta dock att m√•nga m√§nniskor inte vaccinerar sig sj√§lva eller sina barn. I s√• fall f√∂rsvinner &quot;flockimmuniteten&quot;, vilket √∂ppnar m√∂jligheter f√∂r virus och bakterier att etablera sig och sprida sig. Med s√• m√•nga m√§nniskor som √§r resistenta kommer en infektionssjukdom aldrig att f√• en chans att etablera sig och spridas.</p><p>Dessutom b√§r internationella resen√§rer ofta p√• sjukdom fr√•n utlandet, och en ovaccinerad individ l√∂per mycket st√∂rre risk att bli sjuk eller att m√§nniskor har blivit smittade under resan. Den √∂kade incidensen av m√§ssling illustrerar detta i USA de senaste √•ren. S√• l√§nge sjukdomen existerar riskerar vi att bli smittade.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),us=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myt vs Vetenskap ",-1);function hs(h,d){const l=v,c=k,r=f,n=g;return o(),u("div",bt,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",wt,[t(c,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),_t,yt,e("section",jt,[xt,qt,Vt,St,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"K√§lla: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[At,a(" Strukturella skillnader mellan virus och bakterier ")]),_:1}),It,t(n,{class:"mb-8"},{default:s(()=>[a(" Antibiotika kan hj√§lpa immunsystemet att d√∂da bakterieinfektioner men r√•r ej p√• virusinfektioner. Antivirala l√§kemedel fungerar annorlunda √§n antibiotika och √§r f√∂r n√§rvarande endast effektiva mot ett f√•tal virussjukdomar, s√•som influensa, herpes, hepatit B och C samt HIV. Virusinfektioner kan vara mycket sv√•rare att d√∂da √§n bakterieinfektioner eftersom viruset g√•r in i m√§nskliga celler. Immunsystemet kan ibland d√∂da de infekterade cellerna innan viruset kan fortplanta sig. Men eftersom viruset f√∂r√∂kar sig d√∂dar det ofta den infekterade cellen genom att cellen exploderar, vilket g√∂r att viruset kan spridas till andra celler i kroppen. ")]),_:1}),Mt]),Dt,e("section",Ct,[Ot,zt,Ft,Nt,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"K√§lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[Pt,a(" F√∂r varje nytt antigen beh√∂ver v√•r kropp bygga en specifik antikropp ")]),_:1}),$t,Bt,Tt,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"K√§lla: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Et,a(" Antikroppsutveckling genom vaccination ")]),_:1}),Rt]),Ht,e("section",Wt,[Kt,Yt,Ut,Jt,e("div",Lt,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Kirurgisk mask ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respirator) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3-mask (respirator) med ventil ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filtrerande mask ")]),_:1})]),Gt,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[Qt]),_:1})]),Xt,e("section",Zt,[es,e("div",as,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"K√§lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ts,a(" Tv√•lmolekyler som f√∂rst√∂r viruset ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"K√§lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ss,a(" Micell best√•ende av tv√•lmolekyler och virusfragment ")]),_:1})]),is]),rs,e("section",ns,[os,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ls]),_:1}),cs,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ds]),_:1}),ms,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Fler covid-19-myter och relaterad vetenskaplig forskning kan hittas fr√•n: "),us]),_:1})])])])}const ps=b(gt,[["render",hs]]),vs={},ks={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},fs={class:"e-article",lang:"en",style:{hyphens:"auto"}},gs=e("h1",{class:"mb-0"},"Viruses",-1),bs=e("h5",{class:"font-normal uppercase leading-tight"},"Scientific background information",-1),ws={id:"s1"},_s=e("h2",{id:"s1t"},"1. Viruses versus bacteria",-1),ys=e("p",{class:"font-bold"}," Bacteria and viruses can cause many common infections. But what are the differences between these two kinds of infectious organisms? ",-1),js=e("p",null,[e("span",{class:"e-term font-Heading"},"Bacteria"),a(" are tiny microorganisms that are made up of a single cell. They're very diverse and can have many shapes and structural features. Bacteria can live in almost every conceivable environment, including in or on the human body. Only a handful of bacteria cause infections in humans. These bacteria are referred to as pathogenic bacteria. ")],-1),xs=e("p",null,[e("span",{class:"e-term font-Heading"},"Viruses"),a(" are another type of tiny microorganism, even smaller than bacteria. Like bacteria, they're very diverse and have a variety of shapes and features. Viruses are parasitic. That means they require living cells or tissue in which to grow. Viruses can invade the cells of your body, using the components of your cells to grow and multiply. Some viruses even kill host cells as part of their life cycle. Differences between viruses and bacteria can be seen in figure 1 and found in table 1. ")],-1),qs=e("b",null,"Figure 1.",-1),Vs=i('<table class="mt-20"><caption class="text-left pb-4"><b>Table 1.</b> Differences between bacteria and viruses</caption><thead><tr><th></th><th>Bacteria</th><th>Viruses</th></tr></thead><tbody><tr><th class="align-baseline"> Living </th><td><b>Living organism.</b><br>Bacteria are living organisms with a single cell that can generate energy, make their own food, move and reproduce (typically by binary fission). This allows bacteria to live in many places - soil, water, plants, and the human body - and serve many purposes.<br>Bacteria include both parasites and non-parasites. </td><td><b>Nonliving.</b><br>Viruses only grow and reproduce inside the host cells they infect. When found outside of these living cells, viruses are dormant. Their ‚Äúlife,‚Äù therefore, requires the hijacking of the biochemical activities of a living cell.<br>All viruses are intracellular parasites. </td></tr><tr><th class="align-baseline">Number of cells</th><td>Unicellular, one cell</td><td>No cells, not living</td></tr><tr><th class="align-baseline">Repro¬≠duction</th><td>Split into 2</td><td>Invades a host cell and takes over the cell causing it to make copies of the viral DNA/RNA. Destroys the host cell releasing new viruses</td></tr><tr><th class="align-baseline">Size</th><td>Bacteria are much bigger, ranging from 800 nm to 1000 nm. Bacteria can be seen under a light microscope.</td><td>The size of viruses is between 20 nm to 400 nm. Viruses are visible only under electron microscopes.</td></tr><tr><th class="align-baseline">Benefits</th><td>Some bacteria are beneficial, e.g., certain bacteria are required in the gut.</td><td>Viruses are not beneficial. Viruses can be helpful in genetic engineering.</td></tr><tr><th class="align-baseline">Infection</th><td>Bacterial infection is usually confined to a part of the body, described as a localized infection. Infections may be caused by bacteria or by toxins (endotoxins) produced.</td><td>A viral infection is systemic. Viruses infect a host cell and multiply by thousands, leaving the host cell and infecting other body cells.</td></tr><tr><th class="align-baseline">Disease</th><td>Bacterial diseases include pneumonia, tuberculosis, tetanus, and food poisoning.</td><td>Systemic diseases caused by viral infection include influenza, measles, polio, AIDS, and COVID-19.</td></tr><tr><th class="align-baseline">Treat¬≠ment</th><td>Antibiotics and vaccines prevent the disease.</td><td>Vaccines prevent the spread, and antiviral medications help to slow reproduction but cannot stop it completely.</td></tr></tbody></table>',1),Ss=i(`<section class="e-card"><h4 class="mt-4">References</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),As=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Why do antibiotics not kill viruses?</h2><p> Antibiotics target the growth machinery in bacteria (not viruses) to kill or inhibit those particular bacteria. Antibiotics cannot kill viruses because viruses have different structures and replicate differently than bacteria. Moreover, overuse and inappropriate prescribing of antibiotics worldwide are leading to the global healthcare issue of <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiotic resistance</a>. See Table 2 in which conditions antibiotics may be helpful (NB! the decision on its use will be made by your doctor). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Table 2.</b> Need for antibiotics by common respiratory infections </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respi¬≠ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>anti¬≠biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Source: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Is={id:"s3"},Ms=e("h2",{id:"s3t"},"3. How vaccines work",-1),Ds=e("h3",null,"The body's natural response",-1),Cs=e("p",null,[a(" A "),e("span",{class:"e-term font-Heading"},"pathogen"),a(" is a bacterium, virus, parasite, or fungus that can cause disease within the body. Each pathogen is made up of several subparts, usually unique to that specific pathogen and the disease it causes. The subpart of a pathogen that causes the formation of antibodies is called an antigen. The antibodies produced in response to the pathogen's antigen are essential to the immune system. You can consider antibodies as the soldiers in your body's defense system. Each antibody, or soldier, in our system, is trained to recognize one specific antigen. We have thousands of different antibodies in our bodies. When the human body is exposed to an antigen for the first time, it takes time for the immune system to respond and produce antibodies specific to that antigen (Fig. 2). ")],-1),Os=e("p",null," Antibodies to one pathogen generally do not protect against another pathogen except when two pathogens are very similar to each other, like cousins. Once the antigen-specific antibodies are produced, they work with the rest of the immune system to destroy the pathogen and stop the disease. Once the body produces antibodies in its primary response to an antigen, it also creates antibody-producing memory cells, which remain alive even after the antibodies defeat the pathogen. Suppose the body is exposed to the same pathogen more than once. In that case, the antibody response is much faster and more effective than the first time because the memory cells are ready to pump antibodies against that antigen. This means that if the person is exposed to a dangerous pathogen in the future, their immune system will be able to respond immediately, protecting against disease. ",-1),zs=e("b",null,"Figure 2.",-1),Fs=e("h3",null,"How vaccines help?",-1),Ns=e("p",null," Vaccines reduce the risks of getting a disease by working with your body's natural defenses to build protection. When you get a vaccine, your immune system responds. ",-1),Ps=e("p",null," Vaccines contain weakened or inactive parts of a particular organism (antigen) that triggers an immune response within the body (Fig. 3). Newer vaccines contain the blueprint for producing antigens rather than the antigen itself. Regardless of whether the vaccine is made up of the antigen itself or the blueprint so that the body will produce the antigen, this weakened version will not cause the disease in the person receiving the vaccine. However, it will prompt their immune system to respond much as it would have on its first reaction to the actual pathogen. ",-1),$s=e("b",null,"Figure 3.",-1),Bs=i('<p> Vaccines work by exposing your white blood cells to the foreign protein in a virus. Once your body has encountered a virus and performed an immune response (making B and T cells) to the virus, it saves the B and T cells so that if the same virus or bacteria ever infects the body again, the immune system can stage and all-out war, preventing the pathogen from ever making you feel sick. Vaccines introduce the body to the virus so that the body can save up B and T cells without ever making you sick. </p><h3>Immunization and related challenges</h3><p> We now have vaccines to prevent more than 20 life-threatening diseases, helping people of all ages live longer, healthier lives. Immunization currently prevents 2-3 million deaths yearly from diseases like diphtheria, tetanus, pertussis, influenza, and measles. </p><p> We have vaccinations against many serious viral infections (measles, mumps, hepatitis A, hepatitis B, and some viruses - such as those that cause the common cold). Still, the problem remains that they can mutate from one person to the next. When the virus mutates, it changes enough that the immune system no longer recognizes it. The immune cells stored for killing the virus no longer recognize it as the same disease and do not know how to kill it. This is how an infection with the same virus can keep dodging the immune system. Vaccination for these viruses is difficult because they have already changed their format by the time vaccines are develop. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ts=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. The process of developing vaccines, vaccines safety</h2><h3>Development</h3><p> Vaccine development typically begins in a research laboratory located in a university, medical center, or small biotech company. During vaccine development, scientists develop different reagents to test and measure their effect (or lack thereof). Often years of research are needed to find ideas that work. </p><p> Different scientists or research groups may work toward the same goals during vaccine development. The progress of the work is presented in different meetings and peer-reviewed articles in journals. If any work seems promising, pharmaceutical scientists may approach those working on it to expand their research toward product development. </p><h3>Testing</h3><p> If a promising vaccine candidate has been found, it has to be tested on animals. This is called the pre-clinical phase. First small animals like mice, rats, rabbits, and others are used. If the candidate affects small animals, the effect has to be usually proven on larger animals like monkeys. If the vaccine triggers an immune response, it is tested in three phases in human clinical trials (WHO, 2021). </p><p> In Phase 1, the vaccine is given to a few volunteers to assess its safety, confirm it generates an immune response, and determine the proper dosage. Generally, in this phase, vaccines are tested in a small group of young, healthy adult volunteers. </p><p> In phase 2, the vaccine is given to several hundred volunteers to assess its safety and ability further to generate an immune response. Participants in this phase have the same characteristics (such as age and sex) as those for whom the vaccine is intended. There are usually multiple trials in this phase to evaluate various age groups (elderly, adults, children) and different vaccine formulations. Also, a group that does not get the vaccine is usually included in determining whether the changes in the vaccinated group are attributed to the vaccine or have happened by chance. </p><p> In phase 3, the vaccine is given to thousands of volunteers ‚Äì compared to a similar group of people who did not get the vaccine but received a comparator product. This aims to determine if the vaccine is effective against the disease it is designed to protect against. Also, it aims to study its safety in a much larger group of people. Phase 3 trials are often conducted across multiple countries and sites within a country to ensure the findings of the vaccine performance apply to many different populations. </p><p> During phase 2 and 3 trials, the volunteers and the scientists conducting the study are shielded from knowing which volunteers had received the vaccine being tested or the comparator product. This is called ‚Äúblinding‚Äù and is necessary to ensure that neither the volunteers nor the scientists are influenced in their assessment of effectiveness or safety by knowing who got which product. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Authorization and monitoring</h3><p> When the results of all these clinical trials are available, a series of steps are required. Officials in European Medicines Agency and later in each country closely review the study data and decide whether to authorize the vaccine. All the trials have to be correctly done and well documented. A vaccine must be proven safe and effective across a broad population before it is approved. The bar for vaccine safety and efficacy is exceptionally high. This includes reviews of efficacy and safety for regulatory and public health policy approvals. </p><p> Further monitoring of safety and effectiveness takes place during the use of vaccines. This enables scientists to keep track of vaccine impact and safety even as they are used in many people over a long time frame. These data are used to adjust the policies for vaccine usage. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Es={id:"s5"},Rs=e("h2",{id:"s5t"},"5. Masks against viruses and bacteria",-1),Hs=e("p",null," Masks are often used to protect against viruses and bacteria. They had become widespread in the sense of protection against the SARS-CoV-2 virus. Among different types of masks, surgical face masks are among the most commonly used face coverings in the COVID-19 pandemic. Typically, they are blue colored from one side, which should be kept as an outer layer (Fig. 4). The main aim of surgical masks is to protect patients from potential contact with bacteria and viruses exhaled by the wearer. So, they well prevent the spread of the coronavirus through the air but are less effective means of protecting the wearer from the virus. ",-1),Ws=e("p",null," FFP2 or FFP3 masks (often called respirators) should be used to filter and better inhale air. The numbering system (FFP1, FPP2, FFP3) indicates these devices' filtration efficiency (certified as meeting the EN 149-2001 standard). FFP2 and FPP3 have a filtration efficiency for airborne particles (including those that contain the virus) of 92% and 98%, respectively. Both masks also have small inward leakage: <8% and <2%, respectively. In FFP2, special rubber is often used on the outer layer of the respirator. If in occupational environments, a valve (that makes exhaling easier) has been allowed, in the case of SARS-CoV-2, only non-valve respirators should be used in order to filter also exhaled air. ",-1),Ks=e("p",null," With the COVID-19 pandemic, a new face mask has been introduced: the filtering mask. This type of mask is made of multilayer fabric (one has to be a nanofibre filter that guarantees a bacterial and harmful fine dust filtering capacity of at least 90%). This mask combines high filtration capacity with reusability as it can be machine washed at 60 degrees. ",-1),Ys={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Us=i('<p> The efficiency of the masks has been tested in special laboratories, e.g., in the exposure chamber. In those studies, a carrying the viruses. Subsequently, particle concentrations behind the particle generator fill the exposure chamber with small particles; similar to aerosols, the masks are measured and compared to the concentration in the general atmosphere of the exposure chamber. </p><p> However, the strongest evidence is based on epidemiologic data from real-life situations. For instance, the daily COVID-19 growth rate is slowdown after mask mandates in 15 states and the District of Columbia in the US. Another study examined coronavirus deaths across 198 countries and found that those with cultural norms or government policies favoring mask-wearing had lower death rates. </p><p> Many Facebook and social media users have shared misleading posts regarding the prolonged use of face masks causing oxygen deficiency in the body - hypoxia. Nevertheless, research articles and experts suggest that such symptoms are unlikely to occur in most people unless the wearer has pre-existing respiratory illnesses such as asthma or chronic obstructive pulmonary disease (COPD). The risk of hypoxia and hypercapnia (having excessive carbon dioxide in the bloodstream) are unlikely to occur with cloth and surgical masks as they are not tight-fitting. Still, it is warned that face masks should not be placed on young children under two years old, those with breathing difficulty, or when exercising. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',4),Js=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),Ls=e("hr",{class:"mt-10 mb-40"},null,-1),Gs={id:"s6"},Qs=i('<h2 id="s6t">6. Viruses and hand hygiene</h2><h3>Hand sanitiser or soap?</h3><p> Our hands can be a critical vector in the transmission of infections. When applied to hands thoroughly and scrubbed for at least 20 seconds, alcohol-based hand sanitizers and soap will stop the coronavirus. However, soap disrupts the sticky bond between pathogens and your skin, allowing the pathogens to slide right off. Not only are you neutralizing the virus, but you are also physically knocking it off your hands. Practicing good hand hygiene is a simple preventative strategy that most people can easily undertake, and many studies have demonstrated the effectiveness of hand hygiene in preventing the transmission of infectious pathogens, including coronaviruses such as SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Weakening the corona virus with soap</h3><p> Coronaviruses get their name from the &quot;corona&quot; surrounding the virus‚Äî the protein spikes embedded in its surface. The spikes, which are responsible for infecting the host, are anchored into a membrane. The membrane is the &quot;shell&quot; of the virus and the virus&#39;s weak point. </p><p> Soap molecules have two chemically distinct parts: a hydrophilic (water-loving) &quot;head&quot; and a hydrophobic (water-hating) &quot;tail&quot;. The head helps the soap mix with water, while the tail can interact with other hydrophobic molecules like lipids. </p><p> Luckily, the coronavirus&#39;s membrane is mainly made up of lipid molecules. They are held together by weak chemical interactions between individual molecules. The hydrophobic (water-hating) &quot;tails&quot; of soap molecules can break interactions between lipid molecules in the coronavirus membrane (see Fig. 5). </p><p> The soap&#39;s tail can disrupt the weak interactions between lipid molecules in the membrane, tearing it apart. Suppose the virus is broken up before being safely sheltered in a host cell. In that case, it will no longer be able to do its infectious job ‚Äî like a machine with its parts falling out. Soap molecules then surround virus fragments with all tails facing inside. This cluster is called a micelle (see Fig. 6). The outward-facing hydrophilic heads allow the micelle to be washed down the drain with water. Water alone will not do. </p>',9),Xs={class:"grid gap-2 md:grid-cols-2 e-card"},Zs=e("b",null,"Figure 5.",-1),ei=e("b",null,"Figure 6.",-1),ai=i('<p> The given information is also valid for the other enveloped viruses (Influenza, Hepatitis B and C, and Ebola Virus Disease) as their envelopes consist of phospholipids. </p><section class="e-card"><h4 class="mt-0">Reference</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Choosing hand sanitizer</h3><p> The World Health Organization (WHO) recommends alcohol-based hand sanitizers if you have no soap on hand. </p><p><b>Alcohol-based hand sanitizers are thought to work by preventing the proteins of microbes‚Äîincluding bacteria and some viruses‚Äîfrom functioning normally. Hand sanitizers with a high alcohol content might also interfere with the lipid shell surrounding the coronavirus.</b> To be effective, hand sanitizers must contain at least 60 percent alcohol. The additives in the sanitizer can keep the alcohol from evaporating too fast, allowing the virus to be drenched for longer. </p><p> However, there are also certain risks related to using alcohol-based hand sanitizers. There is an increased alcohol poisoning risk for children, and frequent usage of hand sanitizers could result in antimicrobial resistance. There are alternative alcohol-free hand sanitizers, where benzalkonium is most commonly used. Recent studies have indicated that alcohol-free hand sanitizer works just as well and does not cause the familiar &quot;burn&quot; feeling known from using alcohol hand sanitizer. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ti=e("hr",{class:"mt-10 mb-40"},null,-1),si={id:"s7"},ii=i('<h2 id="s7t">7. Vaccine myths</h2><h3><span class="text-rose-400">Myth 1:</span> Vaccines cause autism/serious side effects.</h3><p> The widespread fear that vaccines increase the risk of autism originated with a 1997 study published by Andrew Wakefield, a British surgeon. The article was published in The Lancet, a prestigious medical journal, suggesting that the measles, mumps, and rubella (MMR) vaccine increased autism in British children. </p><p> The paper has since been thoroughly discredited due to serious procedural errors, having only 12 participants in the study, undisclosed financial conflicts of interest, and ethical violations. Andrew Wakefield lost his medical license, and the paper was retracted from The Lancet. </p><p> Currently, against the autism-vaccination link theory, several studies have now identified symptoms of autism in children well before they receive the MMR vaccine. Moreover, recent research provides evidence that autism develops in utero, well before a baby is born or receives vaccinations. None of the latter studies has reported a link between any vaccine and the likelihood of developing autism. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ri=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Here‚Äôs What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety",target:"_blank",rel:"noopener noreferrer"},"Coronavirus disease (COVID-19): Vaccines safety")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ni=i('<h3><span class="text-rose-400">Myth 2:</span> Infant immune systems cannot handle multiple vaccines</h3><p> Children are given vaccines at a young age because they are at the highest risk of getting sick or dying if they get these diseases. Even newborn babies are immune to some diseases (e.g., chickenpox) because they get antibodies from their mothers; this immunity lasts only a few months. Moreover, most babies do not get protective antibodies against diphtheria, whooping cough, polio, tetanus, hepatitis B, or Hib from their mothers. </p><p> To reduce the number of shots a child receives in a doctor&#39;s visit, some vaccines are offered as a combination (two or more different vaccines have been combined into a single shot). Examples of combination vaccines are diphtheria-tetanus-pertussis (DTap) and measles-mumps-rubella (MMR). </p><p> Scientific data show that getting several vaccines simultaneously does not cause any health problems. Infant immune systems are tougher than you might think. Based on the number of antibodies present in the blood, a baby would theoretically have the ability to respond to a far larger number of vaccines than are ever shot (the question has risen if it is 1,000, 10,000, or 100,000 at one time). Even if all ~10 (depending on national vaccination plan) scheduled vaccines were given at once, it would only use a fraction of a baby&#39;s immune capacity. In reality, babies are exposed to countless bacteria and viruses every day, and immunisations are negligible in comparison. Also, studies have not shown that exposure to multiple vaccines through the first 23 months of life would be associated with an increased risk for infections not targeted by vaccines. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Myth 3:</span> Immunity acquired through a disease is better than immunity acquired through vaccination</h3><p> It is true that natural infection almost always results in a stronger immunity to the disease than a vaccination. However, the dangers of this approach far outweigh the relative benefits. The price for immunity after natural infection might be pneumonia from chickenpox or pneumococcus, intellectual disability from Haemophilus influenzae type b (Hib), birth defects from rubella, liver cancer from hepatitis B virus, death from measles, etc. If you wanted to gain immunity to measles, for example, by contracting the disease, you would face a 1 in 500 chance of death from your symptoms. In contrast, the number of people who have had severe allergic reactions from an MMR vaccine is less than one-in-one million. </p><p> Nevertheless, few vaccines induce a better immune response than natural infection. For instance, the Human papillomavirus (HPV) vaccine contains a high purity of the specific protein, leading to a better immune response than natural infection. Other examples include tetanus, Haemophilus influenzae type b (Hib), and pneumococcal vaccine. </p><p> Regarding COVID-19, it needs to be clarified. It has been shown that permanent protection after infection is unlikely. Even though coronavirus patients gained ‚Äúsubstantial immune memory‚Äù that involved all four significant parts of the immune system: memory B cells, antibodies, memory CD4+ T cells, and memory CD8+ T cells, the protection started to reduce after half a year. Also, scientists have shown a ‚Äúmassive dynamic range‚Äù in the immune response between individuals, with a 200-fold difference in antibody levels. </p><p> Other studies have shown that volunteers who received the Moderna vaccine (mRNA) had more antibodies ‚Äî one marker of immune response ‚Äî in their blood than did people who had been sick with COVID-19. However, this fact can be modified by the severity of the disease as there is a correlation between disease severity and lasting immune response ‚Äì most asymptomatic patients had very few antibodies after six months of infection. Thus, the natural immunity generated from a SARS-CoV-2 infection is often unpredictable. Moreover, the antibodies elicited by the mRNA vaccine targeted a broader range of places on the Receptor Binding Domain (RBD) than those elicited by natural infection. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Myth 4:</span> Vaccines contain life-threatening substances.</h3><p> People are concerned about using formaldehyde, mercury, or aluminium in vaccines. On the one hand, these chemicals are toxic to the human body at certain levels. On the other hand, only tiny amounts of these chemicals can be found in vaccines. Those amounts are smaller than we get from nutrition or formaldehyde is produced at higher rates by our own metabolic systems. </p><p> Certain elements, such as aluminium salts, are added to vaccines because they work as an adjuvant, which means their presence boosts the immune response when you are vaccinated. Also, only certain vaccines contain aluminium salts, and new COVID-19 vaccines do not contain them. A few vaccines have contained thimerosal as a preservative; however, none of the vaccines used in children currently contains this. Thimerosal contains ethylmercury, which is cleared from the human body quickly compared to methylmercury, which bioaccumulates ‚Äì so there is also a difference in which form toxic metal is. Nevertheless, COVID-19 vaccines do not contain toxins (e.g.). </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-thimerosal-color-office.pdf</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),oi=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.publichealth.org/public-awareness/understanding-vaccines/goes-vaccine/",target:"_blank",rel:"noopener noreferrer"},"What Goes Into A Vaccine?")]),e("li",null,[a("üì∫"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"What‚Äôs in Vaccines?")])])],-1),li=i('<h3><span class="text-rose-400">Myth 5:</span> Better hygiene and sanitation are responsible for decreased infections, not vaccines</h3><p> This is partly true that vaccines do not deserve all the credit for reducing or eliminating rates of infectious diseases. It has been shown that better sanitation, nutrition, and the development of antibiotics have also helped a lot. Infections such as typhoid and cholera transmitted by contaminated water, a major cause of illness and death early in the 20th century, have been reduced dramatically by better sanitation. A recent review concluded that handwashing in averting infectious diseases. Another recent evidence comes from the COVID-19 lockdown and improved hygiene with dramatically reduced seasonal flu rates. </p><p> However, when these factors are isolated, and infectious disease rates are analysed, the role of vaccines cannot be denied. One example is measles in the United States. When the first measles vaccine was introduced in 1963, infection rates had been steady at around 400,000 cases a year. And while hygienic habits and sanitation did not change much over the following decade, the rate of measles infections dropped precipitously following the vaccine&#39;s introduction, with only around 25,000 cases by 1970. Another example is Hib disease. According to CDC data, the incidence rate for this malady plummeted from 20,000 in 1990 to around 1,500 in 1993 following the vaccine&#39;s introduction. </p><p> Another piece of evidence comes from recent decades. There have not been changes in hygiene in the developed world, but there has been a decrease in vaccination rates. Now several countries, such as the UK, the USA, Germany, Spain, etc., are seeing increasing numbers of measles, and other vaccine-preventable diseases, identified as an emerging disease &quot;hot spots&quot;. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Myth 6:</span> Vaccines can infect the child with the disease it is trying to prevent</h3><p> Some of the vaccines are live vaccines that contain live attenuated microorganisms/viruses, which are still capable of replicating within the host (vaccinee). The microorganisms are &#39;weakened&#39;, meaning they have lost most of their disease-causing capacity but still possess immunogenic properties. Thus, it is always much less severe than if a child became infected with the disease-causing virus itself. Live-attenuated vaccines are for measles, mumps, rubella (MMR combined vaccine), rotavirus, smallpox, chickenpox, and yellow fever vaccine. In most cases, live vaccines show significantly higher immunogenicity than inactivated vaccines since natural infection is imitated almost perfectly by eliciting a more comprehensive range of immunologic responses. However, these vaccines are not favoured for kids with weakened immune systems, such as those being treated for cancer. </p><p> Live vaccines can indeed cause mild symptoms resembling the disease they protect against. However, the vaccine recipients are experiencing a body&#39;s immune response to the vaccine, not the disease itself. There is only one recorded instance in which a vaccine was shown to cause disease. This was the Oral Polio Vaccine (OPV) which is no longer used and currently replaced with a killed virus form known as the inactivated polio vaccine (IPV). </p><section class="e-card"><h4 class="mt-0">Reference</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Myth 7:</span> We do not need to vaccinate because many countries have low infection rates</h3><p> Herd immunity occurs when a large portion of a community (the herd) becomes immune to a disease, making the spread of disease from person to person unlikely. Thanks to &quot;herd immunity,&quot; many people do not see the need for vaccination. As long as a large majority of people are immunised in any population, the unimmunised minority will also be protected. This is important because there is a portion of the population ‚Äì infants, pregnant women, the elderly, and those with weakened immune systems ‚Äì that cannot sometimes receive vaccines. However, suppose many people do not vaccinate themselves or their children. In that case, the &quot;herd immunity&quot; disappears, opening up opportunities for viruses and bacteria to establish themselves and spread. With so many people resistant, an infectious disease will never get a chance to establish itself and spread. </p><p> Moreover, international travel often carries a disease from abroad, and an unvaccinated individual will be at far greater risk of getting sick or people have got infected while travelling. The increased measles incidence illustrates this in the US in recent years. As long as disease exists, we are at risk of getting infected. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),ci=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function di(h,d){const l=v,c=k,r=f,n=g;return o(),u("div",ks,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",fs,[t(c,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),gs,bs,e("section",ws,[_s,ys,js,xs,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Source: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[qs,a(" Structural differences between viruses and bacteria ")]),_:1}),Vs,t(n,{class:"mb-8"},{default:s(()=>[a(" Antibiotics can help the immune system to kill off bacterial infections but are useless against viral infections. Antiviral drugs work differently than antibiotics and are currently only effective against a few viral diseases, such as influenza, herpes, hepatitis B and C, and HIV. Viral infections can be much harder to kill than bacterial infections because the virus goes into human cells. The immune system can sometimes kill the infected cells before the virus can reproduce. However, as the virus reproduces, it often kills the infected cell by exploding out, which allows the virus to spread to other cells in the body. ")]),_:1}),Ss]),As,e("section",Is,[Ms,Ds,Cs,Os,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[zs,a(" For every new antigen, our body needs to build a specific antibody ")]),_:1}),Fs,Ns,Ps,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Source: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[$s,a(" Antibody development through vaccination ")]),_:1}),Bs]),Ts,e("section",Es,[Rs,Hs,Ws,Ks,e("div",Ys,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Surgical mask ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respirator) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3 mask (respirator) with valve ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filtering mask ")]),_:1})]),Us,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[Js]),_:1})]),Ls,e("section",Gs,[Qs,e("div",Xs,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[Zs,a(" Soap molecules destroying the virus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ei,a(" Micelle consisting of soap molecules and virus fragment ")]),_:1})]),ai]),ti,e("section",si,[ii,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ri]),_:1}),ni,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[oi]),_:1}),li,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" More COVID-19 myths and related scientific research can be found from: "),ci]),_:1})])])])}const mi=b(vs,[["render",di]]),wi={__name:"background",setup(h){const{locale:d}=x();return(l,c)=>{const r=_e,n=wa,m=ft,_=ps,y=mi;return o(),u("div",null,[w(d)==="et"?(o(),p(r,{key:0})):w(d)==="el"?(o(),p(n,{key:1})):w(d)==="pt"?(o(),p(m,{key:2})):w(d)==="sv"?(o(),p(_,{key:3})):(o(),p(y,{key:4}))])}}};export{wi as default};
